{
 "transferrin,iron": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "proteins implicated in organellar transport of iron (particularly the mitochondrion), and novel regulators that have been proposed to control iron assimilation. The transport of both <e1>transferrin</e1>-bound and nontransferrin-bound <e2>iron</e2> to peripheral tissues is discussed. Finally, the regulation of iron transport is also considered at the molecular level, with posttranscriptional, transcriptional, and posttranslational control",
    "direct",
    "12755454"
   ],
   [
    "in organellar transport of iron (particularly the mitochondrion), and novel regulators that have been proposed to control iron assimilation. The transport of both transferrin-bound and non<e1>transferrin</e1>-bound <e2>iron</e2> to peripheral tissues is discussed. Finally, the regulation of iron transport is also considered at the molecular level, with posttranscriptional, transcriptional, and posttranslational control",
    "direct",
    "12755454"
   ]
  ]
 },
 "sPGN,CD14": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "2. Here we investigate the mechanism of cellular activation by soluble peptidoglycan (sPGN) and lipoteichoic acid (LTA), main stimulatory components of Gram-positive bacteria. Like LPS, <e1>sPGN</e1> and LTA bind to the glycosylphosphatidylinositol-anchored membrane protein <e2>CD14</e2> and induce activation of the transcription factor NF-kappaB in host cells like macrophages. We show that whole Gram-positive bacteria, sPGN and LTA induce the",
    "direct",
    "10364168"
   ]
  ]
 },
 "CD14,LTA": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "we investigate the mechanism of cellular activation by soluble peptidoglycan (sPGN) and lipoteichoic acid (LTA), main stimulatory components of Gram-positive bacteria. Like LPS, sPGN and <e2>LTA</e2> bind to the glycosylphosphatidylinositol-anchored membrane protein <e1>CD14</e1> and induce activation of the transcription factor NF-kappaB in host cells like macrophages. We show that whole Gram-positive bacteria, sPGN and LTA induce the",
    "direct",
    "10364168"
   ]
  ]
 },
 "LPS,polymyxin B": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "of NF-kappaB in HEK293 cells expressing TLR2 but not in cells expressing TLR1 or TLR4. The sPGN- and LTA-induced NF-kappaB activation was not inhibited by <e2>polymyxin B</e2>, an antibiotic that binds and neutralizes <e1>LPS</e1>. Coexpression together with membrane CD14 enhances sPGN signal transmission through TLR2. In contrast to LPS signaling, activation of TLR2 by sPGN and LTA does",
    "direct",
    "10364168"
   ]
  ]
 },
 "nemo-like kinase,TcfLef": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "overcomes basal repression in the prospective caudal neurectoderm by Tcf homologs that act as inhibitors of Wnt target genes. The vertebrate homolog of Drosophila nemo, <e1>nemo-like kinase</e1> (Nlk), can phosphorylate <e2>Tcf/Lef</e2> proteins and inhibit the DNA-binding ability of beta-catenin/Tcf complexes, thereby blocking activation of Wnt targets. By contrast, mutations in a C. elegans homolog show",
    "direct",
    "15151990"
   ]
  ]
 },
 "Set2,H3": {
  "relations": [
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "characterization of Set2, a novel HMT that is site-specific for lysine 36 (Lys36) of the H3 tail. Using an antiserum directed against Lys36 methylation in <e2>H3</e2>, we show that <e1>Set2</e1>, via its SET domain, is responsible for methylation at this site in vivo. Tethering of Set2 to a heterologous promoter reveals that Set2 represses",
    "direct",
    "11839797"
   ]
  ]
 },
 "E2F-1,PAC1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "target of E2F-1 in signaling apoptosis. We show that ectopic E2F-1 increases expression of PAC1 at both transcriptional and translational levels in breast cancer cells. <e1>E2F-1</e1> physically interacts with the promoter of <e2>PAC1</e2>, binds to its consensus sequence in the promoter and transactivates the PAC1 promoter. E2F-1 suppresses extracellular signal-regulated kinase (ERK) phosphorylation through PAC1 and",
    "direct",
    "17471234"
   ],
   [
    "target of E2F-1 in signaling apoptosis. We show that ectopic E2F-1 increases expression of PAC1 at both transcriptional and translational levels in breast cancer cells. <e1>E2F-1</e1> physically interacts with the promoter of <e2>PAC1</e2>, binds to its consensus sequence in the promoter and transactivates the PAC1 promoter. E2F-1 suppresses extracellular signal-regulated kinase (ERK) phosphorylation through PAC1 and",
    "direct",
    "17471234"
   ]
  ]
 },
 "protein kinase C,eIF-4E": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "Association of initiation factor <e2>eIF-4E</e2> in a cap binding protein complex (eIF-4F) is critical for and enhances phosphorylation by <e1>protein kinase C</e1>. Phosphorylation by protein kinase C of the mRNA cap binding protein purified as part of a cap binding protein complex (eIF-4F) or as",
    "direct",
    "2355012"
   ],
   [
    "Association of initiation factor eIF-4E in a cap binding protein complex (eIF-4F) is critical for and enhances phosphorylation by protein kinase C. Phosphorylation by <e1>protein kinase C</e1> of the mRNA cap binding protein purified as part of a cap binding protein complex (eIF-4F) or as a single protein (<e2>eIF-4E</e2>), has been examined. Significant phosphorylation (up to 1 mol of phosphate/mol of p25 subunit) occurs only when the protein is part of the eIF-4F",
    "direct",
    "2355012"
   ]
  ]
 },
 "protein kinase C,eIF-4F": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "Association of initiation factor eIF-4E in a cap binding protein complex (eIF-4F) is critical for and enhances phosphorylation by protein kinase C. Phosphorylation by <e1>protein kinase C</e1> of the mRNA cap binding protein purified as part of a cap binding protein complex (<e2>eIF-4F</e2>) or as a single protein (eIF-4E), has been examined. Significant phosphorylation (up to 1 mol of phosphate/mol of p25 subunit) occurs only when the",
    "direct",
    "2355012"
   ]
  ]
 },
 "protein kinase C,eIF-4F p25": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "initial rates indicate that the Km values for eIF-4F and eIF-4E are similar, although the Vmax is 5-6 times higher for the complex. Dephosphorylation of <e2>eIF-4F p25</e2>, previously phosphorylated with <e1>protein kinase C</e1>, occurs in reticulocyte lysate with a half-life of 15-20 min, whereas little dephosphorylation is observed after 15 min with the purified phosphorylated eIF-4E.",
    "direct",
    "2355012"
   ]
  ]
 },
 "Frizzled,Wnt": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "several adult pathologies. A diverse array of intracellular signaling pathways has been suggested to transduce the signals exerted in cells when secreted ligands of the <e2>Wnt</e2> family bind to <e1>Frizzled</e1> receptors. Studies with a chimeric receptor composed of Frizzled-2 and the beta2-adrenergic receptor have suggested that the binding of Wnt-5a to Frizzled-2 results in",
    "direct",
    "18929644"
   ],
   [
    "and the apolipoprotein E receptor 2. The LRP5 is a co-receptor of Wnt located on the osteoblast membrane between two other receptors, Frizzled and Kremen. <e1>Frizzled</e1> and LRP5 bind to <e2>Wnt</e2>, thereby stabilizing beta-catenin and activating bone formation. When the dickkopf protein (Dkk) binds to Kremen and LRP5, this last undergoes internalization and therefore",
    "direct",
    "15850991"
   ]
  ]
 },
 "Wnt-5a,Frizzled-2": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "the Wnt family bind to Frizzled receptors. Studies with a chimeric receptor composed of Frizzled-2 and the beta2-adrenergic receptor have suggested that the binding of <e1>Wnt-5a</e1> to <e2>Frizzled-2</e2> results in the activation of G proteins of the Galpha(i) family, the mobilization of calcium from intracellular stores and the induction of gene transcription through",
    "direct",
    "18929644"
   ]
  ]
 },
 "cyclin D1-Cdk4,p27": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Phosphorylation of p27Kip1 regulates assembly and activation of cyclin D1-Cdk4. <e2>p27</e2> mediates Cdk2 inhibition and is also found in <e1>cyclin D1-Cdk4</e1> complexes. The present data support a role for p27 in the assembly of D-type cyclin-Cdk complexes and indicate that both cyclin D1-Cdk4-p27 assembly and",
    "direct",
    "18710949"
   ]
  ]
 },
 "protein kinase B,p27": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "the assembly of D-type cyclin-Cdk complexes and indicate that both cyclin D1-Cdk4-p27 assembly and kinase activation are regulated by p27 phosphorylation. Prior work showed that <e2>p27</e2> can be phosphorylated by <e1>protein kinase B</e1>/Akt (PKB/Akt) at T157 and T198. Here we show that PKB activation and the appearance of p27pT157 and p27pT198 precede p27-cyclin D1-Cdk4 assembly in",
    "direct",
    "18710949"
   ],
   [
    "the assembly of D-type cyclin-Cdk complexes and indicate that both cyclin D1-Cdk4-p27 assembly and kinase activation are regulated by p27 phosphorylation. Prior work showed that <e2>p27</e2> can be phosphorylated by <e1>protein kinase B</e1>/Akt (PKB/Akt) at T157 and T198. Here we show that PKB activation and the appearance of p27pT157 and p27pT198 precede p27-cyclin D1-Cdk4 assembly in",
    "direct",
    "18710949"
   ]
  ]
 },
 "p27,Cdk4": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "appearance of p27pT157 and p27pT198 precede p27-cyclin D1-Cdk4 assembly in early G(1). PI3K/PKB inhibition rapidly reduced p27pT157 and p27pT198 and dissociated cellular p27-cyclin D1-Cdk4. Mutant <e1>p27</e1> allele products lacking phosphorylation at T157 and T198 bound poorly to cellular cyclin D1 and <e2>Cdk4</e2>. Cellular p27pT157 and p27pT198 coprecipitated with Cdk4 but were not detected in Cdk2 complexes. The addition of p27 to recombinant cyclin D1 and",
    "direct",
    "18710949"
   ]
  ]
 },
 "p27,cyclin D1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "appearance of p27pT157 and p27pT198 precede p27-cyclin D1-Cdk4 assembly in early G(1). PI3K/PKB inhibition rapidly reduced p27pT157 and p27pT198 and dissociated cellular p27-cyclin D1-Cdk4. Mutant <e1>p27</e1> allele products lacking phosphorylation at T157 and T198 bound poorly to cellular <e2>cyclin D1</e2> and Cdk4. Cellular p27pT157 and p27pT198 coprecipitated with Cdk4 but were not detected in Cdk2 complexes. The addition of p27 to recombinant cyclin D1",
    "direct",
    "18710949"
   ]
  ]
 },
 "PKB,p27": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "but were not detected in Cdk2 complexes. The addition of p27 to recombinant cyclin D1 and Cdk4 led to cyclin D1-Cdk4-p27 complex formation in vitro. <e2>p27</e2> phosphorylation by <e1>PKB</e1> increased p27-cyclin D1-Cdk4 assembly in vitro but yielded inactive Cdk4. In contrast, Src pretreatment of p27 did not affect p27-cyclin D1-Cdk4 complex formation.",
    "direct",
    "18710949"
   ]
  ]
 },
 "E2F,NPAT": {
  "relations": [
   "in-complex-with",
   "controls-expression-of"
  ],
  "mentions": [
   [
    "<e2>NPAT</e2> expression is regulated by <e1>E2F</e1> and is essential for cell cycle progression. NPAT is an in vivo substrate of cyclin E-Cdk2 kinase and is thought to play a",
    "direct",
    "12665581"
   ],
   [
    "transcription is up-regulated at the G(1)/S-phase boundary in growth-stimulated cells and that the NPAT promoter responds to activation by E2F proteins. We demonstrate that endogenous <e1>E2F</e1> proteins interact with the promoter of the <e2>NPAT</e2> gene in vivo and that induced expression of E2F1 stimulates NPAT mRNA expression, supporting the idea that the expression of NPAT is regulated",
    "direct",
    "12665581"
   ],
   [
    "the promoter of the NPAT gene in vivo and that induced expression of E2F1 stimulates NPAT mRNA expression, supporting the idea that the expression of <e2>NPAT</e2> is regulated by <e1>E2F</e1>. Consistently, we find that the E2F sites in the NPAT promoter are required for its activation during the G(1)/S-phase transition. Moreover, we show",
    "direct",
    "12665581"
   ]
  ]
 },
 "calcineurin,Crz1p": {
  "relations": [
   "controls-phosphorylation-of",
   "in-complex-with",
   "controls-transport-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "docking site. Calcineurin, a conserved Ca(2+)/calmodulin-regulated protein phosphatase, plays a crucial role in Ca(2+) signaling in a wide variety of cell types. In Saccharomyces cerevisiae, <e1>calcineurin</e1> positively regulates transcription in response to stress by dephosphorylating the transcription factor <e2>Crz1p</e2>/Tcn1p. Dephosphorylation promotes Crz1p nuclear localization in part by increasing the efficiency of its nuclear import. In this work, we show that calcineurin-dependent dephosphorylation of",
    "direct",
    "11877380"
   ],
   [
    "Crz1p. In addition, we define the Crz1p nuclear export signal (NES) and show that it interacts with Msn5p in a phosphorylation-dependent manner. This indicates that <e1>calcineurin</e1> regulates <e2>Crz1p</e2> nuclear export by dephosphorylating and inactivating its NES. Finally, we define a motif in Crz1p, PIISIQ, similar to the PxIxIT docking site for calcineurin",
    "direct",
    "11877380"
   ],
   [
    "motif in Crz1p, PIISIQ, similar to the PxIxIT docking site for calcineurin on the mammalian transcription factor NFAT, that mediates the in vivo interaction between <e1>calcineurin</e1> and <e2>Crz1p</e2> and is required for calcineurin-dependent regulation of Crz1p nuclear export and activity. Therefore, in yeast as in mammals, a docking site is required to",
    "direct",
    "11877380"
   ]
  ]
 },
 "Crz1p,Msn5p": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "dephosphorylation of Crz1p also down-regulates its nuclear export. Using a genetic approach, we identify Msn5p as the exportin for Crz1p. In addition, we define the <e1>Crz1p</e1> nuclear export signal (NES) and show that it interacts with <e2>Msn5p</e2> in a phosphorylation-dependent manner. This indicates that calcineurin regulates Crz1p nuclear export by dephosphorylating and inactivating its NES. Finally, we define a motif in",
    "direct",
    "11877380"
   ]
  ]
 },
 "cAMP-dependent protein kinase,elongation factor-2 kinase": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "Phosphorylation of <e2>elongation factor-2 kinase</e2> on serine 499 by <e1>cAMP-dependent protein kinase</e1> induces Ca2+/calmodulin-independent activity. Elongation factor-2 kinase (eEF-2K) negatively regulates mRNA translation via the phosphorylation and inactivation of elongation factor-2 (eEF-2). We have shown previously",
    "direct",
    "11171059"
   ]
  ]
 },
 "eEF-2K,elongation factor-2": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "Phosphorylation of elongation factor-2 kinase on serine 499 by cAMP-dependent protein kinase induces Ca2+/calmodulin-independent activity. Elongation factor-2 kinase (<e1>eEF-2K</e1>) negatively regulates mRNA translation via the phosphorylation and inactivation of <e2>elongation factor-2</e2> (eEF-2). We have shown previously that purified eEF-2K can be phosphorylated in vitro by cAMP-dependent protein kinase (PKA) and that this induces significant Ca(2+)/calmodulin",
    "direct",
    "11171059"
   ]
  ]
 },
 "cAMP-dependent protein kinase,eEF-2K": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "Ca2+/calmodulin-independent activity. Elongation factor-2 kinase (eEF-2K) negatively regulates mRNA translation via the phosphorylation and inactivation of elongation factor-2 (eEF-2). We have shown previously that purified <e2>eEF-2K</e2> can be phosphorylated in vitro by <e1>cAMP-dependent protein kinase</e1> (PKA) and that this induces significant Ca(2+)/calmodulin (CaM)-independent eEF-2K activity [Redpath and Proud (1993) Biochem. J. 293, 31-34]. Furthermore, elevation of cAMP levels in",
    "direct",
    "11171059"
   ]
  ]
 },
 "PKA,glutathione S-transferase (GST)-eEF-2K": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "between elevated cAMP and the inhibition of protein synthesis [Diggle, Redpath, Heesom and Denton (1998) Biochem. J. 336, 525-529]. Here we describe the expression of <e2>glutathione S-transferase (GST)-eEF-2K</e2> fusion protein and the identification of two serine residues that are phosphorylated by <e1>PKA</e1> in vitro. Endoproteinase Arg-C digestion of GST-eEF-2K produced two phosphopeptides that were separated by HPLC and sequenced. (32)P Radioactivity release from these peptides",
    "direct",
    "11171059"
   ]
  ]
 },
 "Axin,GSK3": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "proteins on mTOR, we have reported an effect on beta-catenin signaling at the level of the degradation complex in vitro. The TSC1/TSC2 complex associates with <e2>GSK3</e2> and <e1>Axin</e1> and promotes beta-catenin degradation to inhibit Wnt-stimulated TCF/LEF-dependent transcription. Here, we show that beta-catenin and its effectors, cyclin D1 and connexin 43, were",
    "direct",
    "15972957"
   ]
  ]
 },
 "Axin,TSC1TSC2": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "role of the TSC1/TSC2 proteins on mTOR, we have reported an effect on beta-catenin signaling at the level of the degradation complex in vitro. The <e2>TSC1/TSC2</e2> complex associates with GSK3 and <e1>Axin</e1> and promotes beta-catenin degradation to inhibit Wnt-stimulated TCF/LEF-dependent transcription. Here, we show that beta-catenin and its effectors, cyclin D1 and connexin 43, were",
    "direct",
    "15972957"
   ]
  ]
 },
 "GSK3,TSC1TSC2": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "role of the TSC1/TSC2 proteins on mTOR, we have reported an effect on beta-catenin signaling at the level of the degradation complex in vitro. The <e2>TSC1/TSC2</e2> complex associates with <e1>GSK3</e1> and Axin and promotes beta-catenin degradation to inhibit Wnt-stimulated TCF/LEF-dependent transcription. Here, we show that beta-catenin and its effectors, cyclin D1 and connexin 43,",
    "direct",
    "15972957"
   ]
  ]
 },
 "TSC1TSC2,beta-catenin degradation complex": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "in TSC-related angiomyolipomas and lymphangioleiomyomatosis. This was supported by the failure of three disease-causing TSC2 missense mutants to inhibit Wnt signaling. Further, the interaction between <e1>TSC1/TSC2</e1> and components of the <e2>beta-catenin degradation complex</e2> was dependent on Wnt stimulation such that binding of tuberin to GSK3 and Axin was reduced in the presence of Wnt whereas the tuberin-Dishevelled",
    "direct",
    "15972957"
   ]
  ]
 },
 "tuberin,GSK3": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "to inhibit Wnt signaling. Further, the interaction between TSC1/TSC2 and components of the beta-catenin degradation complex was dependent on Wnt stimulation such that binding of <e1>tuberin</e1> to <e2>GSK3</e2> and Axin was reduced in the presence of Wnt whereas the tuberin-Dishevelled interaction was increased. GSK3 activity played a role in regulating the",
    "direct",
    "15972957"
   ]
  ]
 },
 "tuberin,Axin": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "to inhibit Wnt signaling. Further, the interaction between TSC1/TSC2 and components of the beta-catenin degradation complex was dependent on Wnt stimulation such that binding of <e1>tuberin</e1> to GSK3 and <e2>Axin</e2> was reduced in the presence of Wnt whereas the tuberin-Dishevelled interaction was increased. GSK3 activity played a role in regulating the assembly/stability of",
    "direct",
    "15972957"
   ]
  ]
 },
 "Dishevelled,tuberin": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "degradation complex was dependent on Wnt stimulation such that binding of tuberin to GSK3 and Axin was reduced in the presence of Wnt whereas the <e2>tuberin</e2>-<e1>Dishevelled</e1> interaction was increased. GSK3 activity played a role in regulating the assembly/stability of the degradation complex. Inhibition of GSK3 by lithium chloride reduced its association",
    "direct",
    "15972957"
   ]
  ]
 },
 "TSC1,GSK3": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "the presence of Wnt whereas the tuberin-Dishevelled interaction was increased. GSK3 activity played a role in regulating the assembly/stability of the degradation complex. Inhibition of <e2>GSK3</e2> by lithium chloride reduced its association with <e1>TSC1</e1> whereas disruption of GSK3-phosphorylation sites in TSC1 reduced interaction between TSC2 and TSC1. Collectively, our data provide further evidence that beta-catenin signaling plays a",
    "direct",
    "15972957"
   ]
  ]
 },
 "GSK3,TSC1": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "played a role in regulating the assembly/stability of the degradation complex. Inhibition of GSK3 by lithium chloride reduced its association with TSC1 whereas disruption of <e1>GSK3</e1>-phosphorylation sites in <e2>TSC1</e2> reduced interaction between TSC2 and TSC1. Collectively, our data provide further evidence that beta-catenin signaling plays a role in TSC pathogenesis in vivo",
    "direct",
    "15972957"
   ]
  ]
 },
 "TSC2,TSC1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "of the degradation complex. Inhibition of GSK3 by lithium chloride reduced its association with TSC1 whereas disruption of GSK3-phosphorylation sites in TSC1 reduced interaction between <e1>TSC2</e1> and <e2>TSC1</e2>. Collectively, our data provide further evidence that beta-catenin signaling plays a role in TSC pathogenesis in vivo and suggest a novel role of",
    "direct",
    "15972957"
   ]
  ]
 },
 "E2F,Arf": {
  "relations": [
   "controls-expression-of"
  ],
  "mentions": [
   [
    "proliferation and the tumor surveillance response. These networks are known to intersect with one another, but the mechanisms are poorly understood. Here, we show that <e1>E2F</e1> directly participates in the transcriptional control of <e2>Arf</e2> in both normal and transformed cells. This occurs in a manner that is significantly different from the regulation of classic E2F-responsive targets. In",
    "direct",
    "15175242"
   ]
  ]
 },
 "E2F3,Arf": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "transformed cells. This occurs in a manner that is significantly different from the regulation of classic E2F-responsive targets. In wild-type mouse embryonic fibroblasts (MEFs), the <e2>Arf</e2> promoter is occupied by <e1>E2F3</e1> and not other E2F family members. In quiescent cells, this role is largely fulfilled by E2F3b, an E2F3 isoform whose function was previously",
    "direct",
    "15175242"
   ]
  ]
 },
 "E2F3b,Arf": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "transformed cells. This occurs in a manner that is significantly different from the regulation of classic E2F-responsive targets. In wild-type mouse embryonic fibroblasts (MEFs), the <e2>Arf</e2> promoter is occupied by E2F3 and not other E2F family members. In quiescent cells, this role is largely fulfilled by <e1>E2F3b</e1>, an E2F3 isoform whose function was previously undetermined. E2f3 loss is sufficient to derepress Arf, triggering activation of p53 and expression of p21(Cip1).",
    "direct",
    "15175242"
   ]
  ]
 },
 "E2Fs,Arf": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "E2F-responsive genes. Our data also demonstrate a direct role for E2F in the oncogenic activation of Arf. Specifically, we observe recruitment of the endogenous activating <e1>E2Fs</e1>, E2F1, and E2F3a, to the <e2>Arf</e2> promoter. Thus, distinct E2F complexes directly contribute to the normal repression and oncogenic activation of Arf. We propose that monitoring of E2F levels",
    "direct",
    "15175242"
   ]
  ]
 },
 "E2F1,Arf": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "genes. Our data also demonstrate a direct role for E2F in the oncogenic activation of Arf. Specifically, we observe recruitment of the endogenous activating E2Fs, <e1>E2F1</e1>, and E2F3a, to the <e2>Arf</e2> promoter. Thus, distinct E2F complexes directly contribute to the normal repression and oncogenic activation of Arf. We propose that monitoring of E2F levels",
    "direct",
    "15175242"
   ]
  ]
 },
 "E2F3a,Arf": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "data also demonstrate a direct role for E2F in the oncogenic activation of Arf. Specifically, we observe recruitment of the endogenous activating E2Fs, E2F1, and <e1>E2F3a</e1>, to the <e2>Arf</e2> promoter. Thus, distinct E2F complexes directly contribute to the normal repression and oncogenic activation of Arf. We propose that monitoring of E2F levels",
    "direct",
    "15175242"
   ]
  ]
 },
 "Aof1,histone": {
  "relations": [
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "activation of several inflammatory genes by NF-kappaB. Here we describe that this event is controlled by a feed-forward circuit catalyzed by the activity of the <e2>histone</e2> demethylase <e1>Aof1</e1> (also known as Lsd2/Kdm1b). We find that Aof1 is required for removal of dimethyl H3K9 at specific promoters, and thereby it controls stimulus-induced recruitment",
    "direct",
    "20832726"
   ]
  ]
 },
 "Aof1,NF-kappaB": {
  "relations": [
   "controls-transport-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "that this event is controlled by a feed-forward circuit catalyzed by the activity of the histone demethylase Aof1 (also known as Lsd2/Kdm1b). We find that <e1>Aof1</e1> is required for removal of dimethyl H3K9 at specific promoters, and thereby it controls stimulus-induced recruitment of <e2>NF-kappaB</e2> and gene expression. However, Aof1 is itself recruited by interaction with the c-Rel subunit of NF-kappaB, which is found at low levels associated with promoters",
    "direct",
    "20832726"
   ]
  ]
 },
 "Aof1,c-Rel": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "find that Aof1 is required for removal of dimethyl H3K9 at specific promoters, and thereby it controls stimulus-induced recruitment of NF-kappaB and gene expression. However, <e1>Aof1</e1> is itself recruited by interaction with the <e2>c-Rel</e2> subunit of NF-kappaB, which is found at low levels associated with promoters in unstimulated cells. Thus, at these tightly regulated genes, NF-kappaB functions both",
    "direct",
    "20832726"
   ]
  ]
 },
 "HO,Ace2": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "genes in vivo. Yeast Ace2 and Swi5 are such activators, with targets we classify as Swi5-only, Ace2-only, or both. We define two unique regulatory modes. <e2>Ace2</e2> and Swi5 both bind in vitro to Swi5-only genes such as <e1>HO</e1>, but only Swi5 binds and activates in vivo. In contrast, Ace2 and Swi5 both bind in vivo to Ace2-only genes, such as CTS1,",
    "direct",
    "17898805"
   ]
  ]
 },
 "HO,Swi5": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "vivo. Yeast Ace2 and Swi5 are such activators, with targets we classify as Swi5-only, Ace2-only, or both. We define two unique regulatory modes. Ace2 and <e2>Swi5</e2> both bind in vitro to Swi5-only genes such as <e1>HO</e1>, but only Swi5 binds and activates in vivo. In contrast, Ace2 and Swi5 both bind in vivo to Ace2-only genes, such as CTS1,",
    "direct",
    "17898805"
   ],
   [
    "we classify as Swi5-only, Ace2-only, or both. We define two unique regulatory modes. Ace2 and Swi5 both bind in vitro to Swi5-only genes such as <e1>HO</e1>, but only <e2>Swi5</e2> binds and activates in vivo. In contrast, Ace2 and Swi5 both bind in vivo to Ace2-only genes, such as CTS1, but promoter-bound Swi5 fails",
    "direct",
    "17898805"
   ]
  ]
 },
 "Ace2,CTS1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "regulatory modes. Ace2 and Swi5 both bind in vitro to Swi5-only genes such as HO, but only Swi5 binds and activates in vivo. In contrast, <e1>Ace2</e1> and Swi5 both bind in vivo to Ace2-only genes, such as <e2>CTS1</e2>, but promoter-bound Swi5 fails to activate. We show that activation by Swi5 is prevented by the binding of the Forkhead factors Fkh1 and",
    "direct",
    "17898805"
   ]
  ]
 },
 "Swi5,CTS1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Ace2 and Swi5 both bind in vitro to Swi5-only genes such as HO, but only Swi5 binds and activates in vivo. In contrast, Ace2 and <e1>Swi5</e1> both bind in vivo to Ace2-only genes, such as <e2>CTS1</e2>, but promoter-bound Swi5 fails to activate. We show that activation by Swi5 is prevented by the binding of the Forkhead factors Fkh1 and",
    "direct",
    "17898805"
   ],
   [
    "such as HO, but only Swi5 binds and activates in vivo. In contrast, Ace2 and Swi5 both bind in vivo to Ace2-only genes, such as <e2>CTS1</e2>, but promoter-bound <e1>Swi5</e1> fails to activate. We show that activation by Swi5 is prevented by the binding of the Forkhead factors Fkh1 and Fkh2, which recruit the",
    "direct",
    "17898805"
   ]
  ]
 },
 "Fkh1,Fkh2": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "genes, such as CTS1, but promoter-bound Swi5 fails to activate. We show that activation by Swi5 is prevented by the binding of the Forkhead factors <e1>Fkh1</e1> and <e2>Fkh2</e2>, which recruit the Rpd3(Large) histone deacetylase complex to the CTS1 promoter. Global analysis shows that all Ace2-only genes are bound by both Ace2",
    "direct",
    "17898805"
   ]
  ]
 },
 "Rpd3,CTS1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Swi5 fails to activate. We show that activation by Swi5 is prevented by the binding of the Forkhead factors Fkh1 and Fkh2, which recruit the <e1>Rpd3</e1>(Large) histone deacetylase complex to the <e2>CTS1</e2> promoter. Global analysis shows that all Ace2-only genes are bound by both Ace2 and Swi5, and also by Fkh1/2. Genes normally activated by",
    "direct",
    "17898805"
   ]
  ]
 },
 "Fkh1,2": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Rpd3(Large) histone deacetylase complex to the CTS1 promoter. Global analysis shows that all Ace2-only genes are bound by both Ace2 and Swi5, and also by <e1>Fkh1</e1>/<e2>2</e2>. Genes normally activated by either Ace2 or Swi5 can be converted to Ace2-only genes by the insertion of Fkh-binding sites. Thus Fkh proteins, which function",
    "direct",
    "17898805"
   ]
  ]
 },
 "PI 3-kinase,MyD88": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "activation on cytokine and chemokine expression and the intracellular mechanisms of inflammatory activation were examined in mouse macrophages. LPS stimulation induced a complex formation between <e1>PI 3-kinase</e1> and myeloid differentiation factor 88 (<e2>MyD88</e2>), which was followed by an induction of IL-1beta, tumor necrosis factor-alpha (TNF-alpha) and macrophage inflammatory protein (MIP)-2. The induction of IL-1beta, but not of",
    "direct",
    "12616480"
   ]
  ]
 },
 "p85,Cdc42Hs": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Activation of phosphoinositide 3-kinase activity by <e2>Cdc42Hs</e2> binding to <e1>p85</e1>. The Ras-like GTPase Cdc42 is essential for cell polarity and bud site assembly in Saccharomyces cerevisiae by regulating cell cycle-dependent reorganization of cortical",
    "direct",
    "8034624"
   ],
   [
    "with a GTP gamma S-bound, effector domain GST-Cdc42HsT35A mutant. Both the Rho-GAP homology domain of p85 and the Cdc42Hs-GAP competitively inhibited the binding of recombinant <e1>p85</e1> to <e2>Cdc42Hs</e2>. In addition, PI 3-kinase activity immunoprecipitated from cell lysates with anti-p85 antibody was stimulated 2-4-fold by GST-Cdc42-GTP gamma S. Similar interactions were observed between",
    "direct",
    "8034624"
   ]
  ]
 },
 "guanine,glutathione S-transferase (GST)-Cdc42Hs": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "its role in mammalian cells is unknown. To identify potential effectors of Cdc42Hs, we incubated lysates from NIH 3T3 fibroblasts or PC12 cells with immobilized <e2>glutathione S-transferase (GST)-Cdc42Hs</e2> fusion proteins bound to different <e1>guanine</e1> nucleotides and observed a specific association between the 85-kDa subunit (p85) of phosphatidylinositol 3-kinase (PI 3-kinase) and GTP gamma S (guanosine 5'-3-O-(thio)triphosphate)-bound GST-Cdc42Hs. Recombinant",
    "direct",
    "8034624"
   ]
  ]
 },
 "phosphatidylinositol 3-kinase,p85": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "fibroblasts or PC12 cells with immobilized glutathione S-transferase (GST)-Cdc42Hs fusion proteins bound to different guanine nucleotides and observed a specific association between the 85-kDa subunit (<e2>p85</e2>) of <e1>phosphatidylinositol 3-kinase</e1> (PI 3-kinase) and GTP gamma S (guanosine 5'-3-O-(thio)triphosphate)-bound GST-Cdc42Hs. Recombinant p85 formed a complex with GTP gamma S-bound GST-Cdc42Hs and with a GTPase-defective GTP-bound",
    "direct",
    "8034624"
   ]
  ]
 },
 "phosphatidylinositol 3-kinase,GST-Cdc42Hs": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "PC12 cells with immobilized glutathione S-transferase (GST)-Cdc42Hs fusion proteins bound to different guanine nucleotides and observed a specific association between the 85-kDa subunit (p85) of <e1>phosphatidylinositol 3-kinase</e1> (PI 3-kinase) and GTP gamma S (guanosine 5'-3-O-(thio)triphosphate)-bound <e2>GST-Cdc42Hs</e2>. Recombinant p85 formed a complex with GTP gamma S-bound GST-Cdc42Hs and with a GTPase-defective GTP-bound GST-Cdc42Hs-Q61L mutant, but not with a GTP gamma S-bound, effector",
    "direct",
    "8034624"
   ]
  ]
 },
 "p85,GST-Cdc42Hs": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "fibroblasts or PC12 cells with immobilized glutathione S-transferase (GST)-Cdc42Hs fusion proteins bound to different guanine nucleotides and observed a specific association between the 85-kDa subunit (<e1>p85</e1>) of phosphatidylinositol 3-kinase (PI 3-kinase) and GTP gamma S (guanosine 5'-3-O-(thio)triphosphate)-bound <e2>GST-Cdc42Hs</e2>. Recombinant p85 formed a complex with GTP gamma S-bound GST-Cdc42Hs and with a GTPase-defective GTP-bound GST-Cdc42Hs-Q61L mutant, but not with a GTP gamma S-bound, effector",
    "direct",
    "8034624"
   ]
  ]
 },
 "GTP gamma S,GST-Cdc42Hs": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "S-transferase (GST)-Cdc42Hs fusion proteins bound to different guanine nucleotides and observed a specific association between the 85-kDa subunit (p85) of phosphatidylinositol 3-kinase (PI 3-kinase) and <e1>GTP gamma S</e1> (guanosine 5'-3-O-(thio)triphosphate)-bound <e2>GST-Cdc42Hs</e2>. Recombinant p85 formed a complex with GTP gamma S-bound GST-Cdc42Hs and with a GTPase-defective GTP-bound GST-Cdc42Hs-Q61L mutant, but not with a GTP gamma S-bound, effector",
    "direct",
    "8034624"
   ]
  ]
 },
 "GST-Cdc42Hs,p85": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "guanine nucleotides and observed a specific association between the 85-kDa subunit (p85) of phosphatidylinositol 3-kinase (PI 3-kinase) and GTP gamma S (guanosine 5'-3-O-(thio)triphosphate)-bound GST-Cdc42Hs. Recombinant <e2>p85</e2> formed a complex with GTP gamma S-bound <e1>GST-Cdc42Hs</e1> and with a GTPase-defective GTP-bound GST-Cdc42Hs-Q61L mutant, but not with a GTP gamma S-bound, effector domain GST-Cdc42HsT35A mutant. Both the Rho-GAP homology domain of p85",
    "direct",
    "8034624"
   ]
  ]
 },
 "GST-Cdc42Hs,GTP gamma S": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "specific association between the 85-kDa subunit (p85) of phosphatidylinositol 3-kinase (PI 3-kinase) and GTP gamma S (guanosine 5'-3-O-(thio)triphosphate)-bound GST-Cdc42Hs. Recombinant p85 formed a complex with <e2>GTP gamma S</e2>-bound <e1>GST-Cdc42Hs</e1> and with a GTPase-defective GTP-bound GST-Cdc42Hs-Q61L mutant, but not with a GTP gamma S-bound, effector domain GST-Cdc42HsT35A mutant. Both the Rho-GAP homology domain of p85",
    "direct",
    "8034624"
   ]
  ]
 },
 "GST-Rac1-GTP gamma S,p85": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Cdc42Hs. In addition, PI 3-kinase activity immunoprecipitated from cell lysates with anti-p85 antibody was stimulated 2-4-fold by GST-Cdc42-GTP gamma S. Similar interactions were observed between <e2>p85</e2> and <e1>GST-Rac1-GTP gamma S</e1> but not between p85 and GST-RhoA-GTP gamma S. These findings suggest that PI 3-kinase, through the Rho-GAP homology domain of p85, can couple",
    "direct",
    "8034624"
   ]
  ]
 },
 "p85,GST-RhoA-GTP gamma S": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "cell lysates with anti-p85 antibody was stimulated 2-4-fold by GST-Cdc42-GTP gamma S. Similar interactions were observed between p85 and GST-Rac1-GTP gamma S but not between <e1>p85</e1> and <e2>GST-RhoA-GTP gamma S</e2>. These findings suggest that PI 3-kinase, through the Rho-GAP homology domain of p85, can couple to the effector domain of Cdc42Hs and that",
    "direct",
    "8034624"
   ]
  ]
 },
 "GTP,Cdc42Hs": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "3-kinase, through the Rho-GAP homology domain of p85, can couple to the effector domain of Cdc42Hs and that p85 may be a target for the <e1>GTP</e1>-bound forms of <e2>Cdc42Hs</e2> and Rac1.",
    "direct",
    "8034624"
   ]
  ]
 },
 "GTP,Rac1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "3-kinase, through the Rho-GAP homology domain of p85, can couple to the effector domain of Cdc42Hs and that p85 may be a target for the <e1>GTP</e1>-bound forms of Cdc42Hs and <e2>Rac1</e2>.",
    "direct",
    "8034624"
   ]
  ]
 },
 "NF-kappaB,IkappaBs": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "nonstimulated cells and consequently must be translocated into the nucleus to function. The subcellular location of NF-kappaB is controlled by a family of inhibitory proteins, <e2>IkappaBs</e2>, which bind <e1>NF-kappaB</e1> and mask its nuclear localization signal, thereby preventing nuclear uptake. Exposure of cells to a variety of extracellular stimuli leads to the rapid phosphorylation, ubiquitination,",
    "direct",
    "10837071"
   ]
  ]
 },
 "IKKalpha,IkappaB": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "interleukin-1. The multisubunit IkappaB kinase (IKK) responsible for inducible IkappaB phosphorylation is the point of convergence for most NF-kappaB-activating stimuli. IKK contains two catalytic subunits, <e1>IKKalpha</e1> and IKKbeta, both of which are able to correctly phosphorylate <e2>IkappaB</e2>. Gene knockout studies have shed light on the very different physiological functions of IKKalpha and IKKbeta. After phosphorylation, the IKK phosphoacceptor sites on IkappaB",
    "direct",
    "10837071"
   ]
  ]
 },
 "IKKbeta,IkappaB": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "multisubunit IkappaB kinase (IKK) responsible for inducible IkappaB phosphorylation is the point of convergence for most NF-kappaB-activating stimuli. IKK contains two catalytic subunits, IKKalpha and <e1>IKKbeta</e1>, both of which are able to correctly phosphorylate <e2>IkappaB</e2>. Gene knockout studies have shed light on the very different physiological functions of IKKalpha and IKKbeta. After phosphorylation, the IKK phosphoacceptor sites on IkappaB",
    "direct",
    "10837071"
   ]
  ]
 },
 "IKK,IkappaB": {
  "relations": [
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "IKK phosphoacceptor sites on IkappaB serve as an essential part of a specific recognition site for E3RS(IkappaB/beta-TrCP), an SCF-type E3 ubiquitin ligase, thereby explaining how <e1>IKK</e1> controls <e2>IkappaB</e2> ubiquitination and degradation. A variety of other signaling events, including phosphorylation of NF-kappaB, hyperphosphorylation of IKK, induction of IkappaB synthesis, and the processing of",
    "direct",
    "10837071"
   ]
  ]
 },
 "arachidonic acid,phospholipids": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Crystal structure of a calcium-phospholipid binding domain from cytosolic phospholipase A2. Cytosolic phospholipase A2 (cPLA2) is a calcium-sensitive 85-kDa enzyme that hydrolyzes <e1>arachidonic acid</e1>-containing membrane <e2>phospholipids</e2> to initiate the biosynthesis of eicosanoids and platelet-activating factor, potent inflammatory mediators. The calcium-dependent activation of the enzyme is mediated by an N-terminal C2 domain,",
    "direct",
    "9430701"
   ]
  ]
 },
 "MAPKK,MAPK": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "possesses a nuclear export signal (NES), acts as a cytoplasmic anchor of MAPK. Here we show evidence that tyrosine (Tyr190 in Xenopus MPK1/ERK2) phosphorylation of <e2>MAPK</e2> by <e1>MAPKK</e1> is necessary and sufficient for the dissociation of the MAPKK-MAPK complex, and that the dissociation of the complex is required for the nuclear",
    "direct",
    "10508167"
   ]
  ]
 },
 "ataxia telangiectasia mutated,NBS1": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "Distinct functions of Nijmegen breakage syndrome in ataxia telangiectasia mutated-dependent responses to DNA damage. Phosphorylation of <e2>NBS1</e2>, the product of the gene mutated in Nijmegen breakage syndrome (NBS), by <e1>ataxia telangiectasia mutated</e1> (ATM), the product of the gene mutated in ataxia telangiectasia, is required for activation of the S phase checkpoint in response to ionizing radiation",
    "direct",
    "12861053"
   ]
  ]
 },
 "porin,Toll-like receptor (TLR) 2": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "type 1 response of dendritic cell. Porin of Shigella dysenteriae was incorporated in liposome (PIL) and presented to mouse splenic dendritic cells (DC). PIL up-regulated <e2>Toll-like receptor (TLR) 2</e2> and TLR6 on DC, showing that co-expression of the two TLRs is involved in recognition of <e1>porin</e1>. Detection of myeloid differentiating factor 88 (MyD88)-TLR2 complex confirmed interaction between the two for triggering the downstream signaling, which ultimately led to TLR2-dependent",
    "direct",
    "18931363"
   ]
  ]
 },
 "TLR6,porin": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "cell. Porin of Shigella dysenteriae was incorporated in liposome (PIL) and presented to mouse splenic dendritic cells (DC). PIL up-regulated Toll-like receptor (TLR) 2 and <e1>TLR6</e1> on DC, showing that co-expression of the two TLRs is involved in recognition of <e2>porin</e2>. Detection of myeloid differentiating factor 88 (MyD88)-TLR2 complex confirmed interaction between the two for triggering the downstream signaling, which ultimately led to TLR2-dependent",
    "direct",
    "18931363"
   ]
  ]
 },
 "rapamycin,4E-BP1": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "translation. Eukaryotic initiation factor 4E-binding protein 1 (4E-BP1) undergoes phosphorylation at multiple sites. Here we show that amino acids regulate the N-terminal phosphorylation sites in <e2>4E-BP1</e2> through the RAIP motif in a <e1>rapamycin</e1>-insensitive manner. Several criteria indicate this reflects a rapamycin-insensitive output from mTOR. In contrast, the insulin-stimulated phosphorylation of the C-terminal site Ser64/65 is generally sensitive to",
    "direct",
    "15767663"
   ],
   [
    "translation. Eukaryotic initiation factor 4E-binding protein 1 (4E-BP1) undergoes phosphorylation at multiple sites. Here we show that amino acids regulate the N-terminal phosphorylation sites in <e2>4E-BP1</e2> through the RAIP motif in a rapamycin-insensitive manner. Several criteria indicate this reflects a rapamycin-insensitive output from mTOR. In contrast, the insulin-stimulated phosphorylation of the C-terminal site Ser64/65 is generally sensitive to <e1>rapamycin</e1>, as is phosphorylation of another well-characterized target for mTOR signaling, S6K1. Our data imply that it is unlikely that mTOR directly phosphorylates Thr69/70 in 4E-BP1.",
    "direct",
    "15767663"
   ],
   [
    "translation. Eukaryotic initiation factor 4E-binding protein 1 (4E-BP1) undergoes phosphorylation at multiple sites. Here we show that amino acids regulate the N-terminal phosphorylation sites in <e2>4E-BP1</e2> through the RAIP motif in a rapamycin-insensitive manner. Several criteria indicate this reflects a rapamycin-insensitive output from mTOR. In contrast, the insulin-stimulated phosphorylation of the C-terminal site Ser64/65 is generally sensitive to <e1>rapamycin</e1>, as is phosphorylation of another well-characterized target for mTOR signaling, S6K1. Our data imply that it is unlikely that mTOR directly phosphorylates Thr69/70 in 4E-BP1.",
    "direct",
    "15767663"
   ],
   [
    "hyperphosphorylation, elicited by stimulation of cells with hormones, cytokines, or growth factors, results in an abrogation of eIF4E-binding activity. We reported previously that phosphorylation of <e2>4E-BP1</e2> on Thr 37 and Thr 46 is relatively insensitive to serum deprivation and <e1>rapamycin</e1> treatment, and that phosphorylation of these residues is required for the subsequent phosphorylation of a set of unidentified serum-responsive sites. Here, using mass spectrometry, we",
    "direct",
    "11691836"
   ],
   [
    "hyperphosphorylation, elicited by stimulation of cells with hormones, cytokines, or growth factors, results in an abrogation of eIF4E-binding activity. We reported previously that phosphorylation of <e2>4E-BP1</e2> on Thr 37 and Thr 46 is relatively insensitive to serum deprivation and <e1>rapamycin</e1> treatment, and that phosphorylation of these residues is required for the subsequent phosphorylation of a set of unidentified serum-responsive sites. Here, using mass spectrometry, we",
    "direct",
    "11691836"
   ]
  ]
 },
 "rapamycin,S6K1": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "manner. Several criteria indicate this reflects a rapamycin-insensitive output from mTOR. In contrast, the insulin-stimulated phosphorylation of the C-terminal site Ser64/65 is generally sensitive to <e1>rapamycin</e1>, as is phosphorylation of another well-characterized target for mTOR signaling, <e2>S6K1</e2>. Our data imply that it is unlikely that mTOR directly phosphorylates Thr69/70 in 4E-BP1. Although 4E-BP1 and S6K1 bind the mTOR partner, raptor, our",
    "direct",
    "15767663"
   ],
   [
    "and this is insensitive to rapamycin, most likely placing MAP4K3 upstream of mTOR. Indeed, MAP4K3 is required for phosphorylation of known mTOR targets such as <e2>S6K1</e2> (S6 kinase 1), and overexpression of MAP4K3 promotes the <e1>rapamycin</e1>-sensitive phosphorylation of these same targets. Finally, knockdown of MAP4K3 levels causes a decrease in cell size. The results suggest that MAP4K3 is a new component",
    "direct",
    "17346240"
   ]
  ]
 },
 "mTOR,4E-BP1": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "Ser64/65 is generally sensitive to rapamycin, as is phosphorylation of another well-characterized target for mTOR signaling, S6K1. Our data imply that it is unlikely that <e1>mTOR</e1> directly phosphorylates Thr69/70 in <e2>4E-BP1</e2>. Although 4E-BP1 and S6K1 bind the mTOR partner, raptor, our data indicate that the outputs from mTOR to 4E-BP1 and S6K1 are distinct. In",
    "direct",
    "15767663"
   ],
   [
    "Ser64/65 is generally sensitive to rapamycin, as is phosphorylation of another well-characterized target for mTOR signaling, S6K1. Our data imply that it is unlikely that <e1>mTOR</e1> directly phosphorylates Thr69/70 in <e2>4E-BP1</e2>. Although 4E-BP1 and S6K1 bind the mTOR partner, raptor, our data indicate that the outputs from mTOR to 4E-BP1 and S6K1 are distinct. In",
    "direct",
    "15767663"
   ],
   [
    "mTOR to 4E-BP1 and S6K1 are distinct. In cells, efficient phosphorylation of 4E-BP1 requires it to be able to bind to eIF4E, whereas phosphorylation of <e2>4E-BP1</e2> by <e1>mTOR</e1> in vitro shows no such preference. These data have important implications for understanding signaling downstream of mTOR and the development of new strategies",
    "direct",
    "15767663"
   ]
  ]
 },
 "raptor,4E-BP1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "is phosphorylation of another well-characterized target for mTOR signaling, S6K1. Our data imply that it is unlikely that mTOR directly phosphorylates Thr69/70 in 4E-BP1. Although <e2>4E-BP1</e2> and S6K1 bind the mTOR partner, <e1>raptor</e1>, our data indicate that the outputs from mTOR to 4E-BP1 and S6K1 are distinct. In cells, efficient phosphorylation of 4E-BP1 requires it to be",
    "direct",
    "15767663"
   ]
  ]
 },
 "raptor,S6K1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "of another well-characterized target for mTOR signaling, S6K1. Our data imply that it is unlikely that mTOR directly phosphorylates Thr69/70 in 4E-BP1. Although 4E-BP1 and <e2>S6K1</e2> bind the mTOR partner, <e1>raptor</e1>, our data indicate that the outputs from mTOR to 4E-BP1 and S6K1 are distinct. In cells, efficient phosphorylation of 4E-BP1 requires it to be",
    "direct",
    "15767663"
   ]
  ]
 },
 "eIF4E,4E-BP1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "S6K1 bind the mTOR partner, raptor, our data indicate that the outputs from mTOR to 4E-BP1 and S6K1 are distinct. In cells, efficient phosphorylation of <e2>4E-BP1</e2> requires it to be able to bind to <e1>eIF4E</e1>, whereas phosphorylation of 4E-BP1 by mTOR in vitro shows no such preference. These data have important implications for understanding signaling downstream of mTOR",
    "direct",
    "15767663"
   ],
   [
    "the mRNA cap structure and forms eIF4F complexes that recruit 40S subunits to the mRNA. Formation of eIF4F is blocked by eIF4E-binding proteins such as <e2>4E-BP1</e2>, which interacts with <e1>eIF4E</e1> via a motif in the center of its 118-residue sequence. 4E-BP1 plays key roles in cell proliferation, growth, and survival. Binding of 4E-BP1 to",
    "direct",
    "12588975"
   ],
   [
    "interacts with eIF4E via a motif in the center of its 118-residue sequence. 4E-BP1 plays key roles in cell proliferation, growth, and survival. Binding of <e2>4E-BP1</e2> to <e1>eIF4E</e1> is regulated by hierarchical multisite phosphorylation. Here we demonstrate that three different features in the C terminus of 4E-BP1 play distinct roles in",
    "direct",
    "12588975"
   ]
  ]
 },
 "NFkappaB,IkappaBalpha": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Consequences of fuzziness in the <e1>NFkappaB</e1>/<e2>IkappaBalpha</e2> interaction. This chapter provides a short review of various biophysical experiments that have been applied to the inhibitor of kappa B, IkappaBalpha and its binding",
    "direct",
    "22399319"
   ]
  ]
 },
 "IkappaBalpha,nuclear factor kappa B": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "fuzziness in the NFkappaB/IkappaBalpha interaction. This chapter provides a short review of various biophysical experiments that have been applied to the inhibitor of kappa B, <e1>IkappaBalpha</e1> and its binding partner, <e2>nuclear factor kappa B</e2>, or NFkappaB. The picture that emerges from amide hydrogen/deuterium exchange, NMR and binding kinetics experiments is one in which parts of both proteins",
    "direct",
    "22399319"
   ]
  ]
 },
 "FKBP12-rapamycin-associated protein,CLIP-170": {
  "relations": [
   "controls-phosphorylation-of",
   "in-complex-with",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "The <e1>FKBP12-rapamycin-associated protein</e1> (FRAP) is a <e2>CLIP-170</e2> kinase. CLIP-170/Restin belongs to a family of conserved microtubule (MT)-associated proteins, which are important for MT organization and functions. CLIP-170 is a phosphoprotein and",
    "direct",
    "12231510"
   ],
   [
    "phosphorylation is thought to regulate the binding of CLIP-170 to MTs. However, little is known about the kinase(s) involved. In this study, we show that <e1>FKBP12-rapamycin-associated protein</e1> (FRAP, also called mTOR/RAFT) interacts with <e2>CLIP-170</e2>. CLIP-170 is phosphorylated in vivo at multiple sites, including rapamycin-sensitive and -insensitive sites, and is phosphorylated by FRAP in vitro at the rapamycin-sensitive sites.",
    "direct",
    "12231510"
   ]
  ]
 },
 "FRAP,CLIP-170": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "to MTs. However, little is known about the kinase(s) involved. In this study, we show that FKBP12-rapamycin-associated protein (FRAP, also called mTOR/RAFT) interacts with CLIP-170. <e2>CLIP-170</e2> is phosphorylated in vivo at multiple sites, including rapamycin-sensitive and -insensitive sites, and is phosphorylated by <e1>FRAP</e1> in vitro at the rapamycin-sensitive sites. In addition, rapamycin inhibited the ability of CLIP-170 to bind to MTs. Our observations suggest that multiple",
    "direct",
    "12231510"
   ],
   [
    "the ability of CLIP-170 to bind to MTs. Our observations suggest that multiple CLIP-170 kinases are involved in positive and negative control of CLIP-170, and <e1>FRAP</e1> is a <e2>CLIP-170</e2> kinase positively regulating the MT-binding behavior of CLIP-170.",
    "direct",
    "12231510"
   ]
  ]
 },
 "TLR2,HSP70": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "in human monocytes. Here for the first time, we report that HSP70-induced proinflammatory cytokine production is mediated via the MyD88/IRAK/NF-kappaB signal transduction pathway and that <e2>HSP70</e2> utilizes both <e1>TLR2</e1> (receptor for Gram-positive bacteria) and TLR4 (receptor for Gram-negative bacteria) to transduce its proinflammatory signal in a CD14-dependent fashion. These studies now pave the",
    "direct",
    "11836257"
   ]
  ]
 },
 "TLR4,HSP70": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "in human monocytes. Here for the first time, we report that HSP70-induced proinflammatory cytokine production is mediated via the MyD88/IRAK/NF-kappaB signal transduction pathway and that <e2>HSP70</e2> utilizes both TLR2 (receptor for Gram-positive bacteria) and <e1>TLR4</e1> (receptor for Gram-negative bacteria) to transduce its proinflammatory signal in a CD14-dependent fashion. These studies now pave the way for the development of",
    "direct",
    "11836257"
   ]
  ]
 },
 "Cdc25C,Cdc2": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "by nuclear export and 14-3-3 protein binding. Entry into mitosis requires activation of the Cdc2 protein kinase by the Cdc25C protein phosphatase. The interactions between <e2>Cdc2</e2> and <e1>Cdc25C</e1> are negatively regulated throughout interphase and in response to G2 checkpoint activation. This is accomplished in part by maintaining the Cdc25 phosphatase in a",
    "direct",
    "11313932"
   ]
  ]
 },
 "14-3-3,Cdc25": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "interactions between Cdc2 and Cdc25C are negatively regulated throughout interphase and in response to G2 checkpoint activation. This is accomplished in part by maintaining the <e2>Cdc25</e2> phosphatase in a phosphorylated form that binds <e1>14-3-3</e1> proteins. Here we report that 14-3-3 binding regulates the intracellular trafficking of Cdc25C. Although primarily cytoplasmic, Cdc25C accumulated in the nuclei of leptomycin B",
    "direct",
    "11313932"
   ]
  ]
 },
 "YW3548,MCD4": {
  "relations": [
   "controls-expression-of"
  ],
  "mentions": [
   [
    "only slightly affected the surface expression of GPI-anchored proteins. Biosynthesis of GPI in the Pig-n knockout cells was not affected by YW3548/BE49385A, and yeast overexpressing <e2>MCD4</e2> was highly resistant to <e1>YW3548</e1>/BE49385A, suggesting that Pig-n and Mcd4p are targets of this drug.",
    "direct",
    "10574991"
   ]
  ]
 },
 "IKK,I kappa B alpha": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "Following exposure to diverse pro-inflammatory signals (e.g. TNF alpha, IL1, LPS) various signal transduction cascades are initiated converging on the I kappa B kinase (IKK). <e1>IKK</e1> phosphorylates <e2>I kappa B alpha</e2> on serines 32 and 36 signaling the inhibitory protein for ubiquitin-mediated degradation. The SCF beta-TRCP complex is the ubiquitin ligase responsible for mediating",
    "direct",
    "10918611"
   ],
   [
    "Following exposure to diverse pro-inflammatory signals (e.g. TNF alpha, IL1, LPS) various signal transduction cascades are initiated converging on the I kappa B kinase (IKK). <e1>IKK</e1> phosphorylates <e2>I kappa B alpha</e2> on serines 32 and 36 signaling the inhibitory protein for ubiquitin-mediated degradation. The SCF beta-TRCP complex is the ubiquitin ligase responsible for mediating",
    "direct",
    "10918611"
   ]
  ]
 },
 "Ubc3,I kappa B alpha": {
  "relations": [
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "components. Our results suggest that the cullin specificity of the SCF complex may reflect its ability to associate with Rbx1. We demonstrate specific ubiquitination of <e2>I kappa B alpha</e2> by <e1>Ubc3</e1> and Ubc4 in a phosphorylation and SCF beta-TRCP dependent manner and that both are capable of associating with the SCF beta-TRCP complex isolated",
    "direct",
    "10918611"
   ]
  ]
 },
 "Ubc4,I kappa B alpha": {
  "relations": [
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "components. Our results suggest that the cullin specificity of the SCF complex may reflect its ability to associate with Rbx1. We demonstrate specific ubiquitination of <e2>I kappa B alpha</e2> by Ubc3 and <e1>Ubc4</e1> in a phosphorylation and SCF beta-TRCP dependent manner and that both are capable of associating with the SCF beta-TRCP complex isolated from human",
    "direct",
    "10918611"
   ]
  ]
 },
 "NF-kappaB,Sp1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Sp1/Sp3 and the p65 subunit of NF-kappaB trans-inhibiting effect on COL1A1 expression. Despite no existing kappaB consensus sequence in the COL1A1 promoter, we found that <e2>Sp1</e2>/Sp3/c-Krox and <e1>NF-kappaB</e1> bind and/or are recruited on the proximal promoter in chromatin immunoprecipitation (ChIP) assays. Attempts to elucidate whether interactions between Sp1/Sp3/c-Krox and p65 are necessary to",
    "direct",
    "22139845"
   ]
  ]
 },
 "Sp3,NF-kappaB": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Sp1/Sp3 and the p65 subunit of NF-kappaB trans-inhibiting effect on COL1A1 expression. Despite no existing kappaB consensus sequence in the COL1A1 promoter, we found that Sp1/<e1>Sp3</e1>/c-Krox and <e2>NF-kappaB</e2> bind and/or are recruited on the proximal promoter in chromatin immunoprecipitation (ChIP) assays. Attempts to elucidate whether interactions between Sp1/Sp3/c-Krox and p65 are necessary to",
    "direct",
    "22139845"
   ]
  ]
 },
 "NF-kappaB,c-Krox": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Sp1/Sp3 and the p65 subunit of NF-kappaB trans-inhibiting effect on COL1A1 expression. Despite no existing kappaB consensus sequence in the COL1A1 promoter, we found that Sp1/Sp3/<e2>c-Krox</e2> and <e1>NF-kappaB</e1> bind and/or are recruited on the proximal promoter in chromatin immunoprecipitation (ChIP) assays. Attempts to elucidate whether interactions between Sp1/Sp3/c-Krox and p65 are necessary to",
    "direct",
    "22139845"
   ]
  ]
 },
 "p65,Sp1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "we found that Sp1/Sp3/c-Krox and NF-kappaB bind and/or are recruited on the proximal promoter in chromatin immunoprecipitation (ChIP) assays. Attempts to elucidate whether interactions between <e2>Sp1</e2>/Sp3/c-Krox and <e1>p65</e1> are necessary to mediate the NF-kappaB inhibitory effect on COL1A1 in ANF and SF were carried out; in this regard, immunoprecipitation assays revealed",
    "direct",
    "22139845"
   ],
   [
    "we found that Sp1/Sp3/c-Krox and NF-kappaB bind and/or are recruited on the proximal promoter in chromatin immunoprecipitation (ChIP) assays. Attempts to elucidate whether interactions between <e2>Sp1</e2>/Sp3/c-Krox and <e1>p65</e1> are necessary to mediate the NF-kappaB inhibitory effect on COL1A1 in ANF and SF were carried out; in this regard, immunoprecipitation assays revealed",
    "direct",
    "22139845"
   ]
  ]
 },
 "p65,Sp3": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "we found that Sp1/Sp3/c-Krox and NF-kappaB bind and/or are recruited on the proximal promoter in chromatin immunoprecipitation (ChIP) assays. Attempts to elucidate whether interactions between Sp1/<e2>Sp3</e2>/c-Krox and <e1>p65</e1> are necessary to mediate the NF-kappaB inhibitory effect on COL1A1 in ANF and SF were carried out; in this regard, immunoprecipitation assays revealed",
    "direct",
    "22139845"
   ],
   [
    "we found that Sp1/Sp3/c-Krox and NF-kappaB bind and/or are recruited on the proximal promoter in chromatin immunoprecipitation (ChIP) assays. Attempts to elucidate whether interactions between Sp1/<e2>Sp3</e2>/c-Krox and <e1>p65</e1> are necessary to mediate the NF-kappaB inhibitory effect on COL1A1 in ANF and SF were carried out; in this regard, immunoprecipitation assays revealed",
    "direct",
    "22139845"
   ]
  ]
 },
 "p65,c-Krox": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "we found that Sp1/Sp3/c-Krox and NF-kappaB bind and/or are recruited on the proximal promoter in chromatin immunoprecipitation (ChIP) assays. Attempts to elucidate whether interactions between Sp1/Sp3/<e2>c-Krox</e2> and <e1>p65</e1> are necessary to mediate the NF-kappaB inhibitory effect on COL1A1 in ANF and SF were carried out; in this regard, immunoprecipitation assays revealed",
    "direct",
    "22139845"
   ],
   [
    "we found that Sp1/Sp3/c-Krox and NF-kappaB bind and/or are recruited on the proximal promoter in chromatin immunoprecipitation (ChIP) assays. Attempts to elucidate whether interactions between Sp1/Sp3/<e2>c-Krox</e2> and <e1>p65</e1> are necessary to mediate the NF-kappaB inhibitory effect on COL1A1 in ANF and SF were carried out; in this regard, immunoprecipitation assays revealed",
    "direct",
    "22139845"
   ]
  ]
 },
 "NF-kappaB,COL1A1": {
  "relations": [
   "controls-expression-of"
  ],
  "mentions": [
   [
    "provoked the same effect in SF, suggesting that particular interactions are characteristic of the scleroderma phenotype. In conclusion, our findings highlight a new mechanism for <e2>COL1A1</e2> transcriptional regulation by <e1>NF-kappaB</e1>, and these data could allow the development of new antifibrotic strategies.",
    "direct",
    "22139845"
   ]
  ]
 },
 "hamartin,tuberin": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "sclerosis complex (TSC) is characterized by the formation of hamartomas in multiple organs resulting from mutations in the TSC1 or TSC2 gene. Their protein products, <e1>hamartin</e1> and <e2>tuberin</e2>, respectively, form a functional complex that affects cell growth, differentiation, and proliferation. Several lines of evidence, including renal tumors derived from TSC2+/- animals, suggest",
    "direct",
    "12511557"
   ]
  ]
 },
 "hamartin,beta-catenin degradation complex": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Indeed, hamartin and tuberin co-immunoprecipitated with glycogen synthase kinase 3 beta and Axin, components of this complex in a Wnt-1-dependent manner. Our data suggest that <e1>hamartin</e1> and tuberin negatively regulate beta-catenin stability and activity by participating in the <e2>beta-catenin degradation complex</e2>.",
    "direct",
    "12511557"
   ]
  ]
 },
 "beta-catenin degradation complex,tuberin": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "and tuberin co-immunoprecipitated with glycogen synthase kinase 3 beta and Axin, components of this complex in a Wnt-1-dependent manner. Our data suggest that hamartin and <e2>tuberin</e2> negatively regulate beta-catenin stability and activity by participating in the <e1>beta-catenin degradation complex</e1>.",
    "direct",
    "12511557"
   ]
  ]
 },
 "CUL-1,SKP1SKP2": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Human <e1>CUL-1</e1> associates with the <e2>SKP1/SKP2</e2> complex and regulates p21(CIP1/WAF1) and cyclin D proteins. Deregulation of cell proliferation is a hallmark of cancer. In many transformed cells, the cyclin A/CDK2",
    "direct",
    "9736735"
   ]
  ]
 },
 "APC,ubiquitin": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "and irreversibly, ensuring that all chromosome pairs disjoin almost simultaneously. The regulatory mechanisms that generate this switch-like behaviour are unclear. Anaphase is initiated when a <e2>ubiquitin</e2> ligase, the anaphase-promoting complex (<e1>APC</e1>), triggers the destruction of securin, thereby allowing separase, a protease, to disrupt sister-chromatid cohesion. Here we demonstrate that the cyclin-dependent kinase 1 (Cdk1)-dependent phosphorylation",
    "direct",
    "18552837"
   ]
  ]
 },
 "APC,securin": {
  "relations": [
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "allowing separase, a protease, to disrupt sister-chromatid cohesion. Here we demonstrate that the cyclin-dependent kinase 1 (Cdk1)-dependent phosphorylation of securin near its destruction-box motif inhibits <e2>securin</e2> ubiquitination by the <e1>APC</e1>. The phosphatase Cdc14 reverses securin phosphorylation, thereby increasing the rate of securin ubiquitination. Because separase is known to activate Cdc14 (refs 5 and",
    "direct",
    "18552837"
   ]
  ]
 },
 "Ubc2,ubiquitin": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "ubiquitination site is shown to confer defects in mitotic cell growth and meiosis. uH2B was not detected in rad6 mutants, which are defective for the <e2>ubiquitin</e2>-conjugating enzyme <e1>Ubc2</e1>, thus identifying Rad6 as the major cellular activity that ubiquitinates H2B in yeast.",
    "direct",
    "10642555"
   ]
  ]
 },
 "Rad6,H2B": {
  "relations": [
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "confer defects in mitotic cell growth and meiosis. uH2B was not detected in rad6 mutants, which are defective for the ubiquitin-conjugating enzyme Ubc2, thus identifying <e1>Rad6</e1> as the major cellular activity that ubiquitinates <e2>H2B</e2> in yeast.",
    "direct",
    "10642555"
   ]
  ]
 },
 "PDTC,MMPs": {
  "relations": [
   "controls-expression-of"
  ],
  "mentions": [
   [
    "metalloproteinase (MMP)-1 and MMP-13 in rheumatoid arthritis and osteoarthritis. The objective of this study was to determine the effects of the NF-kappaB inhibitor pyrrolidine dithiocarbamate (<e1>PDTC</e1>) on the expression of <e2>MMPs</e2> in IL-1beta-stimulated fibroblast-like synoviocytes (FLSs) of rheumatoid arthritis patients. FLSs were treated with IL-1beta (10 ng/ml) for 24 h in the presence or",
    "direct",
    "19379726"
   ]
  ]
 },
 "PDTC,MMP": {
  "relations": [
   "controls-expression-of"
  ],
  "mentions": [
   [
    "TNF-alpha-stimulated rheumatoid arthritis FLSs. In contrast, other NF-kappaB inhibitors, such as fenofibrate, N-acetylcysteine and MG132, decreased MMP expression in IL-1beta-stimulated FLSs. The stimulatory effect of <e1>PDTC</e1> on <e2>MMP</e2> expression was not mimicked by specific inhibitors of the mitogen-activated protein kinase (MAPK) signaling pathway. Treatments with 100 muM PDTC did not inhibit",
    "direct",
    "19379726"
   ]
  ]
 },
 "DHFR,E2F": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "demonstrate the presence of E2F1 in the protein-DNA complexes generated on the MP segment. However, the complex formation on MP was not competed by a <e1>DHFR</e1> promoter fragment, known to bind to <e2>E2F</e2>, nor by a consensus E2F binding oligonucleotide. Gel shift assays with point mutant MP fragments indicate that a non-canonical E2F site in the",
    "direct",
    "12015319"
   ]
  ]
 },
 "A20,A20-binding inhibitors of NF-kappa B activation": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "finger protein A20 is involved in the negative feedback regulation of NF-kappa B activation in response to tumor necrosis factor (TNF). We previously demonstrated that <e1>A20</e1> can interact with <e2>A20-binding inhibitors of NF-kappa B activation</e2> (ABINs), which have the potential to inhibit TNF-induced activation of NF-kappa B upon overexpression. The ABIN proteins were therefore proposed to mediate the",
    "direct",
    "12586352"
   ]
  ]
 },
 "ABIN-1,A20": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "mutants interfered in a dominant negative manner with the NF-kappa B inhibiting function of ABIN-1, whereas the A20-mediated inhibition was unaffected. These results suggest that <e2>A20</e2> and <e1>ABIN-1</e1> probably act independently of their mutual interaction.",
    "direct",
    "12586352"
   ]
  ]
 },
 "P38gamma,ATP": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "of apo unphosphorylated ERK2, a related MAP kinase, and apo phosphorylated ERK2 have also been determined. RESULTS: We have determined the structure of doubly phosphorylated <e1>P38gamma</e1> in complex with an <e2>ATP</e2> analog by X-ray crystallography. This is the first report of a structure of an activated kinase in the P38 subfamily, and the first",
    "direct",
    "10508788"
   ]
  ]
 },
 "P38,ATP": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "related MAP kinase, and apo phosphorylated ERK2 have also been determined. RESULTS: We have determined the structure of doubly phosphorylated P38gamma in complex with an <e2>ATP</e2> analog by X-ray crystallography. This is the first report of a structure of an activated kinase in the <e1>P38</e1> subfamily, and the first bound to a nucleotide. P38gamma residue phosphoryl-Thr183 forms hydrogen bonds with five basic amino acids, and these interactions induce",
    "direct",
    "10508788"
   ]
  ]
 },
 "sTLR2,CD14": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "increased cellular response to bacterial lipopeptide. Notably, serum sTLR2 was lower in tuberculosis patients. Coimmunoprecipitation experiments and computational molecular docking studies showed an interaction between <e1>sTLR2</e1> and soluble <e2>CD14</e2> in plasma and milk. These findings suggest the existence of a novel and specific innate immune mechanism regulating microbial-induced TLR triggering, and may lead",
    "direct",
    "14662871"
   ]
  ]
 },
 "p21-activated kinase 1,Raf-1": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "Phosphorylation of <e2>Raf-1</e2> by <e1>p21-activated kinase 1</e1> and Src regulates Raf-1 autoinhibition. Exposure of cells to mitogens or growth factors stimulates Raf-1 activity through a complex mechanism that involves binding",
    "direct",
    "12551923"
   ]
  ]
 },
 "Src,Raf-1": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "Phosphorylation of <e2>Raf-1</e2> by p21-activated kinase 1 and <e1>Src</e1> regulates Raf-1 autoinhibition. Exposure of cells to mitogens or growth factors stimulates Raf-1 activity through a complex mechanism that involves binding to",
    "direct",
    "12551923"
   ],
   [
    "of the Raf-1 autoinhibitory domain blocks extracellular signal-regulated kinase 2 activation by the Raf-1 catalytic domain in mammalian cells. We also show that phosphorylation of <e2>Raf-1</e2> on serine 338 by PAK1 and tyrosines 340 and 341 by <e1>Src</e1> relieves autoinhibition and that this occurs through a specific decrease in the binding of the Raf-1 regulatory domain to its catalytic domain. In",
    "direct",
    "12551923"
   ],
   [
    "of the Raf-1 autoinhibitory domain blocks extracellular signal-regulated kinase 2 activation by the Raf-1 catalytic domain in mammalian cells. We also show that phosphorylation of <e2>Raf-1</e2> on serine 338 by PAK1 and tyrosines 340 and 341 by <e1>Src</e1> relieves autoinhibition and that this occurs through a specific decrease in the binding of the Raf-1 regulatory domain to its catalytic domain. In",
    "direct",
    "12551923"
   ]
  ]
 },
 "PAK1,Raf-1": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "of the Raf-1 autoinhibitory domain blocks extracellular signal-regulated kinase 2 activation by the Raf-1 catalytic domain in mammalian cells. We also show that phosphorylation of <e2>Raf-1</e2> on serine 338 by <e1>PAK1</e1> and tyrosines 340 and 341 by Src relieves autoinhibition and that this occurs through a specific decrease in the binding of the Raf-1",
    "direct",
    "12551923"
   ]
  ]
 },
 "Raf-1,Raf-1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "phosphorylation sites in the catalytic domain that are required for Raf-1 activation, is unlikely to regulate autoinhibition. These results demonstrate that the autoinhibitory domain of <e1>Raf-1</e1> is functional in mammalian cells and that its interaction with the <e2>Raf-1</e2> catalytic domain is regulated by phosphorylation of serine 338 and tyrosines 340 and 341.",
    "direct",
    "12551923"
   ]
  ]
 },
 "NF-kappaB,insulin receptor substrate-2": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Interaction between nuclear <e2>insulin receptor substrate-2</e2> and <e1>NF-kappaB</e1> in IGF-1 induces response in breast cancer cells. Despite significant homology between IRS-1 and IRS-2, recent studies have revealed distinct functions for these adaptor",
    "direct",
    "21042750"
   ]
  ]
 },
 "NF-kappaB,IRS-2": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "induced response in MCF-7 and BT-20 breast cancer cells. In addition, IGF-1 promote nuclear translocation of IRS-2 and NF-kappaB in MCF-7 and BT-20 cells. Nuclear <e2>IRS-2</e2> interaction with <e1>NF-kappaB</e1>-p65 and PI3K binding tyrosine residues of IRS-2 are crucial for the NF-kappaB activities. Moreover, nuclear IRS-2 is recruited to the cyclin D1 promoter both in",
    "direct",
    "21042750"
   ]
  ]
 },
 "NF-kappaB,p65": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "MCF-7 and BT-20 breast cancer cells. In addition, IGF-1 promote nuclear translocation of IRS-2 and NF-kappaB in MCF-7 and BT-20 cells. Nuclear IRS-2 interaction with <e1>NF-kappaB</e1>-<e2>p65</e2> and PI3K binding tyrosine residues of IRS-2 are crucial for the NF-kappaB activities. Moreover, nuclear IRS-2 is recruited to the cyclin D1 promoter both in",
    "direct",
    "21042750"
   ],
   [
    "of constitutively active beta-catenin mimicked the TGF-beta1 effect and completely suppressed RANTES expression induced by TNF-alpha. Interestingly, TGF-beta1 induced a physical interaction between beta-catenin and <e2>p65</e2> <e1>NF-kappaB</e1>, which prevented p65 binding to the kappaB site, sequestered its trans-activating activity, and repressed p65-mediated gene transcription. We conclude that TGF-beta1 inhibition of proinflammatory RANTES",
    "direct",
    "21189258"
   ],
   [
    "binding site. Interestingly, inhibition of Erg expression in quiescent EC results in increased NF-kappaB-dependent ICAM-1 expression, indicating that Erg represses basal NF-kappaB activity. Erg prevents <e1>NF-kappaB</e1> <e2>p65</e2> from binding to the ICAM-1 promoter, suggesting a direct mechanism of interference. Gene set enrichment analysis of transcriptome profiles of Erg and NF-kappaB-dependent genes,",
    "direct",
    "22337883"
   ],
   [
    "revealed rhIL-1beta-stimulated association between IL-33 and p65, whereas binding to the p50 subunit was constitutive. The biological consequence of IL-33/NF-kappaB complex formation was reduction in <e1>NF-kappaB</e1> <e2>p65</e2> binding to its cognate DNA and impairment of p65-triggered transactivation. Overexpression of IL-33 resulted in a reduction and delay in the rhIL-1beta-stimulated expression of",
    "direct",
    "21734074"
   ]
  ]
 },
 "IRS-2,p65": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "induced response in MCF-7 and BT-20 breast cancer cells. In addition, IGF-1 promote nuclear translocation of IRS-2 and NF-kappaB in MCF-7 and BT-20 cells. Nuclear <e1>IRS-2</e1> interaction with NF-kappaB-<e2>p65</e2> and PI3K binding tyrosine residues of IRS-2 are crucial for the NF-kappaB activities. Moreover, nuclear IRS-2 is recruited to the cyclin D1 promoter both in",
    "direct",
    "21042750"
   ]
  ]
 },
 "tyrosine,PI3K": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "BT-20 breast cancer cells. In addition, IGF-1 promote nuclear translocation of IRS-2 and NF-kappaB in MCF-7 and BT-20 cells. Nuclear IRS-2 interaction with NF-kappaB-p65 and <e2>PI3K</e2> binding <e1>tyrosine</e1> residues of IRS-2 are crucial for the NF-kappaB activities. Moreover, nuclear IRS-2 is recruited to the cyclin D1 promoter both in MCF-7 and BT-20",
    "direct",
    "21042750"
   ]
  ]
 },
 "cyclin D1,IRS-2": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "in MCF-7 and BT-20 cells. Nuclear IRS-2 interaction with NF-kappaB-p65 and PI3K binding tyrosine residues of IRS-2 are crucial for the NF-kappaB activities. Moreover, nuclear <e2>IRS-2</e2> is recruited to the <e1>cyclin D1</e1> promoter both in MCF-7 and BT-20 cells. The selective inhibition of NF-kappaB-65 abolished the occupancy of IRS-2 to the cyclin D1 promoters. Our studies",
    "direct",
    "21042750"
   ],
   [
    "Moreover, nuclear IRS-2 is recruited to the cyclin D1 promoter both in MCF-7 and BT-20 cells. The selective inhibition of NF-kappaB-65 abolished the occupancy of <e2>IRS-2</e2> to the <e1>cyclin D1</e1> promoters. Our studies suggest that IRS-2 plays a significant role by activating, at least in part, NF-kappaB via PI3K/Akt pathway in IGF-1-induced responses in",
    "direct",
    "21042750"
   ]
  ]
 },
 "IRS-2,NF-kappaB": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "a significant role by activating, at least in part, NF-kappaB via PI3K/Akt pathway in IGF-1-induced responses in breast cancer cells and the crosstalk between nuclear <e1>IRS-2</e1> and <e2>NF-kappaB</e2> might be responsible for transcriptional progression of the breast cancer cells.",
    "direct",
    "21042750"
   ]
  ]
 },
 "MyD88,TLR": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "(TLR)-induced activation of NF-kappaB. It is composed of a C-terminal Toll/IL-1R homology (TIR) domain and an N-terminal death domain (DD), which mediate the interaction of <e1>MyD88</e1> with the IL-1R/<e2>TLR</e2> and the IL-1R-associated kinase (IRAK), respectively. The interaction of MyD88 with IRAK triggers IRAK phosphorylation, which is essential for its activation and downstream signaling ability.",
    "direct",
    "11909531"
   ]
  ]
 },
 "MyD88,IL-1R": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "(TLR)-induced activation of NF-kappaB. It is composed of a C-terminal Toll/IL-1R homology (TIR) domain and an N-terminal death domain (DD), which mediate the interaction of <e1>MyD88</e1> with the <e2>IL-1R</e2>/TLR and the IL-1R-associated kinase (IRAK), respectively. The interaction of MyD88 with IRAK triggers IRAK phosphorylation, which is essential for its activation and downstream signaling",
    "direct",
    "11909531"
   ]
  ]
 },
 "TLR,IL-1R": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "NF-kappaB. It is composed of a C-terminal Toll/IL-1R homology (TIR) domain and an N-terminal death domain (DD), which mediate the interaction of MyD88 with the <e2>IL-1R</e2>/<e1>TLR</e1> and the IL-1R-associated kinase (IRAK), respectively. The interaction of MyD88 with IRAK triggers IRAK phosphorylation, which is essential for its activation and downstream signaling ability.",
    "direct",
    "11909531"
   ]
  ]
 },
 "MyD88,IRAK": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "(TLR)-induced activation of NF-kappaB. It is composed of a C-terminal Toll/IL-1R homology (TIR) domain and an N-terminal death domain (DD), which mediate the interaction of <e1>MyD88</e1> with the IL-1R/TLR and the IL-1R-associated kinase (<e2>IRAK</e2>), respectively. The interaction of MyD88 with IRAK triggers IRAK phosphorylation, which is essential for its activation and downstream signaling ability. Both domains of MyD88",
    "direct",
    "11909531"
   ],
   [
    "domain and an N-terminal death domain (DD), which mediate the interaction of MyD88 with the IL-1R/TLR and the IL-1R-associated kinase (IRAK), respectively. The interaction of <e1>MyD88</e1> with <e2>IRAK</e2> triggers IRAK phosphorylation, which is essential for its activation and downstream signaling ability. Both domains of MyD88 are separated by a small intermediate domain",
    "direct",
    "11909531"
   ]
  ]
 },
 "MyD88(S),IL-1R": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "which encodes for a protein lacking the ID. MyD88(S) is mainly expressed in the spleen and can be induced in monocytes upon LPS treatment. Although <e1>MyD88(S)</e1> still binds the <e2>IL-1R</e2> and IRAK, it is defective in its ability to induce IRAK phosphorylation and NF-kappaB activation. In contrast, MyD88(S) behaves as a dominant-negative inhibitor of",
    "direct",
    "11909531"
   ]
  ]
 },
 "MyD88(S),IRAK": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "which encodes for a protein lacking the ID. MyD88(S) is mainly expressed in the spleen and can be induced in monocytes upon LPS treatment. Although <e1>MyD88(S)</e1> still binds the IL-1R and <e2>IRAK</e2>, it is defective in its ability to induce IRAK phosphorylation and NF-kappaB activation. In contrast, MyD88(S) behaves as a dominant-negative inhibitor of IL-1-",
    "direct",
    "11909531"
   ]
  ]
 },
 "TRIF,TRAM": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "that TRIF functions downstream of both the TLR3 (dsRNA) and TLR4 (LPS) signaling pathways, whereas the function of TRAM is restricted to the TLR4 pathway. <e2>TRAM</e2> interacts with <e1>TRIF</e1>, MyD88 adaptor-like protein (Mal)/TIRAP, and TLR4 but not with TLR3. These studies suggest that TRIF and TRAM both function in LPS-TLR4 signaling to regulate",
    "direct",
    "14517278"
   ]
  ]
 },
 "TRAM,Mal": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "that TRIF functions downstream of both the TLR3 (dsRNA) and TLR4 (LPS) signaling pathways, whereas the function of TRAM is restricted to the TLR4 pathway. <e1>TRAM</e1> interacts with TRIF, MyD88 adaptor-like protein (<e2>Mal</e2>)/TIRAP, and TLR4 but not with TLR3. These studies suggest that TRIF and TRAM both function in LPS-TLR4 signaling to regulate the MyD88-independent pathway during",
    "direct",
    "14517278"
   ]
  ]
 },
 "TLR4,TRAM": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "that TRIF functions downstream of both the TLR3 (dsRNA) and TLR4 (LPS) signaling pathways, whereas the function of TRAM is restricted to the TLR4 pathway. <e2>TRAM</e2> interacts with TRIF, MyD88 adaptor-like protein (Mal)/TIRAP, and <e1>TLR4</e1> but not with TLR3. These studies suggest that TRIF and TRAM both function in LPS-TLR4 signaling to regulate the MyD88-independent pathway during the",
    "direct",
    "14517278"
   ]
  ]
 },
 "TRAM,TLR3": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "that TRIF functions downstream of both the TLR3 (dsRNA) and TLR4 (LPS) signaling pathways, whereas the function of TRAM is restricted to the TLR4 pathway. <e1>TRAM</e1> interacts with TRIF, MyD88 adaptor-like protein (Mal)/TIRAP, and TLR4 but not with <e2>TLR3</e2>. These studies suggest that TRIF and TRAM both function in LPS-TLR4 signaling to regulate the MyD88-independent pathway during the innate immune response to LPS.",
    "direct",
    "14517278"
   ]
  ]
 },
 "Protor,Rictor": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Identification of <e1>Protor</e1> as a novel <e2>Rictor</e2>-binding component of mTOR complex-2. The mTOR (mammalian target of rapamycin) protein kinase is an important regulator of cell growth. Two complexes of mTOR have",
    "direct",
    "17461779"
   ]
  ]
 },
 "mTORC1,p70 ribosomal S6K": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "been identified: complex 1, consisting of mTOR-Raptor (regulatory associated protein of mTOR)-mLST8 (termed mTORC1), and complex 2, comprising mTOR-Rictor (rapamycininsensitive companion of mTOR)-mLST8-Sin1 (termed mTORC2). <e1>mTORC1</e1> phosphorylates the <e2>p70 ribosomal S6K</e2> (S6 kinase) at its hydrophobic motif (Thr389), whereas mTORC2 phosphorylates PKB (protein kinase B) at its hydrophobic motif (Ser473). In the present study, we",
    "direct",
    "17461779"
   ]
  ]
 },
 "mTORC2,PKB": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "and complex 2, comprising mTOR-Rictor (rapamycininsensitive companion of mTOR)-mLST8-Sin1 (termed mTORC2). mTORC1 phosphorylates the p70 ribosomal S6K (S6 kinase) at its hydrophobic motif (Thr389), whereas <e1>mTORC2</e1> phosphorylates <e2>PKB</e2> (protein kinase B) at its hydrophobic motif (Ser473). In the present study, we report that widely expressed isoforms of unstudied proteins termed Protor-1 (protein",
    "direct",
    "17461779"
   ]
  ]
 },
 "Protor-1,Rictor": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "mTORC2 phosphorylates PKB (protein kinase B) at its hydrophobic motif (Ser473). In the present study, we report that widely expressed isoforms of unstudied proteins termed <e1>Protor-1</e1> (protein observed with Rictor-1) and Protor-2 interact with <e2>Rictor</e2> and are components of mTORC2. We demonstrate that immunoprecipitation of Protor-1 or Protor-2 results in the co-immunoprecipitation of other mTORC2 subunits, but not Raptor,",
    "direct",
    "17461779"
   ],
   [
    "not Raptor, a specific component of mTORC1. We show that detergents such as Triton X-100 or n-octylglucoside dissociate mTOR and mLST8 from a complex of <e1>Protor-1</e1>, Sin1 and <e2>Rictor</e2>. We also provide evidence that Rictor regulates the expression of Protor-1, and that Protor-1 is not required for the assembly of other mTORC2 subunits",
    "direct",
    "17461779"
   ],
   [
    "not Raptor, a specific component of mTORC1. We show that detergents such as Triton X-100 or n-octylglucoside dissociate mTOR and mLST8 from a complex of <e1>Protor-1</e1>, Sin1 and <e2>Rictor</e2>. We also provide evidence that Rictor regulates the expression of Protor-1, and that Protor-1 is not required for the assembly of other mTORC2 subunits",
    "direct",
    "17461779"
   ],
   [
    "provide evidence that Rictor regulates the expression of Protor-1, and that Protor-1 is not required for the assembly of other mTORC2 subunits into a complex. <e1>Protor-1</e1> is a novel <e2>Rictor</e2>-binding subunit of mTORC2, but further work is required to establish its role.",
    "direct",
    "17461779"
   ]
  ]
 },
 "Protor-2,Rictor": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "at its hydrophobic motif (Ser473). In the present study, we report that widely expressed isoforms of unstudied proteins termed Protor-1 (protein observed with Rictor-1) and <e1>Protor-2</e1> interact with <e2>Rictor</e2> and are components of mTORC2. We demonstrate that immunoprecipitation of Protor-1 or Protor-2 results in the co-immunoprecipitation of other mTORC2 subunits, but not Raptor,",
    "direct",
    "17461779"
   ]
  ]
 },
 "Sin1,mTOR": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "the co-immunoprecipitation of other mTORC2 subunits, but not Raptor, a specific component of mTORC1. We show that detergents such as Triton X-100 or n-octylglucoside dissociate <e2>mTOR</e2> and mLST8 from a complex of Protor-1, <e1>Sin1</e1> and Rictor. We also provide evidence that Rictor regulates the expression of Protor-1, and that Protor-1 is not required for the assembly of other",
    "direct",
    "17461779"
   ]
  ]
 },
 "Sin1,Protor-1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "not Raptor, a specific component of mTORC1. We show that detergents such as Triton X-100 or n-octylglucoside dissociate mTOR and mLST8 from a complex of <e2>Protor-1</e2>, <e1>Sin1</e1> and Rictor. We also provide evidence that Rictor regulates the expression of Protor-1, and that Protor-1 is not required for the assembly of other",
    "direct",
    "17461779"
   ],
   [
    "not Raptor, a specific component of mTORC1. We show that detergents such as Triton X-100 or n-octylglucoside dissociate mTOR and mLST8 from a complex of <e2>Protor-1</e2>, <e1>Sin1</e1> and Rictor. We also provide evidence that Rictor regulates the expression of Protor-1, and that Protor-1 is not required for the assembly of other",
    "direct",
    "17461779"
   ]
  ]
 },
 "Sin1,Rictor": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Raptor, a specific component of mTORC1. We show that detergents such as Triton X-100 or n-octylglucoside dissociate mTOR and mLST8 from a complex of Protor-1, <e1>Sin1</e1> and <e2>Rictor</e2>. We also provide evidence that Rictor regulates the expression of Protor-1, and that Protor-1 is not required for the assembly of other mTORC2 subunits",
    "direct",
    "17461779"
   ],
   [
    "Raptor, a specific component of mTORC1. We show that detergents such as Triton X-100 or n-octylglucoside dissociate mTOR and mLST8 from a complex of Protor-1, <e1>Sin1</e1> and <e2>Rictor</e2>. We also provide evidence that Rictor regulates the expression of Protor-1, and that Protor-1 is not required for the assembly of other mTORC2 subunits",
    "direct",
    "17461779"
   ]
  ]
 },
 "mTOR,Protor-1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "the co-immunoprecipitation of other mTORC2 subunits, but not Raptor, a specific component of mTORC1. We show that detergents such as Triton X-100 or n-octylglucoside dissociate <e1>mTOR</e1> and mLST8 from a complex of <e2>Protor-1</e2>, Sin1 and Rictor. We also provide evidence that Rictor regulates the expression of Protor-1, and that Protor-1 is not required for the assembly of",
    "direct",
    "17461779"
   ]
  ]
 },
 "mTOR,Rictor": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "the co-immunoprecipitation of other mTORC2 subunits, but not Raptor, a specific component of mTORC1. We show that detergents such as Triton X-100 or n-octylglucoside dissociate <e1>mTOR</e1> and mLST8 from a complex of Protor-1, Sin1 and <e2>Rictor</e2>. We also provide evidence that Rictor regulates the expression of Protor-1, and that Protor-1 is not required for the assembly of other mTORC2 subunits",
    "direct",
    "17461779"
   ]
  ]
 },
 "Sin1,mLST8": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "of other mTORC2 subunits, but not Raptor, a specific component of mTORC1. We show that detergents such as Triton X-100 or n-octylglucoside dissociate mTOR and <e2>mLST8</e2> from a complex of Protor-1, <e1>Sin1</e1> and Rictor. We also provide evidence that Rictor regulates the expression of Protor-1, and that Protor-1 is not required for the assembly of other",
    "direct",
    "17461779"
   ]
  ]
 },
 "mLST8,Protor-1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "of other mTORC2 subunits, but not Raptor, a specific component of mTORC1. We show that detergents such as Triton X-100 or n-octylglucoside dissociate mTOR and <e1>mLST8</e1> from a complex of <e2>Protor-1</e2>, Sin1 and Rictor. We also provide evidence that Rictor regulates the expression of Protor-1, and that Protor-1 is not required for the assembly of",
    "direct",
    "17461779"
   ]
  ]
 },
 "mLST8,Rictor": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "of other mTORC2 subunits, but not Raptor, a specific component of mTORC1. We show that detergents such as Triton X-100 or n-octylglucoside dissociate mTOR and <e1>mLST8</e1> from a complex of Protor-1, Sin1 and <e2>Rictor</e2>. We also provide evidence that Rictor regulates the expression of Protor-1, and that Protor-1 is not required for the assembly of other mTORC2 subunits",
    "direct",
    "17461779"
   ]
  ]
 },
 "Rictor,Protor-1": {
  "relations": [
   "controls-expression-of"
  ],
  "mentions": [
   [
    "that detergents such as Triton X-100 or n-octylglucoside dissociate mTOR and mLST8 from a complex of Protor-1, Sin1 and Rictor. We also provide evidence that <e1>Rictor</e1> regulates the expression of <e2>Protor-1</e2>, and that Protor-1 is not required for the assembly of other mTORC2 subunits into a complex. Protor-1 is a novel Rictor-binding subunit of mTORC2,",
    "direct",
    "17461779"
   ]
  ]
 },
 "E2F6,E2F": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "regulation of human E2F6 repressor. E2F6 is believed to repress E2F-responsive genes and therefore serve a role in cell cycle regulation. Analysis of the human <e1>E2F6</e1> promoter region revealed the presence of two putative <e2>E2F</e2> binding sites, both of which were found to be functionally critical because deletion or mutations of these sites abolished promoter activity. Ectopic expression of",
    "direct",
    "16107498"
   ]
  ]
 },
 "E2F,E2F6": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "promoter that contained E2F1-related species whose binding was specifically competed by the consensus E2F binding site. Chromatin immunoprecipitation assays with anti-E2Fs demonstrated the association of <e1>E2F</e1> family members with the <e2>E2F6</e2> promoter in vivo. These data indicate that the expression of the E2F6 repressor is influenced at the transcriptional level by E2F family members",
    "direct",
    "16107498"
   ]
  ]
 },
 "PLD1,RhoA": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "to be one such target several years ago; more recent work from our laboratory and others has demonstrated that of the two mammalian PLD isozymes, <e1>PLD1</e1> but not PLD2 is activated by <e2>RhoA</e2> and this activation proceeds through direct binding both in vitro and in vivo. In this study, using a series of RhoA mutants, we",
    "direct",
    "15993039"
   ]
  ]
 },
 "RhoA,PLD1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "residues Asn41, Trp58 and Asp76, using the yeast two-hybrid system, co-immunoprecipitation, and a PLD in vivo assay. The results further substantiate our previous finding that <e1>RhoA</e1> activates <e2>PLD1</e2> through direct interaction. These mutants were then used to investigate the role of PLD1 in the cytoskeletal reorganization stimulated by RhoA signaling. Our results",
    "direct",
    "15993039"
   ]
  ]
 },
 "ATM,p53": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "Activation of the <e1>ATM</e1> kinase by ionizing radiation and phosphorylation of <e2>p53</e2>. The p53 tumor suppressor protein is activated and phosphorylated on serine-15 in response to various DNA damaging agents. The gene product mutated in",
    "direct",
    "9733515"
   ],
   [
    "DNA damaging agents. The gene product mutated in ataxia telangiectasia, ATM, acts upstream of p53 in a signal transduction pathway initiated by ionizing radiation. Immunoprecipitated <e1>ATM</e1> had intrinsic protein kinase activity and phosphorylated <e2>p53</e2> on serine-15 in a manganese-dependent manner. Ionizing radiation, but not ultraviolet radiation, rapidly enhanced this p53-directed kinase activity of endogenous ATM. These observations, along",
    "direct",
    "9733515"
   ],
   [
    "These observations, along with the fact that phosphorylation of p53 on serine-15 in response to ionizing radiation is reduced in ataxia telangiectasia cells, suggest that <e1>ATM</e1> is a protein kinase that phosphorylates <e2>p53</e2> in vivo.",
    "direct",
    "9733515"
   ]
  ]
 },
 "TopoIIalpha,ICBP90": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells. <e2>ICBP90</e2> (Inverted CCAAT box Binding Protein of 90 kDa) is a recently identified nuclear protein that binds to one of the inverted CCAAT boxes of the topoisomerase IIalpha (<e1>TopoIIalpha</e1>) gene promoter. Here, we show that ICBP90 shares structural homology with several other proteins, including Np95, the human and mouse NIRF, suggesting the emergence of",
    "direct",
    "12838312"
   ]
  ]
 },
 "p65,Keap1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Nuclear factor <e1>p65</e1> interacts with <e2>Keap1</e2> to repress the Nrf2-ARE pathway. Keap1 is an inhibitor of Nrf2 involved in Nrf2-dependent antioxidant response. However, the mechanisms on how Keap1 regulates Nrf2-ARE",
    "direct",
    "21262351"
   ],
   [
    "be determined. Here, by using a yeast two-hybrid technology, p65 subunit of NF-kappaB transcription factor was identified as a partner of Keap1. We show that <e2>Keap1</e2> physically associated with <e1>p65</e1> in vivo and in vitro. Overexpression of p65 inhibited Nrf2-dependent transcription induced by diethylmaleate (DEM) or tert-butyl hydroxyquinone (tBHQ). Knock down of Keap1",
    "direct",
    "21262351"
   ]
  ]
 },
 "Keap1,p65": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Nrf2-mediated activation by p65. It was demonstrated that p65 decreased Nrf2 binding to its cognate DNA sequences and enhanced Nrf2 ubiquitination. The N-terminal region of <e2>p65</e2> is necessary for both the interaction with <e1>Keap1</e1> and its transcriptional suppression activity. Moreover, nuclear translocation of Keap1 was augmented by p65. Taken together, our findings suggest that NF-kappaB signaling inhibits Nrf2-ARE",
    "direct",
    "21262351"
   ],
   [
    "activity. Moreover, nuclear translocation of Keap1 was augmented by p65. Taken together, our findings suggest that NF-kappaB signaling inhibits Nrf2-ARE pathway through the interaction of <e2>p65</e2> and <e1>Keap1</e1>.",
    "direct",
    "21262351"
   ]
  ]
 },
 "Mal,Tollinterleukin 1 receptor": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "the cytoplasmic tails of members of the Toll-like receptor/interleukin-1 receptor superfamily. The domain is essential for signaling and is also found in the adaptor proteins <e1>Mal</e1> (MyD88 adaptor-like) and MyD88, which function to couple activation of the receptor to downstream signaling components. Experimental structures of two <e2>Toll/interleukin 1 receptor</e2> domains reveal a alpha-beta-fold similar to that of the bacterial chemotaxis protein CheY, and other evidence suggests that the adaptors can make heterotypic",
    "direct",
    "12888566"
   ]
  ]
 },
 "MyD88,Tollinterleukin 1 receptor": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "members of the Toll-like receptor/interleukin-1 receptor superfamily. The domain is essential for signaling and is also found in the adaptor proteins Mal (MyD88 adaptor-like) and <e1>MyD88</e1>, which function to couple activation of the receptor to downstream signaling components. Experimental structures of two <e2>Toll/interleukin 1 receptor</e2> domains reveal a alpha-beta-fold similar to that of the bacterial chemotaxis protein CheY, and other evidence suggests that the adaptors can make heterotypic",
    "direct",
    "12888566"
   ]
  ]
 },
 "MyD88,Mal": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "other evidence suggests that the adaptors can make heterotypic interactions with both the receptors and themselves. Here we show that the purified TIR domains of <e2>Mal</e2> and <e1>MyD88</e1> can form stable heterodimers and also that Mal homodimers and oligomers are dissociated in the presence of ATP. To identify structural features that may",
    "direct",
    "12888566"
   ],
   [
    "Mal and MyD88 bind to different regions in TLRs 2 and 4, a finding consistent with a cooperative role of the two adaptors in signaling. <e2>Mal</e2> and <e1>MyD88</e1> are predicted to interact at a third non-overlapping site, suggesting that the receptor and adaptors may form heterotetrameric complexes. The theoretical model of the",
    "direct",
    "12888566"
   ]
  ]
 },
 "TLRs 2,Mal": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "and MyD88. We found that although the overall fold is conserved the electrostatic surface potentials are quite distinct. Docking studies of the models suggest that <e2>Mal</e2> and MyD88 bind to different regions in <e1>TLRs 2</e1> and 4, a finding consistent with a cooperative role of the two adaptors in signaling. Mal and MyD88 are predicted to interact at",
    "direct",
    "12888566"
   ],
   [
    "and MyD88. We found that although the overall fold is conserved the electrostatic surface potentials are quite distinct. Docking studies of the models suggest that <e2>Mal</e2> and MyD88 bind to different regions in <e1>TLRs 2</e1> and 4, a finding consistent with a cooperative role of the two adaptors in signaling. Mal and MyD88 are predicted to interact at",
    "direct",
    "12888566"
   ],
   [
    "fold is conserved the electrostatic surface potentials are quite distinct. Docking studies of the models suggest that Mal and MyD88 bind to different regions in <e1>TLRs 2</e1> and 4, a finding consistent with a cooperative role of the two adaptors in signaling. <e2>Mal</e2> and MyD88 are predicted to interact at a third non-overlapping site, suggesting that the receptor and adaptors may form heterotetrameric complexes. The theoretical model",
    "direct",
    "12888566"
   ]
  ]
 },
 "TLRs 2,MyD88": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "We found that although the overall fold is conserved the electrostatic surface potentials are quite distinct. Docking studies of the models suggest that Mal and <e2>MyD88</e2> bind to different regions in <e1>TLRs 2</e1> and 4, a finding consistent with a cooperative role of the two adaptors in signaling. Mal and MyD88 are predicted to interact at",
    "direct",
    "12888566"
   ],
   [
    "fold is conserved the electrostatic surface potentials are quite distinct. Docking studies of the models suggest that Mal and MyD88 bind to different regions in <e1>TLRs 2</e1> and 4, a finding consistent with a cooperative role of the two adaptors in signaling. Mal and <e2>MyD88</e2> are predicted to interact at a third non-overlapping site, suggesting that the receptor and adaptors may form heterotetrameric complexes. The theoretical model of the",
    "direct",
    "12888566"
   ]
  ]
 },
 "4,MyD88": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "We found that although the overall fold is conserved the electrostatic surface potentials are quite distinct. Docking studies of the models suggest that Mal and <e2>MyD88</e2> bind to different regions in TLRs 2 and <e1>4</e1>, a finding consistent with a cooperative role of the two adaptors in signaling. Mal and MyD88 are predicted to interact at a",
    "direct",
    "12888566"
   ]
  ]
 },
 "TLRs 2,4": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "fold is conserved the electrostatic surface potentials are quite distinct. Docking studies of the models suggest that Mal and MyD88 bind to different regions in <e1>TLRs 2</e1> and <e2>4</e2>, a finding consistent with a cooperative role of the two adaptors in signaling. Mal and MyD88 are predicted to interact at a third",
    "direct",
    "12888566"
   ]
  ]
 },
 "MyD88,4": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "the electrostatic surface potentials are quite distinct. Docking studies of the models suggest that Mal and MyD88 bind to different regions in TLRs 2 and <e2>4</e2>, a finding consistent with a cooperative role of the two adaptors in signaling. Mal and <e1>MyD88</e1> are predicted to interact at a third non-overlapping site, suggesting that the receptor and adaptors may form heterotetrameric complexes. The theoretical model of the",
    "direct",
    "12888566"
   ]
  ]
 },
 "Mal,4": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "the electrostatic surface potentials are quite distinct. Docking studies of the models suggest that Mal and MyD88 bind to different regions in TLRs 2 and <e2>4</e2>, a finding consistent with a cooperative role of the two adaptors in signaling. <e1>Mal</e1> and MyD88 are predicted to interact at a third non-overlapping site, suggesting that the receptor and adaptors may form heterotetrameric complexes. The theoretical model",
    "direct",
    "12888566"
   ]
  ]
 },
 "Mal,TLR4": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "glutathione S-transferase pull-downs and co-immunoprecipitations. Neither theoretical nor experimental data suggest a direct role for the conserved proline in the BB-loop in the association of <e2>TLR4</e2>, <e1>Mal</e1>, and MyD88. Finally we show a sequence relationship between the Drosophila protein Tube and Mal that may indicate a functional equivalence of these two",
    "direct",
    "12888566"
   ]
  ]
 },
 "Mal,MyD88": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "S-transferase pull-downs and co-immunoprecipitations. Neither theoretical nor experimental data suggest a direct role for the conserved proline in the BB-loop in the association of TLR4, <e1>Mal</e1>, and <e2>MyD88</e2>. Finally we show a sequence relationship between the Drosophila protein Tube and Mal that may indicate a functional equivalence of these two adaptors in",
    "direct",
    "12888566"
   ]
  ]
 },
 "TLR4,MyD88": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "glutathione S-transferase pull-downs and co-immunoprecipitations. Neither theoretical nor experimental data suggest a direct role for the conserved proline in the BB-loop in the association of <e1>TLR4</e1>, Mal, and <e2>MyD88</e2>. Finally we show a sequence relationship between the Drosophila protein Tube and Mal that may indicate a functional equivalence of these two adaptors in",
    "direct",
    "12888566"
   ]
  ]
 },
 "Puralpha,E2F-1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "expressed multifunctional nucleic acid-binding protein that is involved in many cellular processes including transcriptional regulation, the cell cycle, oncogenic transformation, and post-natal brain development. Previously, <e1>Puralpha</e1> protein was found to bind to <e2>E2F-1</e2>, inhibit E2F-1 transcriptional activity, and reverse the effects of ectopic E2F-1 expression on cell growth. Also Puralpha binds to a GC/GA-rich sequence within",
    "direct",
    "16741925"
   ]
  ]
 },
 "Akt,tuberous sclerosis complex 2": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "growth by activation of the protein kinases Akt (also known as protein kinase B, PKB) and mammalian target of rapamycin (mTOR). It was reported that <e1>Akt</e1> activates mTOR by phosphorylation and inhibition of <e2>tuberous sclerosis complex 2</e2> (TSC2). However, in recent studies the physiological requirement of Akt phosphorylation of TSC2 for mTOR activation has been questioned. Here, we identify PRAS40",
    "direct",
    "17277771"
   ]
  ]
 },
 "Akt,TSC2": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "It was reported that Akt activates mTOR by phosphorylation and inhibition of tuberous sclerosis complex 2 (TSC2). However, in recent studies the physiological requirement of <e1>Akt</e1> phosphorylation of <e2>TSC2</e2> for mTOR activation has been questioned. Here, we identify PRAS40 (proline-rich Akt/PKB substrate 40 kDa) as a novel mTOR binding partner that mediates",
    "direct",
    "17277771"
   ]
  ]
 },
 "PRAS40,mTOR": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "sclerosis complex 2 (TSC2). However, in recent studies the physiological requirement of Akt phosphorylation of TSC2 for mTOR activation has been questioned. Here, we identify <e1>PRAS40</e1> (proline-rich Akt/PKB substrate 40 kDa) as a novel <e2>mTOR</e2> binding partner that mediates Akt signals to mTOR. PRAS40 binds the mTOR kinase domain and its interaction with mTOR is induced under conditions that",
    "direct",
    "17277771"
   ],
   [
    "activation has been questioned. Here, we identify PRAS40 (proline-rich Akt/PKB substrate 40 kDa) as a novel mTOR binding partner that mediates Akt signals to mTOR. <e1>PRAS40</e1> binds the <e2>mTOR</e2> kinase domain and its interaction with mTOR is induced under conditions that inhibit mTOR signalling, such as nutrient or serum deprivation or mitochondrial",
    "direct",
    "17277771"
   ]
  ]
 },
 "mTOR,PRAS40": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "activation has been questioned. Here, we identify PRAS40 (proline-rich Akt/PKB substrate 40 kDa) as a novel mTOR binding partner that mediates Akt signals to mTOR. <e2>PRAS40</e2> binds the mTOR kinase domain and its interaction with <e1>mTOR</e1> is induced under conditions that inhibit mTOR signalling, such as nutrient or serum deprivation or mitochondrial metabolic inhibition. Binding of PRAS40 inhibits mTOR activity",
    "direct",
    "17277771"
   ],
   [
    "and its interaction with mTOR is induced under conditions that inhibit mTOR signalling, such as nutrient or serum deprivation or mitochondrial metabolic inhibition. Binding of <e2>PRAS40</e2> inhibits <e1>mTOR</e1> activity and suppresses constitutive activation of mTOR in cells lacking TSC2. PRAS40 silencing inactivates insulin-receptor substrate-1 (IRS-1) and Akt, and uncouples the response of",
    "direct",
    "17277771"
   ]
  ]
 },
 "Akt,PRAS40": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "activation of mTOR in cells lacking TSC2. PRAS40 silencing inactivates insulin-receptor substrate-1 (IRS-1) and Akt, and uncouples the response of mTOR to Akt signals. Furthermore, <e2>PRAS40</e2> phosphorylation by <e1>Akt</e1> and association with 14-3-3, a cytosolic anchor protein, are crucial for insulin to stimulate mTOR. These findings identify PRAS40 as an important regulator",
    "direct",
    "17277771"
   ]
  ]
 },
 "PRAS40,14-3-3": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "activation of mTOR in cells lacking TSC2. PRAS40 silencing inactivates insulin-receptor substrate-1 (IRS-1) and Akt, and uncouples the response of mTOR to Akt signals. Furthermore, <e1>PRAS40</e1> phosphorylation by Akt and association with <e2>14-3-3</e2>, a cytosolic anchor protein, are crucial for insulin to stimulate mTOR. These findings identify PRAS40 as an important regulator of insulin sensitivity of the",
    "direct",
    "17277771"
   ],
   [
    "is a substrate for phosphorylation by mTORC1. Consistent with this, starvation of cells of amino acids or treatment with rapamycin alters the phosphorylation of PRAS40. <e1>PRAS40</e1> binds <e2>14-3-3</e2> proteins, and this requires both amino acids and insulin. Binding of PRAS40 to 14-3-3 proteins is inhibited by TSC1/2 (negative regulators of mTORC1) and",
    "direct",
    "17604271"
   ]
  ]
 },
 "AML1,IkappaB kinase": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "of AML1-related leukemia are still elusive. Here, we explored immediate target pathways of AML1 by in vitro synchronous inactivation in hematopoietic cells. We found that <e1>AML1</e1> inhibits NF-kappaB signaling through interaction with <e2>IkappaB kinase</e2> complex in the cytoplasm. Remarkably, AML1 mutants found in myeloid tumors lack the ability to inhibit NF-kappaB signaling, and human cases with AML1-related leukemia",
    "direct",
    "22021368"
   ]
  ]
 },
 "Krm,Dkk": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Krm2 were later identified to be the high-affinity receptors for Dickkopf (Dkk), the inhibitor of Wnt/beta-catenin signalling. The formation of a ternary complex composed of <e1>Krm</e1>, <e2>Dkk</e2>, and Lrp5/6 (the coreceptor of Wnt) inhibits Wnt/beta-catenin signalling. In Xenopus gastrula embryos, Wnt/beta-catenin signalling regulates anterior-posterior patterning, with low-signalling in anterior regions. Inhibition",
    "direct",
    "18088386"
   ]
  ]
 },
 "Krm,Lrp56": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Krm2 were later identified to be the high-affinity receptors for Dickkopf (Dkk), the inhibitor of Wnt/beta-catenin signalling. The formation of a ternary complex composed of <e1>Krm</e1>, Dkk, and <e2>Lrp5/6</e2> (the coreceptor of Wnt) inhibits Wnt/beta-catenin signalling. In Xenopus gastrula embryos, Wnt/beta-catenin signalling regulates anterior-posterior patterning, with low-signalling in anterior regions. Inhibition of Krm1/2",
    "direct",
    "18088386"
   ]
  ]
 },
 "Dkk,Lrp56": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "were later identified to be the high-affinity receptors for Dickkopf (Dkk), the inhibitor of Wnt/beta-catenin signalling. The formation of a ternary complex composed of Krm, <e1>Dkk</e1>, and <e2>Lrp5/6</e2> (the coreceptor of Wnt) inhibits Wnt/beta-catenin signalling. In Xenopus gastrula embryos, Wnt/beta-catenin signalling regulates anterior-posterior patterning, with low-signalling in anterior regions. Inhibition of Krm1/2",
    "direct",
    "18088386"
   ]
  ]
 },
 "biliverdin reductase,ERK2": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Formation of ternary complex of human <e1>biliverdin reductase</e1>-protein kinase Cdelta-<e2>ERK2</e2> protein is essential for ERK2-mediated activation of Elk1 protein, nuclear factor-kappaB, and inducible nitric-oxidase synthase (iNOS). Growth factors, insulin, oxidative stress, and cytokines activate ERK1/2",
    "direct",
    "22065579"
   ]
  ]
 },
 "biliverdin reductase,protein kinase Cdelta": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Formation of ternary complex of human <e1>biliverdin reductase</e1>-<e2>protein kinase Cdelta</e2>-ERK2 protein is essential for ERK2-mediated activation of Elk1 protein, nuclear factor-kappaB, and inducible nitric-oxidase synthase (iNOS). Growth factors, insulin, oxidative stress, and cytokines",
    "direct",
    "22065579"
   ]
  ]
 },
 "ERK2,protein kinase Cdelta": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Formation of ternary complex of human biliverdin reductase-<e2>protein kinase Cdelta</e2>-<e1>ERK2</e1> protein is essential for ERK2-mediated activation of Elk1 protein, nuclear factor-kappaB, and inducible nitric-oxidase synthase (iNOS). Growth factors, insulin, oxidative stress, and cytokines activate ERK1/2",
    "direct",
    "22065579"
   ]
  ]
 },
 "PKCdelta,hBVR": {
  "relations": [
   "controls-phosphorylation-of",
   "in-complex-with",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "MEK1/2 and the protein phosphatase PP2A were also present in the complex. When cells were stimulated with insulin-like growth factor-1 (IGF-1), an increased interaction between <e2>hBVR</e2> and <e1>PKCdelta</e1> was detected by FRET-fluorescence lifetime imaging microscopy. hBVR and ERK2 were phosphorylated by PKCdelta; however, the PKC was not a substrate for either ERK2",
    "direct",
    "22065579"
   ],
   [
    "the complex. When cells were stimulated with insulin-like growth factor-1 (IGF-1), an increased interaction between hBVR and PKCdelta was detected by FRET-fluorescence lifetime imaging microscopy. <e2>hBVR</e2> and ERK2 were phosphorylated by <e1>PKCdelta</e1>; however, the PKC was not a substrate for either ERK2 or hBVR. IGF-1 and phorbol ester increased hBVR/PKCdelta binding; hBVR was required for the",
    "direct",
    "22065579"
   ]
  ]
 },
 "PKCdelta,ERK2": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "When cells were stimulated with insulin-like growth factor-1 (IGF-1), an increased interaction between hBVR and PKCdelta was detected by FRET-fluorescence lifetime imaging microscopy. hBVR and <e2>ERK2</e2> were phosphorylated by <e1>PKCdelta</e1>; however, the PKC was not a substrate for either ERK2 or hBVR. IGF-1 and phorbol ester increased hBVR/PKCdelta binding; hBVR was required for the",
    "direct",
    "22065579"
   ]
  ]
 },
 "hBVR,PKCdelta": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "microscopy. hBVR and ERK2 were phosphorylated by PKCdelta; however, the PKC was not a substrate for either ERK2 or hBVR. IGF-1 and phorbol ester increased <e1>hBVR</e1>/<e2>PKCdelta</e2> binding; hBVR was required for the activation of PKCdelta and its interaction with ERK2. The C-terminal phenylalanine residues of PKCdelta (Phe(660), Phe(663), and Phe(665)) were",
    "direct",
    "22065579"
   ],
   [
    "IGF-1 and phorbol ester increased hBVR/PKCdelta binding; hBVR was required for the activation of PKCdelta and its interaction with ERK2. The C-terminal phenylalanine residues of <e2>PKCdelta</e2> (Phe(660), Phe(663), and Phe(665)) were necessary for binding to ERK2 but not for <e1>hBVR</e1> binding. Formation of the hBVR-PKCdelta-ERK2 complex required the hBVR docking site for ERK, FXFP (DEF, C-box) and D(delta)-box (ILXXLXL) motifs. The hBVR-based peptide",
    "direct",
    "22065579"
   ]
  ]
 },
 "hBVR,ERK2": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "and ERK2 were phosphorylated by PKCdelta; however, the PKC was not a substrate for either ERK2 or hBVR. IGF-1 and phorbol ester increased hBVR/PKCdelta binding; <e1>hBVR</e1> was required for the activation of PKCdelta and its interaction with <e2>ERK2</e2>. The C-terminal phenylalanine residues of PKCdelta (Phe(660), Phe(663), and Phe(665)) were necessary for binding to ERK2 but not for hBVR binding. Formation of the",
    "direct",
    "22065579"
   ]
  ]
 },
 "ERK2,PKCdelta": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "IGF-1 and phorbol ester increased hBVR/PKCdelta binding; hBVR was required for the activation of PKCdelta and its interaction with ERK2. The C-terminal phenylalanine residues of <e2>PKCdelta</e2> (Phe(660), Phe(663), and Phe(665)) were necessary for binding to <e1>ERK2</e1> but not for hBVR binding. Formation of the hBVR-PKCdelta-ERK2 complex required the hBVR docking site for ERK, FXFP (DEF, C-box) and D(delta)-box (ILXXLXL)",
    "direct",
    "22065579"
   ],
   [
    "the hBVR-PKCdelta-ERK2 complex required the hBVR docking site for ERK, FXFP (DEF, C-box) and D(delta)-box (ILXXLXL) motifs. The hBVR-based peptide KKRILHCLGLA inhibited PKC activation and <e2>PKCdelta</e2>/<e1>ERK2</e1> interaction. Phorbol ester- and TNF-alpha-dependent activation of the ERK-regulated transcription factors Elk1 and NF-kappaB and expression of the iNOS gene were suppressed by hBVR siRNA;",
    "direct",
    "22065579"
   ]
  ]
 },
 "hBVR,ERK": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "residues of PKCdelta (Phe(660), Phe(663), and Phe(665)) were necessary for binding to ERK2 but not for hBVR binding. Formation of the hBVR-PKCdelta-ERK2 complex required the <e1>hBVR</e1> docking site for <e2>ERK</e2>, FXFP (DEF, C-box) and D(delta)-box (ILXXLXL) motifs. The hBVR-based peptide KKRILHCLGLA inhibited PKC activation and PKCdelta/ERK2 interaction. Phorbol ester- and TNF-alpha-dependent activation of",
    "direct",
    "22065579"
   ]
  ]
 },
 "TLR4,MD-2": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "The role of disulfide bonds in the assembly and function of MD-2. <e2>MD-2</e2> is a secreted glycoprotein that binds to the extracellular domain of Toll-like receptor 4 (<e1>TLR4</e1>) and is required for the activation of TLR4 by lipopolysaccharide (LPS). The protein contains seven Cys residues and consists of a heterogeneous collection",
    "direct",
    "12642668"
   ]
  ]
 },
 "sulfhydryls,MD-2": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "responsiveness to LPS when secreted proteins were added directly to TLR4 reporter cells. Our data are consistent with a model in which most, possibly all <e1>sulfhydryls</e1> lie on the surface of a stable <e2>MD-2</e2> core structure where they form both intra- and interchain disulfide bridges. These disulfide bonds produce a heterogeneous array of oligomers, including some species that",
    "direct",
    "12642668"
   ]
  ]
 },
 "TGF-beta1,IkappaBalpha": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "cells (HKC-8). To delineate the mechanism by which TGF-beta1 inhibits RANTES expression, we examined the potential signal pathway activated by TGF-beta1 in suppressing NF-kappaB signaling. <e1>TGF-beta1</e1> affected neither TNF-alpha-induced <e2>IkappaBalpha</e2> phosphorylation and subsequent degradation, nor p65 NF-kappaB phosphorylation and its nuclear translocation. However, TGF-beta1 could inhibit p65 and p50 binding to the kappaB site in",
    "direct",
    "21189258"
   ]
  ]
 },
 "TGF-beta1,p65": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-transport-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "cells (HKC-8). To delineate the mechanism by which TGF-beta1 inhibits RANTES expression, we examined the potential signal pathway activated by TGF-beta1 in suppressing NF-kappaB signaling. <e1>TGF-beta1</e1> affected neither TNF-alpha-induced IkappaBalpha phosphorylation and subsequent degradation, nor <e2>p65</e2> NF-kappaB phosphorylation and its nuclear translocation. However, TGF-beta1 could inhibit p65 and p50 binding to the kappaB site in human RANTES promoter as",
    "direct",
    "21189258"
   ],
   [
    "cells (HKC-8). To delineate the mechanism by which TGF-beta1 inhibits RANTES expression, we examined the potential signal pathway activated by TGF-beta1 in suppressing NF-kappaB signaling. <e1>TGF-beta1</e1> affected neither TNF-alpha-induced IkappaBalpha phosphorylation and subsequent degradation, nor <e2>p65</e2> NF-kappaB phosphorylation and its nuclear translocation. However, TGF-beta1 could inhibit p65 and p50 binding to the kappaB site in human RANTES promoter as",
    "direct",
    "21189258"
   ]
  ]
 },
 "TGF-beta1,NF-kappaB": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-transport-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "cells (HKC-8). To delineate the mechanism by which TGF-beta1 inhibits RANTES expression, we examined the potential signal pathway activated by TGF-beta1 in suppressing NF-kappaB signaling. <e1>TGF-beta1</e1> affected neither TNF-alpha-induced IkappaBalpha phosphorylation and subsequent degradation, nor p65 <e2>NF-kappaB</e2> phosphorylation and its nuclear translocation. However, TGF-beta1 could inhibit p65 and p50 binding to the kappaB site in human RANTES promoter as revealed by chromatin",
    "direct",
    "21189258"
   ],
   [
    "cells (HKC-8). To delineate the mechanism by which TGF-beta1 inhibits RANTES expression, we examined the potential signal pathway activated by TGF-beta1 in suppressing NF-kappaB signaling. <e1>TGF-beta1</e1> affected neither TNF-alpha-induced IkappaBalpha phosphorylation and subsequent degradation, nor p65 <e2>NF-kappaB</e2> phosphorylation and its nuclear translocation. However, TGF-beta1 could inhibit p65 and p50 binding to the kappaB site in human RANTES promoter as revealed by chromatin",
    "direct",
    "21189258"
   ]
  ]
 },
 "kappaB,p65": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "in suppressing NF-kappaB signaling. TGF-beta1 affected neither TNF-alpha-induced IkappaBalpha phosphorylation and subsequent degradation, nor p65 NF-kappaB phosphorylation and its nuclear translocation. However, TGF-beta1 could inhibit <e2>p65</e2> and p50 binding to the <e1>kappaB</e1> site in human RANTES promoter as revealed by chromatin immunoprecipitation assay and protein-DNA binding assay. We found that TGF-beta1 induced glycogen synthase kinase-3beta (GSK-3beta)",
    "direct",
    "21189258"
   ],
   [
    "mimicked the TGF-beta1 effect and completely suppressed RANTES expression induced by TNF-alpha. Interestingly, TGF-beta1 induced a physical interaction between beta-catenin and p65 NF-kappaB, which prevented <e2>p65</e2> binding to the <e1>kappaB</e1> site, sequestered its trans-activating activity, and repressed p65-mediated gene transcription. We conclude that TGF-beta1 inhibition of proinflammatory RANTES expression is mediated by beta-catenin-triggered blockade",
    "direct",
    "21189258"
   ]
  ]
 },
 "kappaB,p50": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "NF-kappaB signaling. TGF-beta1 affected neither TNF-alpha-induced IkappaBalpha phosphorylation and subsequent degradation, nor p65 NF-kappaB phosphorylation and its nuclear translocation. However, TGF-beta1 could inhibit p65 and <e2>p50</e2> binding to the <e1>kappaB</e1> site in human RANTES promoter as revealed by chromatin immunoprecipitation assay and protein-DNA binding assay. We found that TGF-beta1 induced glycogen synthase kinase-3beta (GSK-3beta)",
    "direct",
    "21189258"
   ]
  ]
 },
 "TGF-beta1,RANTES": {
  "relations": [
   "controls-expression-of"
  ],
  "mentions": [
   [
    "in HKC-8 cells, leading to its inactivation. Knockdown of GSK-3beta mimicked TGF-beta1 and inhibited RANTES induction, whereas overexpression of GSK-3beta abolished the inhibitory effect of <e1>TGF-beta1</e1> and completely restored <e2>RANTES</e2> expression. Furthermore, TGF-beta1 induced the dephosphorylation and activation of beta-catenin, a major downstream target of GSK-3beta. Ectopic expression of constitutively active beta-catenin mimicked the",
    "direct",
    "21189258"
   ]
  ]
 },
 "beta-catenin,NF-kappaB": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Ectopic expression of constitutively active beta-catenin mimicked the TGF-beta1 effect and completely suppressed RANTES expression induced by TNF-alpha. Interestingly, TGF-beta1 induced a physical interaction between <e1>beta-catenin</e1> and p65 <e2>NF-kappaB</e2>, which prevented p65 binding to the kappaB site, sequestered its trans-activating activity, and repressed p65-mediated gene transcription. We conclude that TGF-beta1 inhibition of proinflammatory RANTES",
    "direct",
    "21189258"
   ]
  ]
 },
 "beta-catenin,p65": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Ectopic expression of constitutively active beta-catenin mimicked the TGF-beta1 effect and completely suppressed RANTES expression induced by TNF-alpha. Interestingly, TGF-beta1 induced a physical interaction between <e1>beta-catenin</e1> and <e2>p65</e2> NF-kappaB, which prevented p65 binding to the kappaB site, sequestered its trans-activating activity, and repressed p65-mediated gene transcription. We conclude that TGF-beta1 inhibition",
    "direct",
    "21189258"
   ]
  ]
 },
 "TNFAIP3 interacting protein 1,Nef": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "PPARgamma and NF-kappaB regulate the gene promoter activity of their shared repressor, TNIP1. Human <e1>TNFAIP3 interacting protein 1</e1> (TNIP1) has diverse functions including support of HIV replication through its interaction with viral <e2>Nef</e2> and matrix proteins, reduction of TNFalpha-induced signaling through its interaction with NF-kappaB pathway proteins, and corepression of agonist-bound retinoic acid receptors and peroxisome proliferator-activated",
    "direct",
    "22001530"
   ]
  ]
 },
 "NF-kappaB,TNFAIP3 interacting protein 1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "PPARgamma and NF-kappaB regulate the gene promoter activity of their shared repressor, TNIP1. Human <e2>TNFAIP3 interacting protein 1</e2> (TNIP1) has diverse functions including support of HIV replication through its interaction with viral Nef and matrix proteins, reduction of TNFalpha-induced signaling through its interaction with <e1>NF-kappaB</e1> pathway proteins, and corepression of agonist-bound retinoic acid receptors and peroxisome proliferator-activated receptors (PPAR). The wide tissue distribution of TNIP1 provides the opportunity to influence",
    "direct",
    "22001530"
   ]
  ]
 },
 "p73,p53": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "p63 and p73 transactivate differentiation gene promoters in human keratinocytes. <e2>p53</e2> and its two homologues, <e1>p73</e1> and p63, share considerable structural similarities, an ability to interact between themselves and to transactivate the same promoters, including for example p21. Furthermore, p73",
    "direct",
    "10873608"
   ]
  ]
 },
 "p73,p63": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "p63 and p73 transactivate differentiation gene promoters in human keratinocytes. p53 and its two homologues, <e1>p73</e1> and <e2>p63</e2>, share considerable structural similarities, an ability to interact between themselves and to transactivate the same promoters, including for example p21. Furthermore, p73 can",
    "direct",
    "10873608"
   ]
  ]
 },
 "p53,p63": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "p63 and p73 transactivate differentiation gene promoters in human keratinocytes. <e1>p53</e1> and its two homologues, p73 and <e2>p63</e2>, share considerable structural similarities, an ability to interact between themselves and to transactivate the same promoters, including for example p21. Furthermore, p73 can",
    "direct",
    "10873608"
   ]
  ]
 },
 "c-Abl,p73": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "homologues, p73 and p63, share considerable structural similarities, an ability to interact between themselves and to transactivate the same promoters, including for example p21. Furthermore, <e2>p73</e2> can induce cell death via its interaction with <e1>c-Abl</e1>. In contrast, p63 has been demonstrated to be essential for limb and skin formation. We evaluated the expression of p63 and p73 in differentiating",
    "direct",
    "10873608"
   ]
  ]
 },
 "TRRAP,p53": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "critical in the p53 pathway because the mdm2 protein marks p53 for proteosome-mediated degradation, thereby providing a negative-feedback loop. Here we show that the ATM-related <e1>TRRAP</e1> protein functionally cooperates with <e2>p53</e2> to activate mdm2 transcription. TRRAP is a component of several multiprotein acetyltransferase complexes implicated in both transcriptional regulation and DNA repair. In support",
    "direct",
    "12138177"
   ],
   [
    "complexes in mdm2 expression, we show that transactivation of the mdm2 gene is augmented by pharmacological inhibition of cellular deacetylases. In vitro analysis demonstrates that <e2>p53</e2> directly binds to a <e1>TRRAP</e1> domain previously shown to be an activator docking site. Furthermore, transfection of cells with antisense TRRAP blocks p53-dependent transcription of mdm2. Finally, using",
    "direct",
    "12138177"
   ]
  ]
 },
 "p53,TRRAPacetyltransferase": {
  "relations": [
   "controls-transport-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "chromatin immunoprecipitation, we demonstrate direct p53-dependent recruitment of TRRAP to the mdm2 promoter, followed by increased histone acetylation. These findings suggest a model in which <e1>p53</e1> directly recruits a <e2>TRRAP/acetyltransferase</e2> complex to the mdm2 gene to activate transcription. In addition, this study defines a novel biochemical mechanism utilized by the p53 tumor suppressor to regulate",
    "direct",
    "12138177"
   ]
  ]
 },
 "cyclin,Cdk": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "of the Cdk. Eukaryotic cell cycle progression is controlled by the ordered action of cyclin-dependent kinases, activation of which occurs through the binding of the <e1>cyclin</e1> to the <e2>Cdk</e2> followed by phosphorylation of a conserved threonine in the T-loop of the Cdk by Cdk-activating kinase (CAK). Despite our understanding of the structural",
    "direct",
    "11959850"
   ],
   [
    "cyclin to yield an intermediate complex in which the threonine in the T-loop is not accessible for phosphorylation. Additional contacts between the C-lobe of the <e2>Cdk</e2> and the N-terminal helix of the <e1>cyclin</e1> then induce the isomerization of the Cdk into a fully mature form by promoting the exposure of the T-loop for phosphorylation by CAK and",
    "direct",
    "11959850"
   ]
  ]
 },
 "Cdk-activating kinase,Cdk": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "activation of which occurs through the binding of the cyclin to the Cdk followed by phosphorylation of a conserved threonine in the T-loop of the <e2>Cdk</e2> by <e1>Cdk-activating kinase</e1> (CAK). Despite our understanding of the structural changes, which occur upon Cdk/cyclin formation and activation, little is known about the dynamics of the molecular",
    "direct",
    "11959850"
   ]
  ]
 },
 "Cdk2,cyclin": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "level by rapid kinetics and demonstrate here that it is a two-step process. The first step involves the rapid association between the PSTAIRE helix of <e1>Cdk2</e1> and helices 3 and 5 of the <e2>cyclin</e2> to yield an intermediate complex in which the threonine in the T-loop is not accessible for phosphorylation. Additional contacts between the C-lobe of the",
    "direct",
    "11959850"
   ]
  ]
 },
 "CAK,Cdk": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "not accessible for phosphorylation. Additional contacts between the C-lobe of the Cdk and the N-terminal helix of the cyclin then induce the isomerization of the <e2>Cdk</e2> into a fully mature form by promoting the exposure of the T-loop for phosphorylation by <e1>CAK</e1> and the formation of the substrate binding site. This conformational change is selective for the cyclin partner.",
    "direct",
    "11959850"
   ]
  ]
 },
 "Fob1,Cfi1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "leads to premature release of Cdc14 from the nucleolus in metaphase-arrested cells. Conversely, high levels of FOB1 delay the release of Cdc14 from the nucleolus. <e1>Fob1</e1> associates with <e2>Cfi1</e2>/Net1, and consistent with this observation, we find that the bulk of Cdc14 localizes to the Fob1 binding region within the rDNA repeats. Finally, we",
    "direct",
    "15043811"
   ]
  ]
 },
 "Cdc14,Fob1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "of FOB1 delay the release of Cdc14 from the nucleolus. Fob1 associates with Cfi1/Net1, and consistent with this observation, we find that the bulk of <e1>Cdc14</e1> localizes to the <e2>Fob1</e2> binding region within the rDNA repeats. Finally, we show that Spo12 phosphorylation is cell cycle regulated and affects its binding to Fob1. CONCLUSIONS:",
    "direct",
    "15043811"
   ]
  ]
 },
 "Fob1,Spo12": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "consistent with this observation, we find that the bulk of Cdc14 localizes to the Fob1 binding region within the rDNA repeats. Finally, we show that <e2>Spo12</e2> phosphorylation is cell cycle regulated and affects its binding to <e1>Fob1</e1>. CONCLUSIONS: Fob1 functions as a negative regulator of the FEAR network. We propose that Fob1 helps to prevent the dissociation of Cdc14 from",
    "direct",
    "15043811"
   ]
  ]
 },
 "Cfi1,Cdc14": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "its binding to Fob1. CONCLUSIONS: Fob1 functions as a negative regulator of the FEAR network. We propose that Fob1 helps to prevent the dissociation of <e2>Cdc14</e2> from <e1>Cfi1</e1>/Net1 prior to anaphase and that Spo12 activation during early anaphase promotes the release of Cdc14 from its inhibitor by antagonizing Fob1 function.",
    "direct",
    "15043811"
   ]
  ]
 },
 "Src,p27": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "<e2>p27</e2> phosphorylation by <e1>Src</e1> regulates inhibition of cyclin E-Cdk2. The kinase inhibitor p27Kip1 regulates the G1 cell cycle phase. Here, we present data indicating that the oncogenic",
    "direct",
    "17254967"
   ],
   [
    "Src regulates inhibition of cyclin E-Cdk2. The kinase inhibitor p27Kip1 regulates the G1 cell cycle phase. Here, we present data indicating that the oncogenic kinase <e1>Src</e1> regulates p27 stability through phosphorylation of <e2>p27</e2> at tyrosine 74 and tyrosine 88. Src inhibitors increase cellular p27 stability, and Src overexpression accelerates p27 proteolysis. Src-phosphorylated p27 is shown to",
    "direct",
    "17254967"
   ],
   [
    "Src regulates inhibition of cyclin E-Cdk2. The kinase inhibitor p27Kip1 regulates the G1 cell cycle phase. Here, we present data indicating that the oncogenic kinase <e1>Src</e1> regulates p27 stability through phosphorylation of <e2>p27</e2> at tyrosine 74 and tyrosine 88. Src inhibitors increase cellular p27 stability, and Src overexpression accelerates p27 proteolysis. Src-phosphorylated p27 is shown to",
    "direct",
    "17254967"
   ],
   [
    "regulates p27 stability through phosphorylation of p27 at tyrosine 74 and tyrosine 88. Src inhibitors increase cellular p27 stability, and Src overexpression accelerates p27 proteolysis. <e1>Src</e1>-phosphorylated <e2>p27</e2> is shown to inhibit cyclin E-Cdk2 poorly in vitro, and Src transfection reduces p27-cyclin E-Cdk2 complexes. Our data indicate that phosphorylation by Src impairs",
    "direct",
    "17254967"
   ],
   [
    "proteolysis. Src-phosphorylated p27 is shown to inhibit cyclin E-Cdk2 poorly in vitro, and Src transfection reduces p27-cyclin E-Cdk2 complexes. Our data indicate that phosphorylation by <e1>Src</e1> impairs the Cdk2 inhibitory action of <e2>p27</e2> and reduces its steady-state binding to cyclin E-Cdk2 to facilitate cyclin E-Cdk2-dependent p27 proteolysis. Furthermore, we find that Src-activated breast cancer lines show",
    "direct",
    "17254967"
   ]
  ]
 },
 "p27,cyclin E-Cdk2": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "cyclin E-Cdk2 poorly in vitro, and Src transfection reduces p27-cyclin E-Cdk2 complexes. Our data indicate that phosphorylation by Src impairs the Cdk2 inhibitory action of <e1>p27</e1> and reduces its steady-state binding to <e2>cyclin E-Cdk2</e2> to facilitate cyclin E-Cdk2-dependent p27 proteolysis. Furthermore, we find that Src-activated breast cancer lines show reduced p27 and observe a correlation between Src activation",
    "direct",
    "17254967"
   ]
  ]
 },
 "insulin-like growth factor-1,3-phosphoinositide-dependent protein kinase-1": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "Phosphorylation of Ser-241 is essential for the activity of 3-phosphoinositide-dependent protein kinase-1: identification of five sites of phosphorylation in vivo. <e2>3-phosphoinositide-dependent protein kinase-1</e2> (PDK1) expressed in unstimulated 293 cells was phosphorylated at Ser-25, Ser-241, Ser-393, Ser-396 and Ser-410 and the level of phosphorylation of each site was unaffected by stimulation with <e1>insulin-like growth factor-1</e1>. Mutation of Ser-241 to Ala abolished PDK1 activity, whereas mutation of the other phosphorylation sites individually to Ala did not affect PDK1 activity. Ser-241,",
    "direct",
    "10455013"
   ],
   [
    "Phosphorylation of Ser-241 is essential for the activity of 3-phosphoinositide-dependent protein kinase-1: identification of five sites of phosphorylation in vivo. <e2>3-phosphoinositide-dependent protein kinase-1</e2> (PDK1) expressed in unstimulated 293 cells was phosphorylated at Ser-25, Ser-241, Ser-393, Ser-396 and Ser-410 and the level of phosphorylation of each site was unaffected by stimulation with <e1>insulin-like growth factor-1</e1>. Mutation of Ser-241 to Ala abolished PDK1 activity, whereas mutation of the other phosphorylation sites individually to Ala did not affect PDK1 activity. Ser-241,",
    "direct",
    "10455013"
   ],
   [
    "Phosphorylation of Ser-241 is essential for the activity of 3-phosphoinositide-dependent protein kinase-1: identification of five sites of phosphorylation in vivo. <e2>3-phosphoinositide-dependent protein kinase-1</e2> (PDK1) expressed in unstimulated 293 cells was phosphorylated at Ser-25, Ser-241, Ser-393, Ser-396 and Ser-410 and the level of phosphorylation of each site was unaffected by stimulation with <e1>insulin-like growth factor-1</e1>. Mutation of Ser-241 to Ala abolished PDK1 activity, whereas mutation of the other phosphorylation sites individually to Ala did not affect PDK1 activity. Ser-241,",
    "direct",
    "10455013"
   ],
   [
    "Phosphorylation of Ser-241 is essential for the activity of 3-phosphoinositide-dependent protein kinase-1: identification of five sites of phosphorylation in vivo. <e2>3-phosphoinositide-dependent protein kinase-1</e2> (PDK1) expressed in unstimulated 293 cells was phosphorylated at Ser-25, Ser-241, Ser-393, Ser-396 and Ser-410 and the level of phosphorylation of each site was unaffected by stimulation with <e1>insulin-like growth factor-1</e1>. Mutation of Ser-241 to Ala abolished PDK1 activity, whereas mutation of the other phosphorylation sites individually to Ala did not affect PDK1 activity. Ser-241,",
    "direct",
    "10455013"
   ],
   [
    "Phosphorylation of Ser-241 is essential for the activity of 3-phosphoinositide-dependent protein kinase-1: identification of five sites of phosphorylation in vivo. <e2>3-phosphoinositide-dependent protein kinase-1</e2> (PDK1) expressed in unstimulated 293 cells was phosphorylated at Ser-25, Ser-241, Ser-393, Ser-396 and Ser-410 and the level of phosphorylation of each site was unaffected by stimulation with <e1>insulin-like growth factor-1</e1>. Mutation of Ser-241 to Ala abolished PDK1 activity, whereas mutation of the other phosphorylation sites individually to Ala did not affect PDK1 activity. Ser-241,",
    "direct",
    "10455013"
   ]
  ]
 },
 "protein phosphatase 2A(1),PDK1": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "abolished PDK1 activity, whereas mutation of the other phosphorylation sites individually to Ala did not affect PDK1 activity. Ser-241, unlike the other phosphorylation sites on <e2>PDK1</e2>, was resistant to dephosphorylation by <e1>protein phosphatase 2A(1)</e1>. Ser-241 lies in the activation loop of the PDK1 kinase domain between subdomains VII and VIII in the equivalent position to the site that",
    "direct",
    "10455013"
   ]
  ]
 },
 "PDK1,PDK1": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "equivalent position to the site that PDK1 phosphorylates on its protein kinase substrates. PDK1 expressed in bacteria was active and phosphorylated at Ser-241, suggesting that <e2>PDK1</e2><e1>PDK1</e1> can phosphorylate itself at this site, leading to its own activation.",
    "direct",
    "10455013"
   ]
  ]
 },
 "hepatitis B virus X protein,E2F1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "p53 promoter and overcomes the repressive effect of hepatitis B viral X protein (Hbx) on the p53 promoter. The functional effect of the interaction of <e2>E2F1</e2> and <e1>hepatitis B virus X protein</e1> (HBx) on the promoter of human p53 gene was studied using chloramphenicol acetyl transferase (CAT) assay. E2F1 activated the p53 promoter through E2F1",
    "direct",
    "12625370"
   ]
  ]
 },
 "HBx,E2F1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "heterologous promoter system with the E2F1 binding sites, cotransfection of E2F1 and HBx showed a strong synergistic activation. An in vitro interaction assay showed that <e2>E2F1</e2> and <e1>HBx</e1> physically bind with each other. Analyses of the interaction domain with the GAL4 fusion protein showed that the pRb-binding domain of E2F1 was",
    "direct",
    "12625370"
   ]
  ]
 },
 "p53,UPase": {
  "relations": [
   "controls-expression-of"
  ],
  "mentions": [
   [
    "Immunohistochemical analysis and co-purification studies have revealed the association of UPase with the cytoskeleton and the cellular membrane. The characterization of the promoter region of <e2>UPase</e2> has indicated a direct regulation of its expression by the tumor suppressor gene <e1>p53</e1>. The evaluation of human surgical specimens has shown elevated UPase activity in tumor tissue compared to paired normal tissue.",
    "direct",
    "12084455"
   ]
  ]
 },
 "ATP-binding cassette (ABC) transporter ABCC,prostaglandins": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "from cells is not completely understood. Although poorly membrane permeable, prostaglandins are believed to exit cells by passive diffusion. We have investigated the interaction between <e2>prostaglandins</e2> and members of the <e1>ATP-binding cassette (ABC) transporter ABCC</e1> [multidrug resistance protein (MRP)] family of membrane export pumps. In inside-out membrane vesicles derived from insect cells or HEK293 cells, MRP4 catalyzed the time-",
    "direct",
    "12835412"
   ]
  ]
 },
 "SLP-76,GLK": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "(TCR); however, the direct activator of PKC-theta is unknown. We report that the kinase GLK (MAP4K3) directly activated PKC-theta during TCR signaling. TCR signaling activated <e2>GLK</e2> by inducing its direct interaction with the upstream adaptor <e1>SLP-76</e1>. GLK-deficient mice had impaired immune responses and were resistant to experimental autoimmune encephalomyelitis. Consistent with that, people with systemic lupus erythematosus had considerable enhanced",
    "direct",
    "21983831"
   ]
  ]
 },
 "NSs,TBK1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "encoded by the S segment, suppressed the beta interferon (IFN-beta) and NF-kappaB promoter activities, although NF-kappaB activation appears to facilitate SFTSV replication in human monocytes. <e1>NSs</e1> was found to be associated with <e2>TBK1</e2> and may inhibit the activation of downstream IRF and NF-kappaB signaling through this interaction. Interestingly, we demonstrated that the nucleoprotein (N), also encoded by",
    "direct",
    "22623799"
   ],
   [
    "encoded by the S segment, suppressed the beta interferon (IFN-beta) and NF-kappaB promoter activities, although NF-kappaB activation appears to facilitate SFTSV replication in human monocytes. <e1>NSs</e1> was found to be associated with <e2>TBK1</e2> and may inhibit the activation of downstream IRF and NF-kappaB signaling through this interaction. Interestingly, we demonstrated that the nucleoprotein (N), also encoded by",
    "direct",
    "22623799"
   ]
  ]
 },
 "GSK-3beta,beta-catenin": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "beta-catenin is a key regulatory step during cell fate changes and transformations to tumor cells. Several interacting proteins, including Axin, APC, and the protein kinase <e1>GSK-3beta</e1> are implicated in regulating <e2>beta-catenin</e2> phosphorylation and its subsequent degradation. Wnt signaling stabilizes beta-catenin, but it was not clear whether and how Wnt signaling regulates the beta-catenin complex. Here we",
    "direct",
    "10421629"
   ]
  ]
 },
 "APC,beta-catenin": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "axin complex. The stabilization of beta-catenin is a key regulatory step during cell fate changes and transformations to tumor cells. Several interacting proteins, including Axin, <e1>APC</e1>, and the protein kinase GSK-3beta are implicated in regulating <e2>beta-catenin</e2> phosphorylation and its subsequent degradation. Wnt signaling stabilizes beta-catenin, but it was not clear whether and how Wnt signaling regulates the beta-catenin complex. Here we",
    "direct",
    "10421629"
   ]
  ]
 },
 "Axin,beta-catenin": {
  "relations": [
   "controls-phosphorylation-of",
   "in-complex-with",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "the axin complex. The stabilization of beta-catenin is a key regulatory step during cell fate changes and transformations to tumor cells. Several interacting proteins, including <e1>Axin</e1>, APC, and the protein kinase GSK-3beta are implicated in regulating <e2>beta-catenin</e2> phosphorylation and its subsequent degradation. Wnt signaling stabilizes beta-catenin, but it was not clear whether and how Wnt signaling regulates the beta-catenin complex. Here we",
    "direct",
    "10421629"
   ],
   [
    "not clear whether and how Wnt signaling regulates the beta-catenin complex. Here we show that Axin is dephosphorylated in response to Wnt signaling. The dephosphorylated <e1>Axin</e1> binds <e2>beta-catenin</e2> less efficiently than the phosphorylated form. Thus, Wnt signaling lowers Axin's affinity for beta-catenin, thereby disengaging beta-catenin from the degradation machinery.",
    "direct",
    "10421629"
   ]
  ]
 },
 "beta-catenin,Axin": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "show that Axin is dephosphorylated in response to Wnt signaling. The dephosphorylated Axin binds beta-catenin less efficiently than the phosphorylated form. Thus, Wnt signaling lowers <e2>Axin</e2>'s affinity for <e1>beta-catenin</e1>, thereby disengaging beta-catenin from the degradation machinery.",
    "direct",
    "10421629"
   ]
  ]
 },
 "Cdk4,D-type cyclins": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Cell cycle activation is coordinated by D-type cyclins which are rate limiting and essential for the progression through the G1 phase of the cell cycle. <e2>D-type cyclins</e2> bind to and activate the cyclin-dependent kinases <e1>Cdk4</e1> and Cdk6, which in turn phosphorylate their downstream target, the retinoblastoma protein Rb. Upon Rb phosphorylation, the E2F transcription factors activate the expression of",
    "direct",
    "12459251"
   ]
  ]
 },
 "D-type cyclins,Cdk6": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Cell cycle activation is coordinated by D-type cyclins which are rate limiting and essential for the progression through the G1 phase of the cell cycle. <e1>D-type cyclins</e1> bind to and activate the cyclin-dependent kinases Cdk4 and <e2>Cdk6</e2>, which in turn phosphorylate their downstream target, the retinoblastoma protein Rb. Upon Rb phosphorylation, the E2F transcription factors activate the expression of S-phase",
    "direct",
    "12459251"
   ]
  ]
 },
 "Cdk4,retinoblastoma protein": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "are rate limiting and essential for the progression through the G1 phase of the cell cycle. D-type cyclins bind to and activate the cyclin-dependent kinases <e1>Cdk4</e1> and Cdk6, which in turn phosphorylate their downstream target, the <e2>retinoblastoma protein</e2> Rb. Upon Rb phosphorylation, the E2F transcription factors activate the expression of S-phase genes and thereby induce cell cycle progression. The raise of cyclin",
    "direct",
    "12459251"
   ]
  ]
 },
 "Cdk6,retinoblastoma protein": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "limiting and essential for the progression through the G1 phase of the cell cycle. D-type cyclins bind to and activate the cyclin-dependent kinases Cdk4 and <e1>Cdk6</e1>, which in turn phosphorylate their downstream target, the <e2>retinoblastoma protein</e2> Rb. Upon Rb phosphorylation, the E2F transcription factors activate the expression of S-phase genes and thereby induce cell cycle progression. The raise of cyclin",
    "direct",
    "12459251"
   ]
  ]
 },
 "histone acetylases,cyclin D": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "rely on the kinase function of Cdk4, indicating that this function is probably independent of cell cycle progression. Further extending its role in gene regulation, <e2>cyclin D</e2> interacts with <e1>histone acetylases</e1> such as P/CAF or NcoA/SRC1a but also with components of the transcriptional machinery such as TAF(II)250. Therefore, these studies suggest that the functions of",
    "direct",
    "12459251"
   ]
  ]
 },
 "NcoA,cyclin D": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "rely on the kinase function of Cdk4, indicating that this function is probably independent of cell cycle progression. Further extending its role in gene regulation, <e2>cyclin D</e2> interacts with histone acetylases such as P/CAF or <e1>NcoA</e1>/SRC1a but also with components of the transcriptional machinery such as TAF(II)250. Therefore, these studies suggest that the functions of cyclin D might need",
    "direct",
    "12459251"
   ]
  ]
 },
 "PCAF,cyclin D": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "rely on the kinase function of Cdk4, indicating that this function is probably independent of cell cycle progression. Further extending its role in gene regulation, <e2>cyclin D</e2> interacts with histone acetylases such as <e1>P/CAF</e1> or NcoA/SRC1a but also with components of the transcriptional machinery such as TAF(II)250. Therefore, these studies suggest that the functions of cyclin D",
    "direct",
    "12459251"
   ]
  ]
 },
 "TAF(II)250,cyclin D": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "rely on the kinase function of Cdk4, indicating that this function is probably independent of cell cycle progression. Further extending its role in gene regulation, <e2>cyclin D</e2> interacts with histone acetylases such as P/CAF or NcoA/SRC1a but also with components of the transcriptional machinery such as <e1>TAF(II)250</e1>. Therefore, these studies suggest that the functions of cyclin D might need to be reevaluated. They have established a new cdk-independent role of cyclin D1",
    "direct",
    "12459251"
   ]
  ]
 },
 "Licochalcone A,IkappaBalpha": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "TNFalpha and MCP-1 in C57BL/6 mice was clearly decreased, indicating that Licochalcone A has a potent anti-inflammatory effect both in vitro and in vivo. Strikingly, <e1>Licochalcone A</e1> significantly inhibited LPS-induced NF-kappaB transcriptional activation; however, it had no effect on not only the phosphorylation and degradation of <e2>IkappaBalpha</e2> but also nuclear translocation and DNA binding activity of NF-kappaB p65. Interestingly, Licochalcone A markedly inhibited the phosphorylation of p65 at serine 276. As a",
    "direct",
    "19168128"
   ]
  ]
 },
 "Licochalcone A,NF-kappaB": {
  "relations": [
   "controls-transport-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "TNFalpha and MCP-1 in C57BL/6 mice was clearly decreased, indicating that Licochalcone A has a potent anti-inflammatory effect both in vitro and in vivo. Strikingly, <e1>Licochalcone A</e1> significantly inhibited LPS-induced NF-kappaB transcriptional activation; however, it had no effect on not only the phosphorylation and degradation of IkappaBalpha but also nuclear translocation and DNA binding activity of <e2>NF-kappaB</e2> p65. Interestingly, Licochalcone A markedly inhibited the phosphorylation of p65 at serine 276. As a result, it reduced NF-kappaB transactivation by preventing the interaction of",
    "direct",
    "19168128"
   ]
  ]
 },
 "Licochalcone A,p65": {
  "relations": [
   "controls-transport-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "TNFalpha and MCP-1 in C57BL/6 mice was clearly decreased, indicating that Licochalcone A has a potent anti-inflammatory effect both in vitro and in vivo. Strikingly, <e1>Licochalcone A</e1> significantly inhibited LPS-induced NF-kappaB transcriptional activation; however, it had no effect on not only the phosphorylation and degradation of IkappaBalpha but also nuclear translocation and DNA binding activity of NF-kappaB <e2>p65</e2>. Interestingly, Licochalcone A markedly inhibited the phosphorylation of p65 at serine 276. As a result, it reduced NF-kappaB transactivation by preventing the interaction of",
    "direct",
    "19168128"
   ]
  ]
 },
 "p300,p65": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "p65. Interestingly, Licochalcone A markedly inhibited the phosphorylation of p65 at serine 276. As a result, it reduced NF-kappaB transactivation by preventing the interaction of <e2>p65</e2> with <e1>p300</e1>. Taken together, Licochalcone A might contribute to the potent anti-inflammatory effect of G. inflata through the unique mechanism of NF-kappaB inhibition.",
    "direct",
    "19168128"
   ]
  ]
 },
 "NEMO,RIP": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "negative regulator of NF-kappaB signalling. Optineurin, mutated in certain glaucomas and amyotrophic lateral sclerosis, is also a negative regulator of NF-kappaB activation. It competes with <e1>NEMO</e1> (NF-kappaB essential modulator) for binding to ubiquitinated <e2>RIP</e2> (receptor interacting protein) to prevent NF-kappaB activation. Recently we identified CYLD as optineurin-interacting protein. Here we have analysed the functional significance of interaction of",
    "direct",
    "21408173"
   ]
  ]
 },
 "optineurin,CYLD": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "of NF-kappaB activation. It competes with NEMO (NF-kappaB essential modulator) for binding to ubiquitinated RIP (receptor interacting protein) to prevent NF-kappaB activation. Recently we identified <e2>CYLD</e2> as <e1>optineurin</e1>-interacting protein. Here we have analysed the functional significance of interaction of optineurin with CYLD. Our results show that a glaucoma-associated mutant of optineurin, H486R, is",
    "direct",
    "21408173"
   ]
  ]
 },
 "CYLD,optineurin": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "RIP (receptor interacting protein) to prevent NF-kappaB activation. Recently we identified CYLD as optineurin-interacting protein. Here we have analysed the functional significance of interaction of <e2>optineurin</e2> with <e1>CYLD</e1>. Our results show that a glaucoma-associated mutant of optineurin, H486R, is altered in its interaction with CYLD. Unlike wild-type optineurin, the H486R mutant did",
    "direct",
    "21408173"
   ]
  ]
 },
 "H486R,CYLD": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "as optineurin-interacting protein. Here we have analysed the functional significance of interaction of optineurin with CYLD. Our results show that a glaucoma-associated mutant of optineurin, <e1>H486R</e1>, is altered in its interaction with <e2>CYLD</e2>. Unlike wild-type optineurin, the H486R mutant did not inhibit tumour necrosis factor alpha (TNFalpha)-induced NF-kappaB activation. CYLD mediated inhibition of TNFalpha-induced NF-kappaB activation was",
    "direct",
    "21408173"
   ]
  ]
 },
 "CYLD,RIP": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "cells. Deubiquitination of RIP by over-expressed CYLD was abrogated in optineurin knockdown cells. These results suggest that optineurin regulates NF-kappaB activation by mediating interaction of <e1>CYLD</e1> with ubiquitinated <e2>RIP</e2> thus facilitating deubiquitination of RIP.",
    "direct",
    "21408173"
   ]
  ]
 },
 "TRAIL,KILLER": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "p53-independent upregulation of KILLER/DR5 TRAIL receptor expression by glucocorticoids and interferon-gamma. <e2>KILLER</e2>/DR5 is a death-domain-containing proapoptotic receptor that binds to the cytotoxic ligand <e1>TRAIL</e1>. It was originally reported that induction of KILLER/DR5 mRNA following DNA damage was p53-dependent, but some drugs that induce apoptosis can upregulate KILLER/DR5 mRNA",
    "direct",
    "11139340"
   ]
  ]
 },
 "BTK,BCR": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "mutation also interferes with BCR-directed activation of IkappaB kinase (IKK), which normally targets the NF-kappaB inhibitor IkappaBalpha for degradation. Taken together, these findings indicate that <e1>BTK</e1> couples IKK and NF-kappaB to the <e2>BCR</e2>. Interference with this coupling mechanism may contribute to the B cell deficiencies observed in XLA and xid.",
    "direct",
    "10811867"
   ],
   [
    "mutation also interferes with BCR-directed activation of IkappaB kinase (IKK), which normally targets the NF-kappaB inhibitor IkappaBalpha for degradation. Taken together, these findings indicate that <e1>BTK</e1> couples IKK and NF-kappaB to the <e2>BCR</e2>. Interference with this coupling mechanism may contribute to the B cell deficiencies observed in XLA and xid.",
    "direct",
    "10811867"
   ]
  ]
 },
 "BTK,NF-kappaB": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "mutation also interferes with BCR-directed activation of IkappaB kinase (IKK), which normally targets the NF-kappaB inhibitor IkappaBalpha for degradation. Taken together, these findings indicate that <e1>BTK</e1> couples IKK and <e2>NF-kappaB</e2> to the BCR. Interference with this coupling mechanism may contribute to the B cell deficiencies observed in XLA and xid.",
    "direct",
    "10811867"
   ]
  ]
 },
 "BCR,NF-kappaB": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "BCR-directed activation of IkappaB kinase (IKK), which normally targets the NF-kappaB inhibitor IkappaBalpha for degradation. Taken together, these findings indicate that BTK couples IKK and <e2>NF-kappaB</e2> to the <e1>BCR</e1>. Interference with this coupling mechanism may contribute to the B cell deficiencies observed in XLA and xid.",
    "direct",
    "10811867"
   ]
  ]
 },
 "BTK,IKK": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "mutation also interferes with BCR-directed activation of IkappaB kinase (IKK), which normally targets the NF-kappaB inhibitor IkappaBalpha for degradation. Taken together, these findings indicate that <e1>BTK</e1> couples <e2>IKK</e2> and NF-kappaB to the BCR. Interference with this coupling mechanism may contribute to the B cell deficiencies observed in XLA and xid.",
    "direct",
    "10811867"
   ]
  ]
 },
 "IKK,BCR": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "interferes with BCR-directed activation of IkappaB kinase (IKK), which normally targets the NF-kappaB inhibitor IkappaBalpha for degradation. Taken together, these findings indicate that BTK couples <e1>IKK</e1> and NF-kappaB to the <e2>BCR</e2>. Interference with this coupling mechanism may contribute to the B cell deficiencies observed in XLA and xid.",
    "direct",
    "10811867"
   ]
  ]
 },
 "TRIF,NFkappaB": {
  "relations": [
   "controls-transport-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "x 10(9) bacteria, while MyD88-KO and DKO animals were completely protected from delivery. Intrauterine fetal survival, maintenance of circulating progesterone levels, and nuclear translocation of <e2>NFkappaB</e2> were also dependent upon MyD88 but not <e1>TRIF</e1>. In contrast, induction of uterine interleukin (IL)-1beta and tumor necrosis factor alpha (TNF-alpha) depends upon actions of both MyD88 and TRIF. CONCLUSION: E",
    "direct",
    "19121660"
   ]
  ]
 },
 "NF-kappaB,ICAM-1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "binding site. Interestingly, inhibition of Erg expression in quiescent EC results in increased NF-kappaB-dependent ICAM-1 expression, indicating that Erg represses basal NF-kappaB activity. Erg prevents <e1>NF-kappaB</e1> p65 from binding to the <e2>ICAM-1</e2> promoter, suggesting a direct mechanism of interference. Gene set enrichment analysis of transcriptome profiles of Erg and NF-kappaB-dependent genes, together with chromatin immunoprecipitation (ChIP)",
    "direct",
    "22337883"
   ]
  ]
 },
 "p65,ICAM-1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "site. Interestingly, inhibition of Erg expression in quiescent EC results in increased NF-kappaB-dependent ICAM-1 expression, indicating that Erg represses basal NF-kappaB activity. Erg prevents NF-kappaB <e1>p65</e1> from binding to the <e2>ICAM-1</e2> promoter, suggesting a direct mechanism of interference. Gene set enrichment analysis of transcriptome profiles of Erg and NF-kappaB-dependent genes, together with chromatin immunoprecipitation (ChIP)",
    "direct",
    "22337883"
   ]
  ]
 },
 "eIF4E,eIF4E-binding proteins": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "inhibitor 4E-BP1. In most instances, translation is regulated at the initiation phase, when a ribosome is recruited to the 5' end of an mRNA. The <e2>eIF4E-binding proteins</e2> (4E-BPs) interdict translation initiation by binding to the translation factor <e1>eIF4E</e1>, and preventing recruitment of the translation machinery to mRNA. The 4E-BPs inhibit translation in a reversible manner. Hypophosphorylated 4E-BPs interact avidly with eIF4E, whereas",
    "direct",
    "11691836"
   ]
  ]
 },
 "eIF4E,4E-BPs": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "by binding to the translation factor eIF4E, and preventing recruitment of the translation machinery to mRNA. The 4E-BPs inhibit translation in a reversible manner. Hypophosphorylated <e2>4E-BPs</e2> interact avidly with <e1>eIF4E</e1>, whereas 4E-BP hyperphosphorylation, elicited by stimulation of cells with hormones, cytokines, or growth factors, results in an abrogation of eIF4E-binding activity. We reported previously",
    "direct",
    "11691836"
   ]
  ]
 },
 "4E-BP,eIF4E": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "eIF4E, and preventing recruitment of the translation machinery to mRNA. The 4E-BPs inhibit translation in a reversible manner. Hypophosphorylated 4E-BPs interact avidly with eIF4E, whereas <e1>4E-BP</e1> hyperphosphorylation, elicited by stimulation of cells with hormones, cytokines, or growth factors, results in an abrogation of <e2>eIF4E</e2>-binding activity. We reported previously that phosphorylation of 4E-BP1 on Thr 37 and Thr 46 is relatively insensitive to serum deprivation and rapamycin treatment,",
    "direct",
    "11691836"
   ]
  ]
 },
 "4E-BP1,eIF4E": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "of Ser 65 and Thr 70 alone is insufficient to block binding to eIF4E, indicating that a combination of phosphorylation events is necessary to dissociate <e1>4E-BP1</e1> from <e2>eIF4E</e2>.",
    "direct",
    "11691836"
   ],
   [
    "factor 4E (eIF4E) binds the mRNA cap structure and forms eIF4F complexes that recruit 40S subunits to the mRNA. Formation of eIF4F is blocked by <e2>eIF4E</e2>-binding proteins such as <e1>4E-BP1</e1>, which interacts with eIF4E via a motif in the center of its 118-residue sequence. 4E-BP1 plays key roles in cell proliferation, growth, and survival.",
    "direct",
    "12588975"
   ],
   [
    "terminus (S101). A serine or glutamate at this position is required for efficient phosphorylation at Ser65. A second C-terminal site, S112, directly affects binding of <e1>4E-BP1</e1> to <e2>eIF4E</e2> without influencing phosphorylation of other sites. Thirdly, a conserved C-terminal motif influences phosphorylation of multiple residues, including rapamycin-insensitive sites. These relatively long-range effects",
    "direct",
    "12588975"
   ],
   [
    "Thirdly, a conserved C-terminal motif influences phosphorylation of multiple residues, including rapamycin-insensitive sites. These relatively long-range effects are surprising given the reportedly unstructured nature of <e1>4E-BP1</e1> and may imply that phosphorylation of 4E-BP1 and/or binding to <e2>eIF4E</e2> induces a more-ordered structure. 4E-BP2 and -3 lack phosphorylatable residues corresponding to both S101 and S112. However, in 4E-BP3, replacement of the alanine",
    "direct",
    "12588975"
   ]
  ]
 },
 "Gin4,septin": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "emergence and telophase and are immobile during S, G2, and M phases. Immobilization of the septins is dependent on both Cla4, a PAK-like kinase, and <e1>Gin4</e1>, a septin-dependent kinase that can phosphorylate the <e2>septin</e2> Shs1/Sep7. Induction of septin ring dynamics in telophase is triggered by the translocation of Rts1, a kinetochore-associated regulatory subunit of PP2A phosphatase, to the",
    "direct",
    "12636916"
   ]
  ]
 },
 "Gin4,Shs1": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "emergence and telophase and are immobile during S, G2, and M phases. Immobilization of the septins is dependent on both Cla4, a PAK-like kinase, and <e1>Gin4</e1>, a septin-dependent kinase that can phosphorylate the septin <e2>Shs1</e2>/Sep7. Induction of septin ring dynamics in telophase is triggered by the translocation of Rts1, a kinetochore-associated regulatory subunit of PP2A phosphatase, to the bud",
    "direct",
    "12636916"
   ]
  ]
 },
 "Ipl1p,Mad3p": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "required to correct inappropriate kinetochore-microtubule attachments and for the response to lack of tension between sister kinetochores. Here we identify residues in the checkpoint protein <e2>Mad3p</e2> that are phosphorylated by <e1>Ipl1p</e1>. When phosphorylation of Mad3p at two sites is prevented, the cell's response to reduced kinetochore tension is dramatically curtailed. Our data provide strong",
    "direct",
    "17504936"
   ]
  ]
 },
 "survivin,p130": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "we provide evidence of a molecular link between the regulation of survivin transcription and the RB/E2F family of proteins. We demonstrate that both pRB and <e2>p130</e2> can interact with the <e1>survivin</e1> promoter and can repress survivin transcription. We also show that the E2F activators (E2F1, E2F2, and E2F3) can bind to the survivin promoter and",
    "direct",
    "15271987"
   ]
  ]
 },
 "pRB,survivin": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "embryonic fibroblasts, we provide evidence of a molecular link between the regulation of survivin transcription and the RB/E2F family of proteins. We demonstrate that both <e1>pRB</e1> and p130 can interact with the <e2>survivin</e2> promoter and can repress survivin transcription. We also show that the E2F activators (E2F1, E2F2, and E2F3) can bind to the survivin promoter and",
    "direct",
    "15271987"
   ]
  ]
 },
 "E2F3,survivin": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "both pRB and p130 can interact with the survivin promoter and can repress survivin transcription. We also show that the E2F activators (E2F1, E2F2, and <e1>E2F3</e1>) can bind to the <e2>survivin</e2> promoter and induce survivin transcription. Genetically modified cells that harbor deletions in various members of the RB/E2F family confirm our data from the wild-type",
    "direct",
    "15271987"
   ]
  ]
 },
 "E2F1,survivin": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "We demonstrate that both pRB and p130 can interact with the survivin promoter and can repress survivin transcription. We also show that the E2F activators (<e1>E2F1</e1>, E2F2, and E2F3) can bind to the <e2>survivin</e2> promoter and induce survivin transcription. Genetically modified cells that harbor deletions in various members of the RB/E2F family confirm our data from the wild-type",
    "direct",
    "15271987"
   ]
  ]
 },
 "survivin,E2F2": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "demonstrate that both pRB and p130 can interact with the survivin promoter and can repress survivin transcription. We also show that the E2F activators (E2F1, <e2>E2F2</e2>, and E2F3) can bind to the <e1>survivin</e1> promoter and induce survivin transcription. Genetically modified cells that harbor deletions in various members of the RB/E2F family confirm our data from the wild-type",
    "direct",
    "15271987"
   ]
  ]
 },
 "Fus3,Tec1": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "whether signal-specific activation of mating and invasive growth involves regulation of the transcription factor Tec1 by Fus3 and Kss1. We present evidence that, during mating, <e1>Fus3</e1> phosphorylates <e2>Tec1</e2> to downregulate this invasive growth-specific transcription factor and its target genes. This function of Fus3 is essential for correct execution of the mating program",
    "direct",
    "15558284"
   ]
  ]
 },
 "Kss1,TEC1": {
  "relations": [
   "controls-expression-of"
  ],
  "mentions": [
   [
    "its target genes. This function of Fus3 is essential for correct execution of the mating program and is not shared by Kss1. We find that <e1>Kss1</e1> controls the activity of Tec1 mainly during invasive growth by control of <e2>TEC1</e2> gene expression. Our study suggests that signaling specificity can arise from differential regulation of a single transcription factor by two MAP kinases with",
    "direct",
    "15558284"
   ]
  ]
 },
 "eukaryotic initiation factor 3 (eIF3) translation initiation complex,mTOR": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "targets linked to translation. However, the molecular mechanisms whereby S6K1 is activated, encounters substrate, and contributes to translation initiation are poorly understood. We show that <e2>mTOR</e2> and S6K1 maneuver on and off the <e1>eukaryotic initiation factor 3 (eIF3) translation initiation complex</e1> in a signal-dependent, choreographed fashion. When inactive, S6K1 associates with the eIF3 complex, while the S6K1 activator mTOR/raptor does not. Cell stimulation promotes mTOR/raptor",
    "direct",
    "16286006"
   ]
  ]
 },
 "eukaryotic initiation factor 3 (eIF3) translation initiation complex,S6K1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "to translation. However, the molecular mechanisms whereby S6K1 is activated, encounters substrate, and contributes to translation initiation are poorly understood. We show that mTOR and <e2>S6K1</e2> maneuver on and off the <e1>eukaryotic initiation factor 3 (eIF3) translation initiation complex</e1> in a signal-dependent, choreographed fashion. When inactive, S6K1 associates with the eIF3 complex, while the S6K1 activator mTOR/raptor does not. Cell stimulation promotes mTOR/raptor",
    "direct",
    "16286006"
   ]
  ]
 },
 "S6K1,eIF3 complex": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "show that mTOR and S6K1 maneuver on and off the eukaryotic initiation factor 3 (eIF3) translation initiation complex in a signal-dependent, choreographed fashion. When inactive, <e1>S6K1</e1> associates with the <e2>eIF3 complex</e2>, while the S6K1 activator mTOR/raptor does not. Cell stimulation promotes mTOR/raptor binding to the eIF3 complex and phosphorylation of S6K1 at its hydrophobic motif.",
    "direct",
    "16286006"
   ]
  ]
 },
 "eIF3 complex,raptor": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "S6K1 maneuver on and off the eukaryotic initiation factor 3 (eIF3) translation initiation complex in a signal-dependent, choreographed fashion. When inactive, S6K1 associates with the <e1>eIF3 complex</e1>, while the S6K1 activator mTOR/<e2>raptor</e2> does not. Cell stimulation promotes mTOR/raptor binding to the eIF3 complex and phosphorylation of S6K1 at its hydrophobic motif. Phosphorylation results in S6K1 dissociation, activation,",
    "direct",
    "16286006"
   ],
   [
    "initiation complex in a signal-dependent, choreographed fashion. When inactive, S6K1 associates with the eIF3 complex, while the S6K1 activator mTOR/raptor does not. Cell stimulation promotes mTOR/<e2>raptor</e2> binding to the <e1>eIF3 complex</e1> and phosphorylation of S6K1 at its hydrophobic motif. Phosphorylation results in S6K1 dissociation, activation, and subsequent phosphorylation of its translational targets, including eIF4B, which",
    "direct",
    "16286006"
   ]
  ]
 },
 "eIF3 complex,mTOR": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "S6K1 maneuver on and off the eukaryotic initiation factor 3 (eIF3) translation initiation complex in a signal-dependent, choreographed fashion. When inactive, S6K1 associates with the <e1>eIF3 complex</e1>, while the S6K1 activator <e2>mTOR</e2>/raptor does not. Cell stimulation promotes mTOR/raptor binding to the eIF3 complex and phosphorylation of S6K1 at its hydrophobic motif. Phosphorylation results in S6K1 dissociation,",
    "direct",
    "16286006"
   ],
   [
    "initiation complex in a signal-dependent, choreographed fashion. When inactive, S6K1 associates with the eIF3 complex, while the S6K1 activator mTOR/raptor does not. Cell stimulation promotes <e2>mTOR</e2>/raptor binding to the <e1>eIF3 complex</e1> and phosphorylation of S6K1 at its hydrophobic motif. Phosphorylation results in S6K1 dissociation, activation, and subsequent phosphorylation of its translational targets, including eIF4B, which",
    "direct",
    "16286006"
   ]
  ]
 },
 "eIF3 complex,eIF4B": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "signal-dependent, choreographed fashion. When inactive, S6K1 associates with the eIF3 complex, while the S6K1 activator mTOR/raptor does not. Cell stimulation promotes mTOR/raptor binding to the <e1>eIF3 complex</e1> and phosphorylation of S6K1 at its hydrophobic motif. Phosphorylation results in S6K1 dissociation, activation, and subsequent phosphorylation of its translational targets, including <e2>eIF4B</e2>, which is then recruited into the complex in a phosphorylation-dependent manner. Thus, the eIF3 preinitiation complex acts as a scaffold to coordinate a dynamic",
    "direct",
    "16286006"
   ]
  ]
 },
 "IL-33,NF-kappaB": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "The dual function cytokine <e1>IL-33</e1> interacts with the transcription factor <e2>NF-kappaB</e2> to dampen NF-kappaB-stimulated gene transcription. Full-length IL-33 is a member of the IL-1 family of cytokines, which can act in an autocrine or paracrine",
    "direct",
    "21734074"
   ],
   [
    "an intracrine fashion by translocating to the nucleus, where it binds to the chromatin and modulates gene expression. In this article, we report that full-length <e1>IL-33</e1>, but not mature IL-33, interacts with the transcription factor <e2>NF-kappaB</e2>. This interaction occurs between the N-terminal part of IL-33 from aa 66-109 and the N-terminal Rel homology domain of NF-kappaB p65. Coimmunoprecipitation experiments in cells",
    "direct",
    "21734074"
   ],
   [
    "an intracrine fashion by translocating to the nucleus, where it binds to the chromatin and modulates gene expression. In this article, we report that full-length <e1>IL-33</e1>, but not mature IL-33, interacts with the transcription factor <e2>NF-kappaB</e2>. This interaction occurs between the N-terminal part of IL-33 from aa 66-109 and the N-terminal Rel homology domain of NF-kappaB p65. Coimmunoprecipitation experiments in cells",
    "direct",
    "21734074"
   ]
  ]
 },
 "p65,IL-33": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "aa 66-109 and the N-terminal Rel homology domain of NF-kappaB p65. Coimmunoprecipitation experiments in cells overexpressing IL-33 or endogenously expressing IL-33 revealed rhIL-1beta-stimulated association between <e2>IL-33</e2> and <e1>p65</e1>, whereas binding to the p50 subunit was constitutive. The biological consequence of IL-33/NF-kappaB complex formation was reduction in NF-kappaB p65 binding to its",
    "direct",
    "21734074"
   ]
  ]
 },
 "parathyroid hormone,Pi": {
  "relations": [
   "controls-transport-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "are subdivided into type I (NaPi-1) and a type II (NaPi-2). Electrophysiological studies reveal that Pi transport by Na/Pi cotransporters is electrogenic. Regulation of proximal <e2>Pi</e2> reabsorption by dietary Pi intake and <e1>parathyroid hormone</e1> is primarily due to an alteration of apical type II Na/Pi cotransport; a rapid change of brush-border Na/Pi cotransport most likely occurs via an",
    "direct",
    "8815811"
   ]
  ]
 },
 "Mnd2,APC": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "mutation of Mnd2 phosphorylation sites to aspartic acid resulted in partial suppression of the sporulation defect. No differences were observed in the binding between each <e1>Mnd2</e1> isoform and the <e2>APC</e2> in vitro. However, in vivo, we observed a gradient in the abundance of APC-associated Mnd2 in each strain that was proportional to the",
    "direct",
    "17459880"
   ],
   [
    "were observed in the binding between each Mnd2 isoform and the APC in vitro. However, in vivo, we observed a gradient in the abundance of <e2>APC</e2>-associated <e1>Mnd2</e1> in each strain that was proportional to the observed differences in sporulation and Clb5 levels. Taken together, these data suggest that mitotic phosphorylation of",
    "direct",
    "17459880"
   ]
  ]
 },
 "nitrite,MPO": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "state conditions by using sequential mixing stopped-flow analysis in the pH range 4-8. At 15 degrees C the rate of formation of the low spin <e2>MPO</e2>-<e1>nitrite</e1> complex is (2.5 +/- 0.2) x 10(4) m(-1) s(-1) at pH 7 and (2.2 +/- 0.7) x 10(6) m(-1) s(-1) at pH 5. The dissociation",
    "direct",
    "10777476"
   ]
  ]
 },
 "Hog1,RNA Pol II": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "MAPK. Unexpectedly, recruitment of RNA polymerase (Pol) II complex to target promoters does not depend on the phosphorylation of the Hot1 activator by the MAPK. <e1>Hog1</e1> interacts with the <e2>RNA Pol II</e2> and with general components of the transcription machinery. More over, when tethered to a promoter as a LexA fusion protein, Hog1 activates transcription",
    "direct",
    "12743037"
   ]
  ]
 },
 "RNA Pol II,p38": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "regulated manner. Thus, anchoring of active Hog1 to promoters by the Hot1 activator is essential for recruitment and activation of RNA Pol II. The mammalian <e2>p38</e2> also interacts with the <e1>RNA Pol II</e1>, which might suggest a conserved mechanism for regulation of gene expression by SAPKs among eukaryotic cells.",
    "direct",
    "12743037"
   ]
  ]
 },
 "Na+-H+ exchanger,Na+": {
  "relations": [
   "controls-transport-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "Kinetic properties of the plasma membrane Na+-H+ exchanger. The plasma membrane <e1>Na+-H+ exchanger</e1> is a ubiquitous transport system that participates in diverse cell functions involving the cellular uptake of <e2>Na+</e2> or extrusion of H+. It has a tightly coupled 1:1 stoichiometry, has affinity for Li+ and NH+4 in addition to Na+ and H+,",
    "direct",
    "2581505"
   ]
  ]
 },
 "Na+-H+ exchanger,H+": {
  "relations": [
   "in-complex-with",
   "controls-transport-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "Kinetic properties of the plasma membrane Na+-H+ exchanger. The plasma membrane <e1>Na+-H+ exchanger</e1> is a ubiquitous transport system that participates in diverse cell functions involving the cellular uptake of Na+ or extrusion of <e2>H+</e2>. It has a tightly coupled 1:1 stoichiometry, has affinity for Li+ and NH+4 in addition to Na+ and H+, and can function in",
    "direct",
    "2581505"
   ],
   [
    "Kinetic properties of the plasma membrane Na+-H+ exchanger. The plasma membrane <e1>Na+-H+ exchanger</e1> is a ubiquitous transport system that participates in diverse cell functions involving the cellular uptake of Na+ or extrusion of H+. It has a tightly coupled 1:1 stoichiometry, has affinity for Li+ and NH+4 in addition to Na+ and <e2>H+</e2>, and can function in multiple amiloride-sensitive exchange modes involving these cations. These general transport properties may be explained by kinetic models involving either",
    "direct",
    "2581505"
   ]
  ]
 },
 "NH+4,Na+-H+ exchanger": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Kinetic properties of the plasma membrane Na+-H+ exchanger. The plasma membrane <e2>Na+-H+ exchanger</e2> is a ubiquitous transport system that participates in diverse cell functions involving the cellular uptake of Na+ or extrusion of H+. It has a tightly coupled 1:1 stoichiometry, has affinity for Li+ and <e1>NH+4</e1> in addition to Na+ and H+, and can function in multiple amiloride-sensitive exchange modes involving these cations. These general transport properties may be",
    "direct",
    "2581505"
   ]
  ]
 },
 "NH+4,Li+": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "participates in diverse cell functions involving the cellular uptake of Na+ or extrusion of H+. It has a tightly coupled 1:1 stoichiometry, has affinity for <e2>Li+</e2> and <e1>NH+4</e1> in addition to Na+ and H+, and can function in multiple amiloride-sensitive exchange modes involving these cations. These general transport properties may be",
    "direct",
    "2581505"
   ]
  ]
 },
 "Na+-H+ exchanger,Li+": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Kinetic properties of the plasma membrane Na+-H+ exchanger. The plasma membrane <e1>Na+-H+ exchanger</e1> is a ubiquitous transport system that participates in diverse cell functions involving the cellular uptake of Na+ or extrusion of H+. It has a tightly coupled 1:1 stoichiometry, has affinity for <e2>Li+</e2> and NH+4 in addition to Na+ and H+, and can function in multiple amiloride-sensitive exchange modes involving these cations. These general transport properties",
    "direct",
    "2581505"
   ]
  ]
 },
 "Na+,Na+-H+ exchanger": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Kinetic properties of the plasma membrane Na+-H+ exchanger. The plasma membrane <e2>Na+-H+ exchanger</e2> is a ubiquitous transport system that participates in diverse cell functions involving the cellular uptake of Na+ or extrusion of H+. It has a tightly coupled 1:1 stoichiometry, has affinity for Li+ and NH+4 in addition to <e1>Na+</e1> and H+, and can function in multiple amiloride-sensitive exchange modes involving these cations. These general transport properties may be explained by kinetic models",
    "direct",
    "2581505"
   ]
  ]
 },
 "Na+,H+": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "the cellular uptake of Na+ or extrusion of H+. It has a tightly coupled 1:1 stoichiometry, has affinity for Li+ and NH+4 in addition to <e1>Na+</e1> and <e2>H+</e2>, and can function in multiple amiloride-sensitive exchange modes involving these cations. These general transport properties may be explained by kinetic models involving either",
    "direct",
    "2581505"
   ]
  ]
 },
 "amiloride,cations": {
  "relations": [
   "controls-transport-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "H+. It has a tightly coupled 1:1 stoichiometry, has affinity for Li+ and NH+4 in addition to Na+ and H+, and can function in multiple <e1>amiloride</e1>-sensitive exchange modes involving these <e2>cations</e2>. These general transport properties may be explained by kinetic models involving either cation-hydroxyl cotransport or actual cation-proton exchange. The most important kinetic property of",
    "direct",
    "2581505"
   ]
  ]
 },
 "amiloride,Li+": {
  "relations": [
   "controls-transport-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "participates in diverse cell functions involving the cellular uptake of Na+ or extrusion of H+. It has a tightly coupled 1:1 stoichiometry, has affinity for <e2>Li+</e2> and NH+4 in addition to Na+ and H+, and can function in multiple <e1>amiloride</e1>-sensitive exchange modes involving these cations. These general transport properties may be explained by kinetic models involving either cation-hydroxyl cotransport or actual cation-proton exchange. The most",
    "direct",
    "2581505"
   ]
  ]
 },
 "amiloride,NH+4": {
  "relations": [
   "controls-transport-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "diverse cell functions involving the cellular uptake of Na+ or extrusion of H+. It has a tightly coupled 1:1 stoichiometry, has affinity for Li+ and <e2>NH+4</e2> in addition to Na+ and H+, and can function in multiple <e1>amiloride</e1>-sensitive exchange modes involving these cations. These general transport properties may be explained by kinetic models involving either cation-hydroxyl cotransport or actual cation-proton exchange. The most",
    "direct",
    "2581505"
   ]
  ]
 },
 "amiloride,Na+": {
  "relations": [
   "controls-transport-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "the cellular uptake of Na+ or extrusion of H+. It has a tightly coupled 1:1 stoichiometry, has affinity for Li+ and NH+4 in addition to <e2>Na+</e2> and H+, and can function in multiple <e1>amiloride</e1>-sensitive exchange modes involving these cations. These general transport properties may be explained by kinetic models involving either cation-hydroxyl cotransport or actual cation-proton exchange. The most",
    "direct",
    "2581505"
   ]
  ]
 },
 "amiloride,H+": {
  "relations": [
   "controls-transport-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "uptake of Na+ or extrusion of H+. It has a tightly coupled 1:1 stoichiometry, has affinity for Li+ and NH+4 in addition to Na+ and <e2>H+</e2>, and can function in multiple <e1>amiloride</e1>-sensitive exchange modes involving these cations. These general transport properties may be explained by kinetic models involving either cation-hydroxyl cotransport or actual cation-proton exchange. The most",
    "direct",
    "2581505"
   ]
  ]
 },
 "NRF,p65": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Mapping of <e1>NRF</e1> binding motifs of NF-kappaB <e2>p65</e2> subunit. NF-kappaB repressing factor (NRF) is a nuclear transcription factor that binds to a specific DNA sequence in NF-kappaB target promoters. Previous reports suggested",
    "direct",
    "21821668"
   ],
   [
    "interferes with the transcriptional activity of NF-kappaB binding sites through a direct interaction with NF-kappaB subunits. The aim of this study was to map specific <e1>NRF</e1> binding domains in the NF-kappaB proteins, <e2>p65</e2> and p50. Our data demonstrate that NRF is able to interact with the p65 subunit and inhibit its transcription enhancing activity in reporter gene",
    "direct",
    "21821668"
   ],
   [
    "binding activity of the NRF protein is consistently mediated by the N-terminal domain of NRF (Amino acids 1-380). Moreover, the Rel homology domain (RHD) of <e2>p65</e2> is sufficient for binding to the N-terminal domain of <e1>NRF</e1>. Using detailed peptide mapping studies, we finally identify three peptide motifs in p65 RHD showing distinctive binding specificities for the NRF protein. According",
    "direct",
    "21821668"
   ],
   [
    "(RHD) of p65 is sufficient for binding to the N-terminal domain of NRF. Using detailed peptide mapping studies, we finally identify three peptide motifs in <e2>p65</e2> RHD showing distinctive binding specificities for the <e1>NRF</e1> protein. According to the predicted structure of p65, all three peptide motifs align within an exposed region of p65 and might hint at",
    "direct",
    "21821668"
   ]
  ]
 },
 "NRF,NF-kappaB": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Mapping of <e1>NRF</e1> binding motifs of <e2>NF-kappaB</e2> p65 subunit. NF-kappaB repressing factor (NRF) is a nuclear transcription factor that binds to a specific DNA sequence in NF-kappaB target promoters. Previous reports",
    "direct",
    "21821668"
   ]
  ]
 },
 "p65,NF-kappaB": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Mapping of NRF binding motifs of <e2>NF-kappaB</e2> <e1>p65</e1> subunit. NF-kappaB repressing factor (NRF) is a nuclear transcription factor that binds to a specific DNA sequence in NF-kappaB target promoters. Previous reports suggested",
    "direct",
    "21821668"
   ],
   [
    "kappaB-luciferase activity. Moreover, SDF-1alpha-mediated increase of kappaB-luciferase activity was inhibited by pre-transfection of DN-p85, DN-Akt or DN-ERK2. Increase of IKK alpha/beta phosphorylation and binding of <e1>p65</e1> and p50 to the <e2>NF-kappaB</e2> element were both antagonized by PI3K and ERK inhibitors. Our results demonstrate a mechanism linking SDF-1alpha and IL-6, and provide additional support for the notion",
    "direct",
    "19285061"
   ]
  ]
 },
 "NRF,p50": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "interferes with the transcriptional activity of NF-kappaB binding sites through a direct interaction with NF-kappaB subunits. The aim of this study was to map specific <e1>NRF</e1> binding domains in the NF-kappaB proteins, p65 and <e2>p50</e2>. Our data demonstrate that NRF is able to interact with the p65 subunit and inhibit its transcription enhancing activity in reporter gene experiments.",
    "direct",
    "21821668"
   ]
  ]
 },
 "p65,NRF": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "NF-kappaB subunits. The aim of this study was to map specific NRF binding domains in the NF-kappaB proteins, p65 and p50. Our data demonstrate that <e2>NRF</e2> is able to interact with the <e1>p65</e1> subunit and inhibit its transcription enhancing activity in reporter gene experiments. Using tandem affinity purifications (TAP), we show that NRF protein significantly binds",
    "direct",
    "21821668"
   ],
   [
    "able to interact with the p65 subunit and inhibit its transcription enhancing activity in reporter gene experiments. Using tandem affinity purifications (TAP), we show that <e2>NRF</e2> protein significantly binds to the endogenous <e1>p65</e1>, subunit but not to the p50 subunit. The selective binding activity of the NRF protein is consistently mediated by the N-terminal domain of NRF",
    "direct",
    "21821668"
   ]
  ]
 },
 "p50,NRF": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "able to interact with the p65 subunit and inhibit its transcription enhancing activity in reporter gene experiments. Using tandem affinity purifications (TAP), we show that <e2>NRF</e2> protein significantly binds to the endogenous p65, subunit but not to the <e1>p50</e1> subunit. The selective binding activity of the NRF protein is consistently mediated by the N-terminal domain of NRF (Amino acids 1-380). Moreover, the",
    "direct",
    "21821668"
   ]
  ]
 },
 "ROS,AT(1)R": {
  "relations": [
   "controls-expression-of"
  ],
  "mentions": [
   [
    "contrast, nitric oxide (NO) decreases AT(1)R density through cysteine modification (S-nitrosylation) of a transcriptional factor, nuclear factor kappaB (NF-kappaB). The difference between the effects of <e1>ROS</e1> and NO on <e2>AT(1)R</e2> expression may be caused by the difference between intracellular location of ROS signaling and that of NO signaling, as the agonist-induced S-nitrosylation of NF-kappaB",
    "direct",
    "21078404"
   ]
  ]
 },
 "NO,AT(1)R": {
  "relations": [
   "controls-expression-of"
  ],
  "mentions": [
   [
    "oxide (NO) decreases AT(1)R density through cysteine modification (S-nitrosylation) of a transcriptional factor, nuclear factor kappaB (NF-kappaB). The difference between the effects of ROS and <e1>NO</e1> on <e2>AT(1)R</e2> expression may be caused by the difference between intracellular location of ROS signaling and that of NO signaling, as the agonist-induced S-nitrosylation of NF-kappaB",
    "direct",
    "21078404"
   ]
  ]
 },
 "NF-kappaB,NO synthase": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "by the difference between intracellular location of ROS signaling and that of NO signaling, as the agonist-induced S-nitrosylation of NF-kappaB requires a local interaction between <e2>NO synthase</e2> (NOS) and <e1>NF-kappaB</e1> in the perinuclear region. Thus, the spatial and temporal regulation of cysteine modification by ROS or RNS may underlie the resultant changes of AT(1)R signaling",
    "direct",
    "21078404"
   ]
  ]
 },
 "MAPKAP kinase-2,p38": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "a putative nuclear localisation signal which we show is functional and required for activation by a variety of stimuli. Following phosphorylation of MAPKAP kinase-2, nuclear <e2>p38</e2> was exported to the cytoplasm in a complex with <e1>MAPKAP kinase-2</e1>. Export of MAPKAP kinase-2 required phosphorylation by p38 but did not appear to require the kinase activity of MAPKAP kinase-2. The p38 activators MKK3",
    "direct",
    "9768359"
   ]
  ]
 },
 "p38,MAPKAP kinase-2": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "by a variety of stimuli. Following phosphorylation of MAPKAP kinase-2, nuclear p38 was exported to the cytoplasm in a complex with MAPKAP kinase-2. Export of <e2>MAPKAP kinase-2</e2> required phosphorylation by <e1>p38</e1> but did not appear to require the kinase activity of MAPKAP kinase-2. The p38 activators MKK3 and MKK6 were present in both the",
    "direct",
    "9768359"
   ]
  ]
 },
 "p53,mdm2": {
  "relations": [
   "controls-expression-of"
  ],
  "mentions": [
   [
    "The decrease in transcription from the P1 promoter was sufficient to reduce the level of p90(MDM2) and correlated with a prolonged increase in p53. Thus, <e1>p53</e1>-independent transcription of <e2>mdm2</e2> appears critical to p53's regulation.",
    "direct",
    "11593391"
   ],
   [
    "progression and commitment to apoptosis. Expression of hdm2, and its mouse orthologue mdm2, is known to be induced by p53, but recent evidence has demonstrated <e2>mdm2</e2> expression can also be regulated via <e1>p53</e1>-independent pathways. However the p53 independent mechanisms that control transcription of the human hdm2 gene have not been studied. Differential levels of hdm2 mRNA",
    "direct",
    "12750288"
   ]
  ]
 },
 "protein phosphatase 2A,protein kinase C beta II": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "the detergent-soluble fraction of cells. Specifically, the threonine at position 500 (T500) on the activation loop, and T641 and S660 on the carboxyl terminus of <e2>protein kinase C beta II</e2> are phosphorylated in vivo. T500 and S660 are selectively dephosphorylated in vitro by <e1>protein phosphatase 2A</e1> to yield an enzyme that is still capable of lipid-dependent activation, whereas all three residues are dephosphorylated by protein phosphatase 1 to yield an",
    "direct",
    "8749392"
   ],
   [
    "the detergent-soluble fraction of cells. Specifically, the threonine at position 500 (T500) on the activation loop, and T641 and S660 on the carboxyl terminus of <e2>protein kinase C beta II</e2> are phosphorylated in vivo. T500 and S660 are selectively dephosphorylated in vitro by <e1>protein phosphatase 2A</e1> to yield an enzyme that is still capable of lipid-dependent activation, whereas all three residues are dephosphorylated by protein phosphatase 1 to yield an",
    "direct",
    "8749392"
   ]
  ]
 },
 "protein phosphatase 1,protein kinase C beta II": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "the detergent-soluble fraction of cells. Specifically, the threonine at position 500 (T500) on the activation loop, and T641 and S660 on the carboxyl terminus of <e2>protein kinase C beta II</e2> are phosphorylated in vivo. T500 and S660 are selectively dephosphorylated in vitro by protein phosphatase 2A to yield an enzyme that is still capable of lipid-dependent activation, whereas all three residues are dephosphorylated by <e1>protein phosphatase 1</e1> to yield an inactive enzyme. Biochemical analysis reveals that protein kinase C autophosphorylates on S660, that autophosphorylation on S660 follows T641 autophosphorylation, that autophosphorylation",
    "direct",
    "8749392"
   ],
   [
    "the detergent-soluble fraction of cells. Specifically, the threonine at position 500 (T500) on the activation loop, and T641 and S660 on the carboxyl terminus of <e2>protein kinase C beta II</e2> are phosphorylated in vivo. T500 and S660 are selectively dephosphorylated in vitro by protein phosphatase 2A to yield an enzyme that is still capable of lipid-dependent activation, whereas all three residues are dephosphorylated by <e1>protein phosphatase 1</e1> to yield an inactive enzyme. Biochemical analysis reveals that protein kinase C autophosphorylates on S660, that autophosphorylation on S660 follows T641 autophosphorylation, that autophosphorylation",
    "direct",
    "8749392"
   ],
   [
    "the detergent-soluble fraction of cells. Specifically, the threonine at position 500 (T500) on the activation loop, and T641 and S660 on the carboxyl terminus of <e2>protein kinase C beta II</e2> are phosphorylated in vivo. T500 and S660 are selectively dephosphorylated in vitro by protein phosphatase 2A to yield an enzyme that is still capable of lipid-dependent activation, whereas all three residues are dephosphorylated by <e1>protein phosphatase 1</e1> to yield an inactive enzyme. Biochemical analysis reveals that protein kinase C autophosphorylates on S660, that autophosphorylation on S660 follows T641 autophosphorylation, that autophosphorylation",
    "direct",
    "8749392"
   ]
  ]
 },
 "protein kinase C,protein kinase C": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "is still capable of lipid-dependent activation, whereas all three residues are dephosphorylated by protein phosphatase 1 to yield an inactive enzyme. Biochemical analysis reveals that <e2>protein kinase C</e2><e1>protein kinase C</e1> autophosphorylates on S660, that autophosphorylation on S660 follows T641 autophosphorylation, that autophosphorylation on S660 is accompanied by the release of protein kinase",
    "direct",
    "8749392"
   ],
   [
    "is still capable of lipid-dependent activation, whereas all three residues are dephosphorylated by protein phosphatase 1 to yield an inactive enzyme. Biochemical analysis reveals that <e2>protein kinase C</e2><e1>protein kinase C</e1> autophosphorylates on S660, that autophosphorylation on S660 follows T641 autophosphorylation, that autophosphorylation on S660 is accompanied by the release of protein kinase",
    "direct",
    "8749392"
   ],
   [
    "is still capable of lipid-dependent activation, whereas all three residues are dephosphorylated by protein phosphatase 1 to yield an inactive enzyme. Biochemical analysis reveals that <e2>protein kinase C</e2><e1>protein kinase C</e1> autophosphorylates on S660, that autophosphorylation on S660 follows T641 autophosphorylation, that autophosphorylation on S660 is accompanied by the release of protein kinase",
    "direct",
    "8749392"
   ],
   [
    "is still capable of lipid-dependent activation, whereas all three residues are dephosphorylated by protein phosphatase 1 to yield an inactive enzyme. Biochemical analysis reveals that <e2>protein kinase C</e2><e1>protein kinase C</e1> autophosphorylates on S660, that autophosphorylation on S660 follows T641 autophosphorylation, that autophosphorylation on S660 is accompanied by the release of protein kinase",
    "direct",
    "8749392"
   ],
   [
    "is still capable of lipid-dependent activation, whereas all three residues are dephosphorylated by protein phosphatase 1 to yield an inactive enzyme. Biochemical analysis reveals that <e2>protein kinase C</e2><e1>protein kinase C</e1> autophosphorylates on S660, that autophosphorylation on S660 follows T641 autophosphorylation, that autophosphorylation on S660 is accompanied by the release of protein kinase",
    "direct",
    "8749392"
   ],
   [
    "into the cytosol, and that T500 is not an autophosphorylation site. CONCLUSIONS: Structural and biochemical analyses of native and phosphatase-treated protein kinase C indicate that <e2>protein kinase C</e2><e1>protein kinase C</e1> is processed by three phosphorylations. Firstly, trans-phosphorylation on the activation loop (T500) renders it catalytically competent to autophosphorylate. Secondly, a subsequent autophosphorylation",
    "direct",
    "8749392"
   ],
   [
    "into the cytosol, and that T500 is not an autophosphorylation site. CONCLUSIONS: Structural and biochemical analyses of native and phosphatase-treated protein kinase C indicate that <e2>protein kinase C</e2><e1>protein kinase C</e1> is processed by three phosphorylations. Firstly, trans-phosphorylation on the activation loop (T500) renders it catalytically competent to autophosphorylate. Secondly, a subsequent autophosphorylation",
    "direct",
    "8749392"
   ],
   [
    "into the cytosol, and that T500 is not an autophosphorylation site. CONCLUSIONS: Structural and biochemical analyses of native and phosphatase-treated protein kinase C indicate that <e2>protein kinase C</e2><e1>protein kinase C</e1> is processed by three phosphorylations. Firstly, trans-phosphorylation on the activation loop (T500) renders it catalytically competent to autophosphorylate. Secondly, a subsequent autophosphorylation",
    "direct",
    "8749392"
   ]
  ]
 },
 "Elm1,Gin4": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "Direct phosphorylation and activation of a Nim1-related kinase <e2>Gin4</e2> by <e1>Elm1</e1> in budding yeast. In budding yeast, Gin4, a Nim1-related kinase, plays an important role in proper organization of the septin ring at the",
    "direct",
    "16861226"
   ],
   [
    "important for septin assembly, is critical for proper modification of Gin4 and its physiological substrate Shs1. In vitro studies with purified recombinant proteins demonstrated that <e1>Elm1</e1> directly phosphorylates and activates <e2>Gin4</e2>, which in turn phosphorylates Shs1. Consistent with these observations, acute inhibition of Elm1 activity abolished mitotic Gin4 phosphorylation and Gin4-dependent Shs1 modification in vivo.",
    "direct",
    "16861226"
   ]
  ]
 },
 "LRP5,Frizzled": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "and the apolipoprotein E receptor 2. The LRP5 is a co-receptor of Wnt located on the osteoblast membrane between two other receptors, Frizzled and Kremen. <e2>Frizzled</e2> and <e1>LRP5</e1> bind to Wnt, thereby stabilizing beta-catenin and activating bone formation. When the dickkopf protein (Dkk) binds to Kremen and LRP5, this last undergoes",
    "direct",
    "15850991"
   ]
  ]
 },
 "LRP5,Wnt": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "apolipoprotein E receptor 2. The LRP5 is a co-receptor of Wnt located on the osteoblast membrane between two other receptors, Frizzled and Kremen. Frizzled and <e1>LRP5</e1> bind to <e2>Wnt</e2>, thereby stabilizing beta-catenin and activating bone formation. When the dickkopf protein (Dkk) binds to Kremen and LRP5, this last undergoes internalization and therefore",
    "direct",
    "15850991"
   ]
  ]
 },
 "Kremen,dickkopf": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "the osteoblast membrane between two other receptors, Frizzled and Kremen. Frizzled and LRP5 bind to Wnt, thereby stabilizing beta-catenin and activating bone formation. When the <e2>dickkopf</e2> protein (Dkk) binds to <e1>Kremen</e1> and LRP5, this last undergoes internalization and therefore becomes unable to bind Wnt; this leads to degradation of beta-catenin and to inhibition of bone",
    "direct",
    "15850991"
   ]
  ]
 },
 "Kremen,LRP5": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "other receptors, Frizzled and Kremen. Frizzled and LRP5 bind to Wnt, thereby stabilizing beta-catenin and activating bone formation. When the dickkopf protein (Dkk) binds to <e1>Kremen</e1> and <e2>LRP5</e2>, this last undergoes internalization and therefore becomes unable to bind Wnt; this leads to degradation of beta-catenin and to inhibition of bone formation.",
    "direct",
    "15850991"
   ]
  ]
 },
 "dickkopf,LRP5": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "the osteoblast membrane between two other receptors, Frizzled and Kremen. Frizzled and LRP5 bind to Wnt, thereby stabilizing beta-catenin and activating bone formation. When the <e1>dickkopf</e1> protein (Dkk) binds to Kremen and <e2>LRP5</e2>, this last undergoes internalization and therefore becomes unable to bind Wnt; this leads to degradation of beta-catenin and to inhibition of bone formation.",
    "direct",
    "15850991"
   ]
  ]
 },
 "Wnt,LRP5": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Frizzled and Kremen. Frizzled and LRP5 bind to Wnt, thereby stabilizing beta-catenin and activating bone formation. When the dickkopf protein (Dkk) binds to Kremen and <e2>LRP5</e2>, this last undergoes internalization and therefore becomes unable to bind <e1>Wnt</e1>; this leads to degradation of beta-catenin and to inhibition of bone formation. In humans, loss of LRP5 function causes osteoporosis-pseudoglioma syndrome, which is",
    "direct",
    "15850991"
   ]
  ]
 },
 "LRP5,Dkk": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "osteoporosis-pseudoglioma syndrome, which is characterized by congenital blindness and extremely severe childhood-onset osteoporosis (lumbar spine Z-score often < -4) with fractures. The G171V mutation prevents <e2>Dkk</e2> from binding to <e1>LRP5</e1>, thereby increasing LRP5 function; the result is high bone mass due to uncoupling of bone formation and resorption. The Z-scores in this condition",
    "direct",
    "15850991"
   ]
  ]
 },
 "Fkh1p,Mcm1p": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "for controlling a different set of genes. Additional in vitro studies provided a mechanistic explanation for this differential promoter-occupancy. Specifically, the Fkh2p, but not the <e1>Fkh1p</e1>, was capable of binding cooperatively with <e2>Mcm1p</e2>. The Mcm1p-Fkh2p cooperative binding was enhanced by, but did not require, the presence of a Mcm1p-binding site within a target promoter. Consistent with these",
    "direct",
    "11562353"
   ]
  ]
 },
 "Fkh2p,Mcm1p": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "each was primarily responsible for controlling a different set of genes. Additional in vitro studies provided a mechanistic explanation for this differential promoter-occupancy. Specifically, the <e1>Fkh2p</e1>, but not the Fkh1p, was capable of binding cooperatively with <e2>Mcm1p</e2>. The Mcm1p-Fkh2p cooperative binding was enhanced by, but did not require, the presence of a Mcm1p-binding site within a target promoter. Consistent with these",
    "direct",
    "11562353"
   ],
   [
    "vitro studies provided a mechanistic explanation for this differential promoter-occupancy. Specifically, the Fkh2p, but not the Fkh1p, was capable of binding cooperatively with Mcm1p. The <e2>Mcm1p</e2>-<e1>Fkh2p</e1> cooperative binding was enhanced by, but did not require, the presence of a Mcm1p-binding site within a target promoter. Consistent with these data, Mcm1p was",
    "direct",
    "11562353"
   ]
  ]
 },
 "Fkh,Mcm1p": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "was enhanced by, but did not require, the presence of a Mcm1p-binding site within a target promoter. Consistent with these data, Mcm1p was present at <e1>Fkh</e1>-controlled promoters in vivo regardless of whether they contained <e2>Mcm1p</e2>-binding sites, suggesting a role for Mcm1p at promoters not thought previously to be under Mcm1p control. Analysis of Fkh1p and Fkh2p binding to promoter",
    "direct",
    "11562353"
   ]
  ]
 },
 "Fkh2p,Fkh1p": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "vivo regardless of whether they contained Mcm1p-binding sites, suggesting a role for Mcm1p at promoters not thought previously to be under Mcm1p control. Analysis of <e2>Fkh1p</e2> and <e1>Fkh2p</e1> binding to promoter targets in vivo by use of mutant strains indicated that the two proteins compete for promoter-occupancy at a number of target",
    "direct",
    "11562353"
   ]
  ]
 },
 "aminoimidazole-4-carboxamide ribonucleotide transformylaseIMP cyclohydrolase,antifolates": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Crystal structures of human bifunctional enzyme <e1>aminoimidazole-4-carboxamide ribonucleotide transformylase/IMP cyclohydrolase</e1> in complex with potent sulfonyl-containing <e2>antifolates</e2>. Aminoimidazole-4-carboxamide ribonucleotide (AICAR) transformylase/IMP cyclohydrolase (ATIC) is a bifunctional enzyme with folate-dependent AICAR transformylase and IMP cyclohydrolase activities that catalyzes the last two steps of",
    "direct",
    "14966129"
   ]
  ]
 },
 "aminoimidazole-4-carboxamide ribonucleotide transformylaseIMP cyclohydrolase,sulfonyl": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Crystal structures of human bifunctional enzyme <e1>aminoimidazole-4-carboxamide ribonucleotide transformylase/IMP cyclohydrolase</e1> in complex with potent <e2>sulfonyl</e2>-containing antifolates. Aminoimidazole-4-carboxamide ribonucleotide (AICAR) transformylase/IMP cyclohydrolase (ATIC) is a bifunctional enzyme with folate-dependent AICAR transformylase and IMP cyclohydrolase activities that catalyzes the last two",
    "direct",
    "14966129"
   ]
  ]
 },
 "antifolates,sulfonyl": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Crystal structures of human bifunctional enzyme aminoimidazole-4-carboxamide ribonucleotide transformylase/IMP cyclohydrolase in complex with potent <e2>sulfonyl</e2>-containing <e1>antifolates</e1>. Aminoimidazole-4-carboxamide ribonucleotide (AICAR) transformylase/IMP cyclohydrolase (ATIC) is a bifunctional enzyme with folate-dependent AICAR transformylase and IMP cyclohydrolase activities that catalyzes the last two steps of",
    "direct",
    "14966129"
   ]
  ]
 },
 "p53,hdm2": {
  "relations": [
   "controls-expression-of"
  ],
  "mentions": [
   [
    "orthologue mdm2, is known to be induced by p53, but recent evidence has demonstrated mdm2 expression can also be regulated via p53-independent pathways. However the <e1>p53</e1> independent mechanisms that control transcription of the human <e2>hdm2</e2> gene have not been studied. Differential levels of hdm2 mRNA and protein expression have been reported in several types of human malignancy, including breast",
    "direct",
    "12750288"
   ]
  ]
 },
 "ERalpha,hdm2": {
  "relations": [
   "controls-expression-of"
  ],
  "mentions": [
   [
    "not been studied. Differential levels of hdm2 mRNA and protein expression have been reported in several types of human malignancy, including breast cancers in which <e2>hdm2</e2> expression correlates with positive estrogen receptor alpha (<e1>ERalpha</e1>) status. Experimental models have demonstrated that hdm2 overexpression can promote breast cancer development. Here, we show that the elevated level of hdm2 protein in",
    "direct",
    "12750288"
   ]
  ]
 },
 "hdm2,AP1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "as of known regulators of the mouse mdm2-P2 promoter, including ERalpha and ras-raf-mitogen-activated protein/extracellular signal-regulated kinase (MEK) mitogen-activated protein kinase (MAPK) signaling. We show that <e1>hdm2</e1>-P2 activity in T47D cells is dependent on the integrity of both an evolutionarily conserved composite binding site for <e2>AP1</e2> and ETS family transcription factors (AP1-ETS) and a nonconserved upstream (nnGGGGC)(5) repeat sequence. Lack of hdm2-P2 activity in ERalpha(-ve) cells is shown to",
    "direct",
    "12750288"
   ]
  ]
 },
 "AP1,hdm2": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "as of known regulators of the mouse mdm2-P2 promoter, including ERalpha and ras-raf-mitogen-activated protein/extracellular signal-regulated kinase (MEK) mitogen-activated protein kinase (MAPK) signaling. We show that <e2>hdm2</e2>-P2 activity in T47D cells is dependent on the integrity of both an evolutionarily conserved composite binding site for AP1 and ETS family transcription factors (<e1>AP1</e1>-ETS) and a nonconserved upstream (nnGGGGC)(5) repeat sequence. Lack of hdm2-P2 activity in ERalpha(-ve) cells is shown to be a consequence of reduced transcriptional activation",
    "direct",
    "12750288"
   ]
  ]
 },
 "ETS,hdm2": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "as of known regulators of the mouse mdm2-P2 promoter, including ERalpha and ras-raf-mitogen-activated protein/extracellular signal-regulated kinase (MEK) mitogen-activated protein kinase (MAPK) signaling. We show that <e2>hdm2</e2>-P2 activity in T47D cells is dependent on the integrity of both an evolutionarily conserved composite binding site for AP1 and ETS family transcription factors (AP1-<e1>ETS</e1>) and a nonconserved upstream (nnGGGGC)(5) repeat sequence. Lack of hdm2-P2 activity in ERalpha(-ve) cells is shown to be a consequence of reduced transcriptional activation",
    "direct",
    "12750288"
   ]
  ]
 },
 "TCF,beta-catenin": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "pathway regulates many developmental processes through a complex of beta-catenin and the T-cell factor/lymphoid enhancer factor (TCF/LEF) family of high-mobility-group transcription factors. Wnt stabilizes cytosolic <e2>beta-catenin</e2>, which then binds to <e1>TCF</e1> and activates gene transcription. This signalling cascade is conserved in vertebrates, Drosophila and Caenorhabditis elegans. In C. elegans, the proteins MOM-4 and LIT-1",
    "direct",
    "10391247"
   ]
  ]
 },
 "NLK,TCF": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "activity and downregulates transcriptional activation mediated by beta-catenin and TCF. Injection of NLK suppresses the induction of axis duplication by microinjected beta-catenin in Xenopus embryos. <e1>NLK</e1> phosphorylates <e2>TCF</e2>/LEF factors and inhibits the interaction of the beta-catenin-TCF complex with DNA. Thus, the TAK1-NLK-MAPK-like pathway negatively regulates the Wnt signalling pathway.",
    "direct",
    "10391247"
   ]
  ]
 },
 "NLK,LEF factors": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "activity and downregulates transcriptional activation mediated by beta-catenin and TCF. Injection of NLK suppresses the induction of axis duplication by microinjected beta-catenin in Xenopus embryos. <e1>NLK</e1> phosphorylates TCF/<e2>LEF factors</e2> and inhibits the interaction of the beta-catenin-TCF complex with DNA. Thus, the TAK1-NLK-MAPK-like pathway negatively regulates the Wnt signalling pathway.",
    "direct",
    "10391247"
   ]
  ]
 },
 "cyclins,CDK": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "S phase. The 'mitotic or G2 cyclins', which include cyclin A and cyclin B, are involved in the control of G2/M transition and mitosis. The <e1>cyclins</e1> bind to and activate the <e2>CDK</e2>, which leads to phosphorylation (and then inhibition) of the tumor suppressor protein, pRb. pRb controls commitment to progress from the G1 to S",
    "direct",
    "11355576"
   ]
  ]
 },
 "p16INK4A,CDK4": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "properties, and their activity is carefully regulated at multiple levels including negative control by two families of CDK inhibitors. While members of the INK4 family (<e1>p16INK4A</e1>, p15INK4B, p18INK4C, p19INK4D) interact specifically with <e2>CDK4</e2> and CDK6, the CIP/KIP inhibitors p21CIP1/WAF1, p27KIP1 and p57KIP2 inhibit a broader spectrum of CDK. The interplay between p16INK4A, cyclin D/CDK, and pRb/E2F together",
    "direct",
    "11355576"
   ]
  ]
 },
 "p16INK4A,CDK6": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "properties, and their activity is carefully regulated at multiple levels including negative control by two families of CDK inhibitors. While members of the INK4 family (<e1>p16INK4A</e1>, p15INK4B, p18INK4C, p19INK4D) interact specifically with CDK4 and <e2>CDK6</e2>, the CIP/KIP inhibitors p21CIP1/WAF1, p27KIP1 and p57KIP2 inhibit a broader spectrum of CDK. The interplay between p16INK4A, cyclin D/CDK, and pRb/E2F together constitute",
    "direct",
    "11355576"
   ]
  ]
 },
 "CDK4,p15INK4B": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "and their activity is carefully regulated at multiple levels including negative control by two families of CDK inhibitors. While members of the INK4 family (p16INK4A, <e2>p15INK4B</e2>, p18INK4C, p19INK4D) interact specifically with <e1>CDK4</e1> and CDK6, the CIP/KIP inhibitors p21CIP1/WAF1, p27KIP1 and p57KIP2 inhibit a broader spectrum of CDK. The interplay between p16INK4A, cyclin D/CDK, and pRb/E2F together",
    "direct",
    "11355576"
   ]
  ]
 },
 "p15INK4B,CDK6": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "and their activity is carefully regulated at multiple levels including negative control by two families of CDK inhibitors. While members of the INK4 family (p16INK4A, <e1>p15INK4B</e1>, p18INK4C, p19INK4D) interact specifically with CDK4 and <e2>CDK6</e2>, the CIP/KIP inhibitors p21CIP1/WAF1, p27KIP1 and p57KIP2 inhibit a broader spectrum of CDK. The interplay between p16INK4A, cyclin D/CDK, and pRb/E2F together constitute",
    "direct",
    "11355576"
   ]
  ]
 },
 "CDK4,p18INK4C": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "their activity is carefully regulated at multiple levels including negative control by two families of CDK inhibitors. While members of the INK4 family (p16INK4A, p15INK4B, <e2>p18INK4C</e2>, p19INK4D) interact specifically with <e1>CDK4</e1> and CDK6, the CIP/KIP inhibitors p21CIP1/WAF1, p27KIP1 and p57KIP2 inhibit a broader spectrum of CDK. The interplay between p16INK4A, cyclin D/CDK, and pRb/E2F together",
    "direct",
    "11355576"
   ]
  ]
 },
 "p18INK4C,CDK6": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "their activity is carefully regulated at multiple levels including negative control by two families of CDK inhibitors. While members of the INK4 family (p16INK4A, p15INK4B, <e1>p18INK4C</e1>, p19INK4D) interact specifically with CDK4 and <e2>CDK6</e2>, the CIP/KIP inhibitors p21CIP1/WAF1, p27KIP1 and p57KIP2 inhibit a broader spectrum of CDK. The interplay between p16INK4A, cyclin D/CDK, and pRb/E2F together constitute",
    "direct",
    "11355576"
   ]
  ]
 },
 "CDK4,p19INK4D": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "activity is carefully regulated at multiple levels including negative control by two families of CDK inhibitors. While members of the INK4 family (p16INK4A, p15INK4B, p18INK4C, <e2>p19INK4D</e2>) interact specifically with <e1>CDK4</e1> and CDK6, the CIP/KIP inhibitors p21CIP1/WAF1, p27KIP1 and p57KIP2 inhibit a broader spectrum of CDK. The interplay between p16INK4A, cyclin D/CDK, and pRb/E2F together",
    "direct",
    "11355576"
   ]
  ]
 },
 "p19INK4D,CDK6": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "activity is carefully regulated at multiple levels including negative control by two families of CDK inhibitors. While members of the INK4 family (p16INK4A, p15INK4B, p18INK4C, <e1>p19INK4D</e1>) interact specifically with CDK4 and <e2>CDK6</e2>, the CIP/KIP inhibitors p21CIP1/WAF1, p27KIP1 and p57KIP2 inhibit a broader spectrum of CDK. The interplay between p16INK4A, cyclin D/CDK, and pRb/E2F together constitute",
    "direct",
    "11355576"
   ]
  ]
 },
 "IKK beta,I kappa B beta": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "multiprotein complex, the I kappa B kinase (IKK) complex, which is composed of at least three identified subunits. Two of these polypeptides, IKK alpha and <e1>IKK beta</e1>, also known as IKK1 and IKK2, are the catalytic subunits of the kinase complex and phosphorylate I kappa B alpha and <e2>I kappa B beta</e2>. The third component, NEMO/IKK gamma, does not exhibit kinase activity, but rather constitutes a regulatory subunit. In the present study, C-terminal truncated",
    "direct",
    "11485410"
   ]
  ]
 },
 "IKK alpha,I kappa B alpha": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "mediated by a multiprotein complex, the I kappa B kinase (IKK) complex, which is composed of at least three identified subunits. Two of these polypeptides, <e1>IKK alpha</e1> and IKK beta, also known as IKK1 and IKK2, are the catalytic subunits of the kinase complex and phosphorylate <e2>I kappa B alpha</e2> and I kappa B beta. The third component, NEMO/IKK gamma, does not exhibit kinase activity, but rather constitutes a regulatory subunit. In the",
    "direct",
    "11485410"
   ]
  ]
 },
 "YY1,raptor": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "YY1 caused a significant decrease in mitochondrial gene expression and in respiration, and YY1 was required for rapamycin-dependent repression of those genes. Moreover, mTOR and <e2>raptor</e2> interacted with <e1>YY1</e1>, and inhibition of mTOR resulted in a failure of YY1 to interact with and be coactivated by PGC-1alpha. We have therefore identified a",
    "direct",
    "18046414"
   ]
  ]
 },
 "YY1,mTOR": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Knockdown of YY1 caused a significant decrease in mitochondrial gene expression and in respiration, and YY1 was required for rapamycin-dependent repression of those genes. Moreover, <e2>mTOR</e2> and raptor interacted with <e1>YY1</e1>, and inhibition of mTOR resulted in a failure of YY1 to interact with and be coactivated by PGC-1alpha. We have therefore identified a",
    "direct",
    "18046414"
   ],
   [
    "gene expression and in respiration, and YY1 was required for rapamycin-dependent repression of those genes. Moreover, mTOR and raptor interacted with YY1, and inhibition of <e2>mTOR</e2> resulted in a failure of <e1>YY1</e1> to interact with and be coactivated by PGC-1alpha. We have therefore identified a mechanism by which a nutrient sensor (mTOR) balances energy metabolism",
    "direct",
    "18046414"
   ]
  ]
 },
 "raptor,mTOR": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Knockdown of YY1 caused a significant decrease in mitochondrial gene expression and in respiration, and YY1 was required for rapamycin-dependent repression of those genes. Moreover, <e2>mTOR</e2> and <e1>raptor</e1> interacted with YY1, and inhibition of mTOR resulted in a failure of YY1 to interact with and be coactivated by PGC-1alpha. We have therefore",
    "direct",
    "18046414"
   ]
  ]
 },
 "NF-kappaB,p50": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Moreover, SDF-1alpha-mediated increase of kappaB-luciferase activity was inhibited by pre-transfection of DN-p85, DN-Akt or DN-ERK2. Increase of IKK alpha/beta phosphorylation and binding of p65 and <e2>p50</e2> to the <e1>NF-kappaB</e1> element were both antagonized by PI3K and ERK inhibitors. Our results demonstrate a mechanism linking SDF-1alpha and IL-6, and provide additional support for the notion",
    "direct",
    "19285061"
   ]
  ]
 },
 "IkappaB,p50-p65": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "is, therefore, pivotal in the development of acute and chronic inflammatory diseases. In its inactive state, NF-kappaB is constitutively present in the cytoplasm as a <e2>p50-p65</e2> heterodimer bound to its inhibitory protein <e1>IkappaB</e1>. Proinflammatory cytokines, such as tumor necrosis factor (TNF), activate NF-kappaB by stimulating the activity of the IkappaB kinases (IKKs) which phosphorylate IkappaBalpha on serine",
    "direct",
    "10542212"
   ]
  ]
 },
 "IKKs,IkappaBalpha": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "heterodimer bound to its inhibitory protein IkappaB. Proinflammatory cytokines, such as tumor necrosis factor (TNF), activate NF-kappaB by stimulating the activity of the IkappaB kinases (<e1>IKKs</e1>) which phosphorylate <e2>IkappaBalpha</e2> on serine residues 32 and 36, targeting it for rapid degradation by the 26 S proteasome. This enables the release and nuclear translocation of the",
    "direct",
    "10542212"
   ],
   [
    "heterodimer bound to its inhibitory protein IkappaB. Proinflammatory cytokines, such as tumor necrosis factor (TNF), activate NF-kappaB by stimulating the activity of the IkappaB kinases (<e1>IKKs</e1>) which phosphorylate <e2>IkappaBalpha</e2> on serine residues 32 and 36, targeting it for rapid degradation by the 26 S proteasome. This enables the release and nuclear translocation of the",
    "direct",
    "10542212"
   ]
  ]
 },
 "p105,c-Rel": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Identification of complex formation between two intracellular tyrosine kinase substrates: human <e2>c-Rel</e2> and the <e1>p105</e1> precursor of p50 NF-kappa B. Immune complexes of the product of the c-rel protooncogene and of p105, the p50 NF-kappa B precursor, isolated",
    "direct",
    "1437141"
   ]
  ]
 },
 "nuclear factor-kappaB,Forkhead Box M1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "prognostic factors for laryngeal squamous cell carcinoma (P = .038, P = .014, and P = .005, respectively). Furthermore, a significant correlation was observed between <e2>Forkhead Box M1</e2> transcription factor and <e1>nuclear factor-kappaB</e1> (rs = 0.683, P < .001), indicating the potential direct or indirect interaction between them. In conclusion, our results suggest that overexpressions of Forkhead Box",
    "direct",
    "21334713"
   ],
   [
    "nuclear factor-kappaB (rs = 0.683, P < .001), indicating the potential direct or indirect interaction between them. In conclusion, our results suggest that overexpressions of <e2>Forkhead Box M1</e2> transcription factor and <e1>nuclear factor-kappaB</e1> and the possible interaction between them may play important roles in the development and progression of laryngeal squamous cell carcinoma, and Forkhead Box M1 transcription",
    "direct",
    "21334713"
   ]
  ]
 },
 "Toll-like receptor 2,6": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Cooperation of <e1>Toll-like receptor 2</e1> and <e2>6</e2> for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling",
    "direct",
    "11441107"
   ]
  ]
 },
 "TLR6,TLR2": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "of TLR2 or TLR6 inhibit the responses of STF and OspA-L as well as PSM in TLR2-transfected HMEC, supporting the concept of functional cooperation between <e2>TLR2</e2> and <e1>TLR6</e1> for all these TLR2 ligands. Moreover, we show that Toll-interacting protein (Tollip) coimmunoprecipitates with TLR2 and TLR4 using HEK 293 cells, and overexpression",
    "direct",
    "11441107"
   ]
  ]
 },
 "TLR2,TLR6": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "cells, and overexpression of Tollip inhibits NF-kappaB activation in response to TLR2 and TLR4 signaling. Collectively, these findings suggest that there is functional interaction between <e1>TLR2</e1> and <e2>TLR6</e2> in the cellular response to STF and OspA-L in addition to S. epidermidis (PSM) Ags, and that engagement of TLR2 triggers a signaling",
    "direct",
    "11441107"
   ]
  ]
 },
 "p105,NF-kappa B": {
  "relations": [
   "controls-transport-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "The NF-kappa B precursor <e1>p105</e1> and the proto-oncogene product Bcl-3 are I kappa B molecules and control nuclear translocation of <e2>NF-kappa B</e2>. We have examined the interaction of the NF-kappa B precursor p105 with NF-kappa B subunits. Similar to an I kappa B molecule, p105 associates",
    "direct",
    "8428580"
   ]
  ]
 },
 "Bcl-3,NF-kappa B": {
  "relations": [
   "controls-transport-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "The NF-kappa B precursor p105 and the proto-oncogene product <e1>Bcl-3</e1> are I kappa B molecules and control nuclear translocation of <e2>NF-kappa B</e2>. We have examined the interaction of the NF-kappa B precursor p105 with NF-kappa B subunits. Similar to an I kappa B molecule, p105 associates",
    "direct",
    "8428580"
   ]
  ]
 },
 "p105,p65": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "of NF-kappa B. We have examined the interaction of the NF-kappa B precursor p105 with NF-kappa B subunits. Similar to an I kappa B molecule, <e1>p105</e1> associates in the cytoplasm with p50 or <e2>p65</e2>. Through this assembly, p105 efficiently blocks nuclear transfer of either subunit. Moreover, the p105 protein inhibits DNA binding of dimeric NF-kappa B subunits",
    "direct",
    "8428580"
   ],
   [
    "of NF-kappa B. We have examined the interaction of the NF-kappa B precursor p105 with NF-kappa B subunits. Similar to an I kappa B molecule, <e1>p105</e1> associates in the cytoplasm with p50 or <e2>p65</e2>. Through this assembly, p105 efficiently blocks nuclear transfer of either subunit. Moreover, the p105 protein inhibits DNA binding of dimeric NF-kappa B subunits",
    "direct",
    "8428580"
   ]
  ]
 },
 "p105,p50": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "of NF-kappa B. We have examined the interaction of the NF-kappa B precursor p105 with NF-kappa B subunits. Similar to an I kappa B molecule, <e1>p105</e1> associates in the cytoplasm with <e2>p50</e2> or p65. Through this assembly, p105 efficiently blocks nuclear transfer of either subunit. Moreover, the p105 protein inhibits DNA binding of dimeric NF-kappa",
    "direct",
    "8428580"
   ],
   [
    "of NF-kappa B. We have examined the interaction of the NF-kappa B precursor p105 with NF-kappa B subunits. Similar to an I kappa B molecule, <e1>p105</e1> associates in the cytoplasm with <e2>p50</e2> or p65. Through this assembly, p105 efficiently blocks nuclear transfer of either subunit. Moreover, the p105 protein inhibits DNA binding of dimeric NF-kappa",
    "direct",
    "8428580"
   ]
  ]
 },
 "Bcl-3,p65": {
  "relations": [
   "controls-transport-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "NF-kappa B subunits in a similar, but not identical, manner to its isolated C-terminal domain, which contains an ankyrin-like repeat domain (ARD). The proto-oncogene product <e1>Bcl-3</e1> also controls nuclear translocation of p50, but not of <e2>p65</e2>. Hence, p50 can be retained in the cytoplasm via at least three distinct interactions: through direct interactions either with its own precursor, with",
    "direct",
    "8428580"
   ]
  ]
 },
 "Bcl-3,p50": {
  "relations": [
   "controls-transport-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "NF-kappa B subunits in a similar, but not identical, manner to its isolated C-terminal domain, which contains an ankyrin-like repeat domain (ARD). The proto-oncogene product <e1>Bcl-3</e1> also controls nuclear translocation of <e2>p50</e2>, but not of p65. Hence, p50 can be retained in the cytoplasm via at least three distinct interactions: through direct interactions either with",
    "direct",
    "8428580"
   ]
  ]
 },
 "p65,I kappa B alpha": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "can be retained in the cytoplasm via at least three distinct interactions: through direct interactions either with its own precursor, with Bcl-3 or indirectly through <e2>I kappa B alpha</e2> or -beta when attached to <e1>p65</e1>. We discuss a function of p105 as a cytoplasmic assembly unit for homo- and heteromeric NF-kappa B complexes and of Bcl-3 as an",
    "direct",
    "8428580"
   ]
  ]
 },
 "p65,-beta": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "cytoplasm via at least three distinct interactions: through direct interactions either with its own precursor, with Bcl-3 or indirectly through I kappa B alpha or <e2>-beta</e2> when attached to <e1>p65</e1>. We discuss a function of p105 as a cytoplasmic assembly unit for homo- and heteromeric NF-kappa B complexes and of Bcl-3 as an",
    "direct",
    "8428580"
   ]
  ]
 },
 "NF-kappa B,p105": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "either with its own precursor, with Bcl-3 or indirectly through I kappa B alpha or -beta when attached to p65. We discuss a function of <e2>p105</e2> as a cytoplasmic assembly unit for homo- and heteromeric <e1>NF-kappa B</e1> complexes and of Bcl-3 as an I kappa B with novel subunit specificity.",
    "direct",
    "8428580"
   ]
  ]
 },
 "Bcl-3,p105": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "either with its own precursor, with Bcl-3 or indirectly through I kappa B alpha or -beta when attached to p65. We discuss a function of <e2>p105</e2> as a cytoplasmic assembly unit for homo- and heteromeric NF-kappa B complexes and of <e1>Bcl-3</e1> as an I kappa B with novel subunit specificity.",
    "direct",
    "8428580"
   ]
  ]
 },
 "EXT1,EXT2": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "The putative tumor suppressors <e1>EXT1</e1> and <e2>EXT2</e2> form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate. Hereditary multiple exostoses, a dominantly inherited",
    "direct",
    "10639137"
   ],
   [
    "in vivo and in vitro assays, we show that EXT2 does not harbor significant glycosyltransferase activity in the absence of EXT1. Instead, it appears that <e1>EXT1</e1> and <e2>EXT2</e2> form a hetero-oligomeric complex in vivo that leads to the accumulation of both proteins in the Golgi apparatus. Remarkably, the Golgi-localized EXT1/EXT2 complex",
    "direct",
    "10639137"
   ],
   [
    "that EXT1 and EXT2 form a hetero-oligomeric complex in vivo that leads to the accumulation of both proteins in the Golgi apparatus. Remarkably, the Golgi-localized <e1>EXT1</e1>/<e2>EXT2</e2> complex possesses substantially higher glycosyltransferase activity than EXT1 or EXT2 alone, which suggests that the complex represents the biologically relevant form of the enzyme(s). These",
    "direct",
    "10639137"
   ]
  ]
 },
 "Ste20,Cdc42": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "RGA1, but not RGA2 or BEM3, caused hyperinvasive growth. Furthermore, overproduction or loss of Rga1 and Rga2, but not Bem3, affected the two-hybrid interaction of <e2>Cdc42</e2> with <e1>Ste20</e1>, a p21-activated kinase (PAK) kinase required for haploid invasive growth. These results suggest Rga1, and possibly Rga2, facilitate the interaction of Cdc42 with Ste20",
    "direct",
    "12455995"
   ]
  ]
 },
 "Cdc42,Ste20": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "of Cdc42 with Ste20, a p21-activated kinase (PAK) kinase required for haploid invasive growth. These results suggest Rga1, and possibly Rga2, facilitate the interaction of <e1>Cdc42</e1> with <e2>Ste20</e2> to mediate signaling in the haploid invasive growth pathway. Deletion of BEM3 resulted in cells with severe morphological defects not observed in rga1delta or",
    "direct",
    "12455995"
   ]
  ]
 },
 "PIG-S,GPI8": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "<e1>PIG-S</e1> and PIG-T, essential for GPI anchor attachment to proteins, form a complex with GAA1 and <e2>GPI8</e2>. Many eukaryotic cell surface proteins are anchored to the plasma membrane via glycosylphosphatidylinositol (GPI). The GPI transamidase mediates GPI anchoring in the endoplasmic",
    "direct",
    "11483512"
   ],
   [
    "recombination. PIG-S and PIG-T knockout cells were defective in transfer of GPI to proteins, particularly in formation of the carbonyl intermediates. We also demonstrate that <e1>PIG-S</e1> and PIG-T form a protein complex with GAA1 and <e2>GPI8</e2>, and that PIG-T maintains the complex by stabilizing the expression of GAA1 and GPI8. Saccharomyces cerevisiae Gpi16p (YHR188C) and Gpi17p (YDR434W) are orthologues",
    "direct",
    "11483512"
   ]
  ]
 },
 "GPI8,PIG-T": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "PIG-S and <e2>PIG-T</e2>, essential for GPI anchor attachment to proteins, form a complex with GAA1 and <e1>GPI8</e1>. Many eukaryotic cell surface proteins are anchored to the plasma membrane via glycosylphosphatidylinositol (GPI). The GPI transamidase mediates GPI anchoring in the endoplasmic",
    "direct",
    "11483512"
   ]
  ]
 },
 "PIG-S,GAA1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "<e1>PIG-S</e1> and PIG-T, essential for GPI anchor attachment to proteins, form a complex with <e2>GAA1</e2> and GPI8. Many eukaryotic cell surface proteins are anchored to the plasma membrane via glycosylphosphatidylinositol (GPI). The GPI transamidase mediates GPI anchoring in",
    "direct",
    "11483512"
   ]
  ]
 },
 "GAA1,PIG-T": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "PIG-S and <e2>PIG-T</e2>, essential for GPI anchor attachment to proteins, form a complex with <e1>GAA1</e1> and GPI8. Many eukaryotic cell surface proteins are anchored to the plasma membrane via glycosylphosphatidylinositol (GPI). The GPI transamidase mediates GPI anchoring in",
    "direct",
    "11483512"
   ],
   [
    "and PIG-T knockout cells were defective in transfer of GPI to proteins, particularly in formation of the carbonyl intermediates. We also demonstrate that PIG-S and <e2>PIG-T</e2> form a protein complex with <e1>GAA1</e1> and GPI8, and that PIG-T maintains the complex by stabilizing the expression of GAA1 and GPI8. Saccharomyces cerevisiae Gpi16p (YHR188C) and Gpi17p (YDR434W) are",
    "direct",
    "11483512"
   ],
   [
    "proteins, particularly in formation of the carbonyl intermediates. We also demonstrate that PIG-S and PIG-T form a protein complex with GAA1 and GPI8, and that <e2>PIG-T</e2> maintains the complex by stabilizing the expression of <e1>GAA1</e1> and GPI8. Saccharomyces cerevisiae Gpi16p (YHR188C) and Gpi17p (YDR434W) are orthologues of PIG-T and PIG-S, respectively.",
    "direct",
    "11483512"
   ]
  ]
 },
 "GAA1,PIG-S": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "recombination. PIG-S and PIG-T knockout cells were defective in transfer of GPI to proteins, particularly in formation of the carbonyl intermediates. We also demonstrate that <e2>PIG-S</e2> and PIG-T form a protein complex with <e1>GAA1</e1> and GPI8, and that PIG-T maintains the complex by stabilizing the expression of GAA1 and GPI8. Saccharomyces cerevisiae Gpi16p (YHR188C) and Gpi17p (YDR434W) are",
    "direct",
    "11483512"
   ]
  ]
 },
 "PIG-T,GPI8": {
  "relations": [
   "in-complex-with",
   "controls-expression-of"
  ],
  "mentions": [
   [
    "and PIG-T knockout cells were defective in transfer of GPI to proteins, particularly in formation of the carbonyl intermediates. We also demonstrate that PIG-S and <e1>PIG-T</e1> form a protein complex with GAA1 and <e2>GPI8</e2>, and that PIG-T maintains the complex by stabilizing the expression of GAA1 and GPI8. Saccharomyces cerevisiae Gpi16p (YHR188C) and Gpi17p (YDR434W) are orthologues",
    "direct",
    "11483512"
   ],
   [
    "proteins, particularly in formation of the carbonyl intermediates. We also demonstrate that PIG-S and PIG-T form a protein complex with GAA1 and GPI8, and that <e1>PIG-T</e1> maintains the complex by stabilizing the expression of GAA1 and <e2>GPI8</e2>. Saccharomyces cerevisiae Gpi16p (YHR188C) and Gpi17p (YDR434W) are orthologues of PIG-T and PIG-S, respectively.",
    "direct",
    "11483512"
   ],
   [
    "proteins, particularly in formation of the carbonyl intermediates. We also demonstrate that PIG-S and PIG-T form a protein complex with GAA1 and GPI8, and that <e1>PIG-T</e1> maintains the complex by stabilizing the expression of GAA1 and <e2>GPI8</e2>. Saccharomyces cerevisiae Gpi16p (YHR188C) and Gpi17p (YDR434W) are orthologues of PIG-T and PIG-S, respectively.",
    "direct",
    "11483512"
   ]
  ]
 },
 "PIG-T,GAA1": {
  "relations": [
   "controls-expression-of"
  ],
  "mentions": [
   [
    "proteins, particularly in formation of the carbonyl intermediates. We also demonstrate that PIG-S and PIG-T form a protein complex with GAA1 and GPI8, and that <e1>PIG-T</e1> maintains the complex by stabilizing the expression of <e2>GAA1</e2> and GPI8. Saccharomyces cerevisiae Gpi16p (YHR188C) and Gpi17p (YDR434W) are orthologues of PIG-T and PIG-S, respectively.",
    "direct",
    "11483512"
   ]
  ]
 },
 "PTEN,RNA polymerase (Pol) III": {
  "relations": [
   "controls-expression-of"
  ],
  "mentions": [
   [
    "frequently lost in human cancers, possesses a lipid phosphatase activity that represses phosphatidylinositol 3-kinase (PI3K) signaling, controlling cell growth, proliferation, and survival. The potential for <e1>PTEN</e1> to regulate the synthesis of <e2>RNA polymerase (Pol) III</e2> transcription products, including tRNAs and 5S rRNAs, was evaluated. The expression of PTEN in PTEN-deficient cells repressed RNA Pol III transcription, whereas decreased",
    "direct",
    "18391023"
   ]
  ]
 },
 "TATA-binding protein,Brf1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "its lipid phosphatase activity, inhibiting the PI3K/Akt/mTOR/S6K pathway to decrease transcription. PTEN, through the inactivation of mTOR, targets the TFIIIB complex, disrupting the association between <e1>TATA-binding protein</e1> and <e2>Brf1</e2>. Kinetic analysis revealed that PTEN initially induces a decrease in the serine phosphorylation of Brf1, leading to a selective reduction in the occupancy",
    "direct",
    "18391023"
   ]
  ]
 },
 "IRAK,Tollip": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "through its ability to potently suppress the activity of IL-1 receptor-associated kinase (IRAK) after TLR activation. In addition, we show for the first time that <e2>Tollip</e2> is a bona fide substrate for IRAK and is phosphorylated by <e1>IRAK</e1> upon stimulation with lipopolysaccharide or IL-1. Negative regulation of TLR signaling by Tollip may therefore serve to limit the production of proinflammatory mediators",
    "direct",
    "11751856"
   ]
  ]
 },
 "Mps1p,Spc110p": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "Yeast <e1>Mps1p</e1> phosphorylates the spindle pole component <e2>Spc110p</e2> in the N-terminal domain. The yeast spindle pole body (SPB) component Spc110p (Nuf1p) undergoes specific serine/threonine phosphorylation as the mitotic spindle apparatus forms, and",
    "direct",
    "11278681"
   ],
   [
    "phosphorylation persists until cells enter anaphase. We demonstrate that the dual-specificity kinase Mps1p is essential for the mitosis-specific phosphorylation of Spc110p in vivo and that <e1>Mps1p</e1> phosphorylates <e2>Spc110p</e2> in vitro. Phosphopeptides generated by proteolytic cleavage were identified and sequenced by mass spectrometry. Ser(60), Thr(64), and Thr(68) are the major sites in Spc110p",
    "direct",
    "11278681"
   ],
   [
    "phosphorylates Spc110p in vitro. Phosphopeptides generated by proteolytic cleavage were identified and sequenced by mass spectrometry. Ser(60), Thr(64), and Thr(68) are the major sites in <e2>Spc110p</e2> phosphorylated by <e1>Mps1p</e1> in vitro, and alanine substitution at these sites abolishes the mitosis-specific isoform in vivo. This is the first time that phosphorylation sites of",
    "direct",
    "11278681"
   ],
   [
    "phosphorylates Spc110p in vitro. Phosphopeptides generated by proteolytic cleavage were identified and sequenced by mass spectrometry. Ser(60), Thr(64), and Thr(68) are the major sites in <e2>Spc110p</e2> phosphorylated by <e1>Mps1p</e1> in vitro, and alanine substitution at these sites abolishes the mitosis-specific isoform in vivo. This is the first time that phosphorylation sites of",
    "direct",
    "11278681"
   ],
   [
    "phosphorylates Spc110p in vitro. Phosphopeptides generated by proteolytic cleavage were identified and sequenced by mass spectrometry. Ser(60), Thr(64), and Thr(68) are the major sites in <e2>Spc110p</e2> phosphorylated by <e1>Mps1p</e1> in vitro, and alanine substitution at these sites abolishes the mitosis-specific isoform in vivo. This is the first time that phosphorylation sites of",
    "direct",
    "11278681"
   ],
   [
    "with a specific dysfunction for the alanine substitution mutations, simultaneous mutation of all four serine/threonine residues to aspartate does not confer any defect. Sites of <e1>Mps1p</e1> phosphorylation and Ser(36) are located within the N-terminal globular domain of <e2>Spc110p</e2>, which resides at the inner plaque of the SPB and binds the Tub4p complex.",
    "direct",
    "11278681"
   ]
  ]
 },
 "Tub4p,Spc110p": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "all four serine/threonine residues to aspartate does not confer any defect. Sites of Mps1p phosphorylation and Ser(36) are located within the N-terminal globular domain of <e2>Spc110p</e2>, which resides at the inner plaque of the SPB and binds the <e1>Tub4p</e1> complex.",
    "direct",
    "11278681"
   ]
  ]
 },
 "HDAC1,beta-catenin": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "whereas gain-of-function analysis of Kaiso dose-dependently resulted in synergistic and suppressive effects. Our analyses further suggest Kaiso can regulate TCF/LEF1-activity for these effects via modulating <e1>HDAC1</e1> and <e2>beta-catenin</e2>-complex formation. Our studies together provide insights into why Kaiso null mice display resistance to intestinal tumors when crossed onto an Apc(Min/+) background.",
    "direct",
    "19166851"
   ]
  ]
 },
 "acyl-CoA,carnitine": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "tissues which have limited capacity to metabolize propionyl-CoA. These results also show propionyl-CoA must be formed during the metabolism of alpha-ketoisovalerate and that extra-mitochondrial free <e2>carnitine</e2> rapidly interacts with matrix short-chain aliphatic <e1>acyl-CoA</e1> generated from alpha-keto acids of branched-chain amino acids and pyruvate in the presence and absence of malate.",
    "direct",
    "3759988"
   ]
  ]
 },
 "Snf1,Msn2": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "the Msn2 nuclear import domain and therefore a potential mediator of glucose starvation signals that target this transcription factor. Apart from PKA, the protein kinase <e1>Snf1</e1> can also directly modify one of the <e2>Msn2</e2> phosphorylation sites (S582) and thereby repress Msn2 function. Consequently, in snf1 mutants, rephosphorylation of the NLS happens to be much slower during prolonged",
    "direct",
    "16281053"
   ]
  ]
 },
 "Cdc5p,Ndd1p": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "Cdc5p in controlling cell-cycle-dependent gene expression that is crucial for the execution of mitosis in the model eukaryote Saccharomyces cerevisiae. In particular, we find that <e1>Cdc5p</e1> is temporally recruited to promoters of the cell-cycle-regulated CLB2 gene cluster, where it targets the Mcm1p-Fkh2p-Ndd1p transcription factor complex, through direct phosphorylation of the coactivator protein <e2>Ndd1p</e2>. This phosphorylation event is required for the normal temporal expression of cell-cycle-regulated genes such as CLB2 and SWI5 in G2/M phases. Furthermore, severe defects",
    "direct",
    "17122856"
   ]
  ]
 },
 "cyclin D3,E2F1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "-2, and -3A) potently activate a cyclin D3 promoter reporter, whereas growth-restraining members of the family (E2F4, -5, and -6) have little effect. Third, recombinant <e2>E2F1</e2> binds with high affinity to the <e1>cyclin D3</e1> promoter in vitro. Fourth, chromatin immunoprecipitation assays demonstrate that endogenous E2F1 is associated with the cyclin D3 promoter in vivo. Finally, mapping experiments localize",
    "direct",
    "12611887"
   ]
  ]
 },
 "E2F1,cyclin D3": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "-6) have little effect. Third, recombinant E2F1 binds with high affinity to the cyclin D3 promoter in vitro. Fourth, chromatin immunoprecipitation assays demonstrate that endogenous <e1>E2F1</e1> is associated with the <e2>cyclin D3</e2> promoter in vivo. Finally, mapping experiments localize the essential E2F regulatory element of the cyclin D3 promoter to a noncanonical E2F site in the",
    "direct",
    "12611887"
   ]
  ]
 },
 "Mpk1,Rlm1": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "Regulation of the yeast Rlm1 transcription factor by the Mpk1 cell wall integrity MAP kinase. The <e1>Mpk1</e1> MAP kinase of the Saccharomyces cerevisiae cell wall integrity signalling pathway phosphorylates and activates the <e2>Rlm1</e2> transcription factor in response to cell wall stress. Rlm1 is related to mammalian MEF2 isoforms, and shares a similar DNA-binding specificity. Signalling through",
    "direct",
    "12410835"
   ],
   [
    "Finally, intracellular localization analyses show that Rlm1 resides in the nucleus regardless of its activation and phosphorylation status. Together these observations support the inference that <e1>Mpk1</e1> regulates the <e2>Rlm1</e2> transcriptional activation function by phosphorylation of Ser427 and Thr439.",
    "direct",
    "12410835"
   ],
   [
    "Finally, intracellular localization analyses show that Rlm1 resides in the nucleus regardless of its activation and phosphorylation status. Together these observations support the inference that <e1>Mpk1</e1> regulates the <e2>Rlm1</e2> transcriptional activation function by phosphorylation of Ser427 and Thr439.",
    "direct",
    "12410835"
   ]
  ]
 },
 "nim1,wee1": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "regulator of mitosis by down-regulating the wee1 pathway in yeast cells. We have overexpressed the nim1 protein in both bacteria and insect cells. The recombinant <e1>nim1</e1> protein autophosphorylates on both tyrosine and serine residues and can phosphorylate the isolated <e2>wee1</e2> protein directly in a cell-free system. The nim1-catalyzed phosphorylation of the wee1 protein occurs in its C-terminal region and leads to a substantial drop",
    "direct",
    "7681363"
   ]
  ]
 },
 "MEKK1,TRAF2": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "TRAF6 with repeats of the immunophilin FKBP12, we demonstrate that their effector domains are composed of their amino-terminal Zn and RING fingers. Oligomerization of the <e2>TRAF2</e2> effector domain results in specific binding to <e1>MEKK1</e1>, a protein kinase capable of JNK, p38, and IKK activation, and induction of TNF-alpha and IL-1 responsive genes. TNF-alpha also enhances the binding",
    "direct",
    "10346818"
   ]
  ]
 },
 "TRAF2,MEKK1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "a protein kinase capable of JNK, p38, and IKK activation, and induction of TNF-alpha and IL-1 responsive genes. TNF-alpha also enhances the binding of native <e1>TRAF2</e1> to <e2>MEKK1</e2> and stimulates the kinase activity of the latter. Thus, TNF-alpha and IL-1 signaling is based on oligomerization of TRAF2 and TRAF6 leading to",
    "direct",
    "10346818"
   ]
  ]
 },
 "TRAF2,TRAF6": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "the binding of native TRAF2 to MEKK1 and stimulates the kinase activity of the latter. Thus, TNF-alpha and IL-1 signaling is based on oligomerization of <e1>TRAF2</e1> and <e2>TRAF6</e2> leading to activation of effector kinases.",
    "direct",
    "10346818"
   ]
  ]
 },
 "CITED2,p300": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "protein interaction networks. In this study, we show that ectopic expression or knockdown of CITED2 attenuates or potentiates, respectively, the expression of NF-kappaB-responsive genes. Mechanistically, <e1>CITED2</e1> constitutively localizes inside the nucleus and interacts specifically with the coactivator <e2>p300</e2>. This prevents p65 from binding to p300, impairs p65 acetylation, and attenuates p65 binding to its cognate promoters. Furthermore, LPS induces CITED2 expression via",
    "direct",
    "21098220"
   ]
  ]
 },
 "p65,p300": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "attenuates or potentiates, respectively, the expression of NF-kappaB-responsive genes. Mechanistically, CITED2 constitutively localizes inside the nucleus and interacts specifically with the coactivator p300. This prevents <e1>p65</e1> from binding to <e2>p300</e2>, impairs p65 acetylation, and attenuates p65 binding to its cognate promoters. Furthermore, LPS induces CITED2 expression via NF-kappaB in macrophages. CITED2 sensitizes cells",
    "direct",
    "21098220"
   ]
  ]
 },
 "14-3-3beta,p90 ribosomal S6 kinase (RSK) isoform 1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "<e1>14-3-3beta</e1> is a <e2>p90 ribosomal S6 kinase (RSK) isoform 1</e2>-binding protein that negatively regulates RSK kinase activity. p90 ribosomal S6 kinase 1 (RSK1) is a serine/threonine kinase that is activated by extracellular signal-related",
    "direct",
    "12618428"
   ]
  ]
 },
 "14-3-3beta,RSK1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "basal conditions, RSK1 is located in the cytosol and upon stimulation, RSK1 translocates to the plasma membrane where it is fully activated. The ability of <e2>RSK1</e2> to bind the adapter protein <e1>14-3-3beta</e1> was investigated because RSK1 contains several putative 14-3-3-binding motifs. We demonstrate that RSK1 specifically and directly binds 14-3-3beta. This interaction was dependent on phosphorylation of",
    "direct",
    "12618428"
   ],
   [
    "demonstrate that RSK1 specifically and directly binds 14-3-3beta. This interaction was dependent on phosphorylation of serine 154 within the motif RLSKEV of RSK1. Binding of <e2>RSK1</e2> to <e1>14-3-3beta</e1> was maximal under basal conditions and decreased significantly upon mitogen stimulation. After 5 min of serum stimulation, a portion of 14-3-3beta and RSK1 translocated to",
    "direct",
    "12618428"
   ],
   [
    "for RSK1 kinase activity (Ser(380) and Ser(363)) in RSK1S154A compared with RSK1 wild type, demonstrated that 14-3-3 interferes with RSK1 phosphorylation. These data suggest that <e1>14-3-3beta</e1> binding negatively regulates <e2>RSK1</e2> activity to maintain signal specificity and that association/dissociation of the 14-3-3beta-RSK1 complex is likely to be important for mitogen-mediated RSK1 activation.",
    "direct",
    "12618428"
   ]
  ]
 },
 "RSK1,14-3-3": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "stimulation, RSK1 translocates to the plasma membrane where it is fully activated. The ability of RSK1 to bind the adapter protein 14-3-3beta was investigated because <e1>RSK1</e1> contains several putative <e2>14-3-3</e2>-binding motifs. We demonstrate that RSK1 specifically and directly binds 14-3-3beta. This interaction was dependent on phosphorylation of serine 154 within the motif RLSKEV of",
    "direct",
    "12618428"
   ]
  ]
 },
 "RSK1,14-3-3beta": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "is fully activated. The ability of RSK1 to bind the adapter protein 14-3-3beta was investigated because RSK1 contains several putative 14-3-3-binding motifs. We demonstrate that <e1>RSK1</e1> specifically and directly binds <e2>14-3-3beta</e2>. This interaction was dependent on phosphorylation of serine 154 within the motif RLSKEV of RSK1. Binding of RSK1 to 14-3-3beta was maximal under basal conditions",
    "direct",
    "12618428"
   ],
   [
    "is fully activated. The ability of RSK1 to bind the adapter protein 14-3-3beta was investigated because RSK1 contains several putative 14-3-3-binding motifs. We demonstrate that <e1>RSK1</e1> specifically and directly binds <e2>14-3-3beta</e2>. This interaction was dependent on phosphorylation of serine 154 within the motif RLSKEV of RSK1. Binding of RSK1 to 14-3-3beta was maximal under basal conditions",
    "direct",
    "12618428"
   ]
  ]
 },
 "Esa1p,histone H4 acetyltransferase": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "NuA4, an essential transcription adaptor/<e2>histone H4 acetyltransferase</e2> complex containing <e1>Esa1p</e1> and the ATM-related cofactor Tra1p. Post-translational acetylation of histone H4 N-terminal tail in chromatin has been associated with several nuclear processes including transcription. We",
    "direct",
    "10487762"
   ]
  ]
 },
 "Esa1p,Tra1p": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "NuA4, an essential transcription adaptor/histone H4 acetyltransferase complex containing <e1>Esa1p</e1> and the ATM-related cofactor <e2>Tra1p</e2>. Post-translational acetylation of histone H4 N-terminal tail in chromatin has been associated with several nuclear processes including transcription. We report the purification and characterization",
    "direct",
    "10487762"
   ]
  ]
 },
 "histone H4 acetyltransferase,Tra1p": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "NuA4, an essential transcription adaptor/<e1>histone H4 acetyltransferase</e1> complex containing Esa1p and the ATM-related cofactor <e2>Tra1p</e2>. Post-translational acetylation of histone H4 N-terminal tail in chromatin has been associated with several nuclear processes including transcription. We report the purification and characterization",
    "direct",
    "10487762"
   ]
  ]
 },
 "NuA4,histone H4": {
  "relations": [
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "H4 N-terminal tail in chromatin has been associated with several nuclear processes including transcription. We report the purification and characterization of a native multisubunit complex (<e1>NuA4</e1>) from yeast that acetylates nucleosomal <e2>histone H4</e2>. NuA4 has an apparent molecular mass of 1.3 MDa. All four conserved lysines of histone H4 can be acetylated by NuA4. We have identified",
    "direct",
    "10487762"
   ],
   [
    "native multisubunit complex (NuA4) from yeast that acetylates nucleosomal histone H4. NuA4 has an apparent molecular mass of 1.3 MDa. All four conserved lysines of <e2>histone H4</e2> can be acetylated by <e1>NuA4</e1>. We have identified the catalytic subunit of the complex as the product of ESA1, an essential gene required for cell cycle progression in",
    "direct",
    "10487762"
   ]
  ]
 },
 "ABIN,A20": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "The zinc finger protein <e2>A20</e2> inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein <e1>ABIN</e1>. The zinc finger protein A20 is a tumor necrosis factor (TNF)- and interleukin 1 (IL-1)-inducible protein that negatively regulates nuclear factor-kappa B (NF-kappaB)-dependent gene",
    "direct",
    "10385526"
   ],
   [
    "that is different from the NIK-IkappaB kinase pathway and that is specifically involved in the transactivation of NF-kappaB. Via yeast two-hybrid screening, we found that <e2>A20</e2> binds to a novel protein, <e1>ABIN</e1>, which mimics the NF-kappaB inhibiting effects of A20 upon overexpression, suggesting that the effect of A20 is mediated by its interaction with this NF-kappaB",
    "direct",
    "10385526"
   ]
  ]
 },
 "A20,ABIN": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "we found that A20 binds to a novel protein, ABIN, which mimics the NF-kappaB inhibiting effects of A20 upon overexpression, suggesting that the effect of <e1>A20</e1> is mediated by its interaction with this NF-kappaB inhibiting protein, <e2>ABIN</e2>.",
    "direct",
    "10385526"
   ]
  ]
 },
 "mTOR,elongation factor 2 kinase": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "A novel <e1>mTOR</e1>-regulated phosphorylation site in <e2>elongation factor 2 kinase</e2> modulates the activity of the kinase and its binding to calmodulin. Eukaryotic elongation factor 2 (eEF2) kinase is an unusual calcium- and calmodulin-dependent",
    "direct",
    "15024086"
   ]
  ]
 },
 "calmodulin,elongation factor 2 kinase": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "A novel mTOR-regulated phosphorylation site in <e2>elongation factor 2 kinase</e2> modulates the activity of the kinase and its binding to <e1>calmodulin</e1>. Eukaryotic elongation factor 2 (eEF2) kinase is an unusual calcium- and calmodulin-dependent protein kinase that is regulated by insulin through the rapamycin-sensitive mTOR pathway. Here",
    "direct",
    "15024086"
   ]
  ]
 },
 "eEF2 kinase,calmodulin": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "unusual calcium- and calmodulin-dependent protein kinase that is regulated by insulin through the rapamycin-sensitive mTOR pathway. Here we show that insulin decreases the ability of <e1>eEF2 kinase</e1> to bind <e2>calmodulin</e2> in a rapamycin-sensitive manner. We identify a novel phosphorylation site in eEF2 kinase (Ser78) that is located immediately next to its calmodulin-binding motif. Phosphorylation of",
    "direct",
    "15024086"
   ]
  ]
 },
 "calmodulin,eEF2 kinase": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Here we show that insulin decreases the ability of eEF2 kinase to bind calmodulin in a rapamycin-sensitive manner. We identify a novel phosphorylation site in <e2>eEF2 kinase</e2> (Ser78) that is located immediately next to its <e1>calmodulin</e1>-binding motif. Phosphorylation of this site is increased by insulin in a rapamycin-sensitive fashion. Regulation of the phosphorylation of Ser78 also requires amino acids and the",
    "direct",
    "15024086"
   ],
   [
    "the protein kinase phosphoinositide-dependent kinase 1. Mutation of this site to alanine strongly attenuates the effects of insulin and rapamycin both on the binding of <e1>calmodulin</e1> to <e2>eEF2 kinase</e2> and on eEF2 kinase activity. Phosphorylation of Ser78 is thus likely to link insulin and mTOR signaling to the control of eEF2 phosphorylation and",
    "direct",
    "15024086"
   ]
  ]
 },
 "insulin,eEF2": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "insulin and rapamycin both on the binding of calmodulin to eEF2 kinase and on eEF2 kinase activity. Phosphorylation of Ser78 is thus likely to link <e1>insulin</e1> and mTOR signaling to the control of <e2>eEF2</e2> phosphorylation and chain elongation. This site is not a target for known kinases in the mTOR pathway, e.g., the S6 kinases, implying that",
    "direct",
    "15024086"
   ]
  ]
 },
 "Clb5,Sld2": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "phosphorylation of 150 Cdk1 (Cdc28) substrates. About 24% of these proteins were phosphorylated more efficiently by Clb5-Cdk1 than Clb2-Cdk1. The Clb5-specific targets include several proteins (<e2>Sld2</e2>, Cdc6, Orc6, Mcm3 and Cdh1) involved in early S-phase events. Clb5 specificity depended on an interaction between a hydrophobic patch in Clb5 and a short sequence in the substrate (the RXL or Cy motif). Phosphorylation of <e1>Clb5</e1>-specific targets during S phase was reduced by replacing Clb5 with Clb2 or by mutating the substrate RXL motif, confirming the importance of Clb5",
    "direct",
    "15744308"
   ]
  ]
 },
 "Clb5,Cdc6": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "of 150 Cdk1 (Cdc28) substrates. About 24% of these proteins were phosphorylated more efficiently by Clb5-Cdk1 than Clb2-Cdk1. The Clb5-specific targets include several proteins (Sld2, <e2>Cdc6</e2>, Orc6, Mcm3 and Cdh1) involved in early S-phase events. Clb5 specificity depended on an interaction between a hydrophobic patch in Clb5 and a short sequence in the substrate (the RXL or Cy motif). Phosphorylation of <e1>Clb5</e1>-specific targets during S phase was reduced by replacing Clb5 with Clb2 or by mutating the substrate RXL motif, confirming the importance of Clb5",
    "direct",
    "15744308"
   ]
  ]
 },
 "Clb5,Orc6": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "150 Cdk1 (Cdc28) substrates. About 24% of these proteins were phosphorylated more efficiently by Clb5-Cdk1 than Clb2-Cdk1. The Clb5-specific targets include several proteins (Sld2, Cdc6, <e2>Orc6</e2>, Mcm3 and Cdh1) involved in early S-phase events. Clb5 specificity depended on an interaction between a hydrophobic patch in Clb5 and a short sequence in the substrate (the RXL or Cy motif). Phosphorylation of <e1>Clb5</e1>-specific targets during S phase was reduced by replacing Clb5 with Clb2 or by mutating the substrate RXL motif, confirming the importance of Clb5",
    "direct",
    "15744308"
   ]
  ]
 },
 "Clb5,Mcm3": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "Cdk1 (Cdc28) substrates. About 24% of these proteins were phosphorylated more efficiently by Clb5-Cdk1 than Clb2-Cdk1. The Clb5-specific targets include several proteins (Sld2, Cdc6, Orc6, <e2>Mcm3</e2> and Cdh1) involved in early S-phase events. Clb5 specificity depended on an interaction between a hydrophobic patch in Clb5 and a short sequence in the substrate (the RXL or Cy motif). Phosphorylation of <e1>Clb5</e1>-specific targets during S phase was reduced by replacing Clb5 with Clb2 or by mutating the substrate RXL motif, confirming the importance of Clb5",
    "direct",
    "15744308"
   ]
  ]
 },
 "Clb5,Cdh1": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "substrates. About 24% of these proteins were phosphorylated more efficiently by Clb5-Cdk1 than Clb2-Cdk1. The Clb5-specific targets include several proteins (Sld2, Cdc6, Orc6, Mcm3 and <e2>Cdh1</e2>) involved in early S-phase events. Clb5 specificity depended on an interaction between a hydrophobic patch in Clb5 and a short sequence in the substrate (the RXL or Cy motif). Phosphorylation of <e1>Clb5</e1>-specific targets during S phase was reduced by replacing Clb5 with Clb2 or by mutating the substrate RXL motif, confirming the importance of Clb5",
    "direct",
    "15744308"
   ]
  ]
 },
 "SWI5,HO": {
  "relations": [
   "controls-expression-of"
  ],
  "mentions": [
   [
    "Parallel pathways of gene regulation: homologous regulators <e1>SWI5</e1> and ACE2 differentially control transcription of <e2>HO</e2> and chitinase. Two independent pathways of transcriptional regulation that show functional homology have been identified in yeast. It has been demonstrated previously that",
    "direct",
    "1730413"
   ]
  ]
 },
 "ACE2,HO": {
  "relations": [
   "controls-expression-of"
  ],
  "mentions": [
   [
    "Parallel pathways of gene regulation: homologous regulators SWI5 and <e1>ACE2</e1> differentially control transcription of <e2>HO</e2> and chitinase. Two independent pathways of transcriptional regulation that show functional homology have been identified in yeast. It has been demonstrated previously that",
    "direct",
    "1730413"
   ]
  ]
 },
 "SWI5,chitinase": {
  "relations": [
   "controls-expression-of"
  ],
  "mentions": [
   [
    "Parallel pathways of gene regulation: homologous regulators <e1>SWI5</e1> and ACE2 differentially control transcription of HO and <e2>chitinase</e2>. Two independent pathways of transcriptional regulation that show functional homology have been identified in yeast. It has been demonstrated previously that SWI5 encodes a",
    "direct",
    "1730413"
   ]
  ]
 },
 "ACE2,chitinase": {
  "relations": [
   "controls-expression-of"
  ],
  "mentions": [
   [
    "Parallel pathways of gene regulation: homologous regulators SWI5 and <e1>ACE2</e1> differentially control transcription of HO and <e2>chitinase</e2>. Two independent pathways of transcriptional regulation that show functional homology have been identified in yeast. It has been demonstrated previously that SWI5 encodes a",
    "direct",
    "1730413"
   ]
  ]
 },
 "S112,4E-BP1": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "phosphorylation site in its C terminus (S101). A serine or glutamate at this position is required for efficient phosphorylation at Ser65. A second C-terminal site, <e1>S112</e1>, directly affects binding of <e2>4E-BP1</e2> to eIF4E without influencing phosphorylation of other sites. Thirdly, a conserved C-terminal motif influences phosphorylation of multiple residues, including rapamycin-insensitive sites. These relatively long-range",
    "direct",
    "12588975"
   ]
  ]
 },
 "eIF4E,4E-BP3": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "phosphorylation of 4E-BP1 and/or binding to eIF4E induces a more-ordered structure. 4E-BP2 and -3 lack phosphorylatable residues corresponding to both S101 and S112. However, in <e2>4E-BP3</e2>, replacement of the alanine at the position corresponding to S112 by serine or glutamate did not confer the ability to be released from <e1>eIF4E</e1> in response to insulin.",
    "direct",
    "12588975"
   ]
  ]
 },
 "CEBPA,p50": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "leukemia (AML). We have previously shown that C/EBPalpha or its AML mutants synergize with NF-kappaB p50 to activate antiapoptotic genes, including BCL2 and FLIP. Furthermore, <e2>p50</e2> binds and activates the <e1>CEBPA</e1> gene in myeloid cells. We now report that C/EBPalpha or C/EBPalpha leucine zipper AML mutants bind in vivo to the nfkb1 (p50) promoter and",
    "direct",
    "21346255"
   ]
  ]
 },
 "p50,CEBPalpha": {
  "relations": [
   "in-complex-with",
   "controls-expression-of"
  ],
  "mentions": [
   [
    "NF-kappaB p50 to activate antiapoptotic genes, including BCL2 and FLIP. Furthermore, p50 binds and activates the CEBPA gene in myeloid cells. We now report that <e2>C/EBPalpha</e2> or C/EBPalpha leucine zipper AML mutants bind in vivo to the nfkb1 (<e1>p50</e1>) promoter and induce its expression even in the presence of cycloheximide. Induction of p50 by C/EBPalpha depends on 2 conserved kappaB sites in the",
    "direct",
    "21346255"
   ],
   [
    "presence of cycloheximide. Induction of p50 by C/EBPalpha depends on 2 conserved kappaB sites in the nfkb1 promoter. C/EBPalpha did not induce p65 expression. Thus, <e2>C/EBPalpha</e2> and <e1>p50</e1> reciprocally regulate each other's expression, establishing a positive feedback relationship. Although p50 homodimers inhibit transcription, C/EBPalpha and p50 synergistically activate antiapoptotic genes. ChIP",
    "direct",
    "21346255"
   ]
  ]
 },
 "CEBPalpha,p50": {
  "relations": [
   "controls-expression-of"
  ],
  "mentions": [
   [
    "presence of cycloheximide. Induction of p50 by C/EBPalpha depends on 2 conserved kappaB sites in the nfkb1 promoter. C/EBPalpha did not induce p65 expression. Thus, <e1>C/EBPalpha</e1> and <e2>p50</e2> reciprocally regulate each other's expression, establishing a positive feedback relationship. Although p50 homodimers inhibit transcription, C/EBPalpha and p50 synergistically activate antiapoptotic genes. ChIP",
    "direct",
    "21346255"
   ]
  ]
 },
 "FLIP,histone deacetylase 1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "a positive feedback relationship. Although p50 homodimers inhibit transcription, C/EBPalpha and p50 synergistically activate antiapoptotic genes. ChIP analysis showed that C/EBPalpha diminishes the occupation of <e2>histone deacetylase 1</e2> (HDAC1) or HDAC3 on the endogenous <e1>FLIP</e1> promoter but not in mice lacking p50. Coimmunoprecipitation confirmed that C/EBPalpha, its AML variants, or C/EBPbeta disrupt interaction between p50 and HDACs dependent on",
    "direct",
    "21346255"
   ]
  ]
 },
 "FLIP,HDAC3": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "p50 homodimers inhibit transcription, C/EBPalpha and p50 synergistically activate antiapoptotic genes. ChIP analysis showed that C/EBPalpha diminishes the occupation of histone deacetylase 1 (HDAC1) or <e2>HDAC3</e2> on the endogenous <e1>FLIP</e1> promoter but not in mice lacking p50. Coimmunoprecipitation confirmed that C/EBPalpha, its AML variants, or C/EBPbeta disrupt interaction between p50 and HDACs dependent on",
    "direct",
    "21346255"
   ]
  ]
 },
 "p50,HDACs": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "or HDAC3 on the endogenous FLIP promoter but not in mice lacking p50. Coimmunoprecipitation confirmed that C/EBPalpha, its AML variants, or C/EBPbeta disrupt interaction between <e1>p50</e1> and <e2>HDACs</e2> dependent on the C/EBP basic region. These findings suggest that C/EBPs displace HDACs from p50 homodimers bound to antiapoptotic genes, contributing to NF-kappaB dysregulation",
    "direct",
    "21346255"
   ]
  ]
 },
 "SUMO-1,NF-kappaB": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Purification of <e1>SUMO-1</e1> modified IkappaBalpha and complex formation with <e2>NF-kappaB</e2>. Covalent modification of proteins with SUMO (Small Ubiquitin-like MOdifier) affects many cellular processes, including transcriptional regulation, DNA repair and signal transduction. Although hundreds of",
    "direct",
    "21708266"
   ]
  ]
 },
 "E2F8,E2F": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "of two distinct E2F-related DNA binding domains suggesting that E2F8 and, the recently, identified E2F7 form a subgroup within the E2F family. We show that <e2>E2F</e2> transcription factors bind the <e1>E2F8</e1> promoter in vivo and that expression of E2F8 is being induced at the G1/S transition. Purified recombinant E2F8 binds specifically to a consensus",
    "direct",
    "16179649"
   ]
  ]
 },
 "IL-23,IL-17": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "mechanism involving Akt-, p38 MAPK-, and ERK 1/2-dependent NF-kappaB signalling versus the JNK/AP-1 pathway. Taken together, our findings suggest that disruption of the interaction between <e2>IL-17</e2> and <e1>IL-23</e1> may be a potential therapeutic approach in the treatment of periodontitis.",
    "direct",
    "21145111"
   ]
  ]
 },
 "E2F1,ARHI": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "breast epithelial cells, breast cancer cells have significantly elevated expression of E2F1, 4 and increased E2F DNA-binding activity. Moreover, chromatin immunoprecipitation experiments revealed that both <e1>E2F1</e1> and 4 bind to the <e2>ARHI</e2> promoter in breast cancer cells in vivo. This binding was reduced when the cells were treated with the histone deacetylase (HDAC) inhibitor--trichostatin A",
    "direct",
    "16158053"
   ]
  ]
 },
 "4,ARHI": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "cells, breast cancer cells have significantly elevated expression of E2F1, 4 and increased E2F DNA-binding activity. Moreover, chromatin immunoprecipitation experiments revealed that both E2F1 and <e1>4</e1> bind to the <e2>ARHI</e2> promoter in breast cancer cells in vivo. This binding was reduced when the cells were treated with the histone deacetylase (HDAC) inhibitor--trichostatin A",
    "direct",
    "16158053"
   ]
  ]
 },
 "Aurora B,Bir1p": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "the regulation of septin dynamics during anaphase. Here, we present data that is consistent with there being multiple passenger protein complexes. Our data show that <e2>Bir1p</e2> links together a large passenger complex containing Ndc10p, Sli15p (INCENP), and Ipl1p (<e1>Aurora B</e1>) and that the interaction between Bir1p and Sli15p is specifically involved in regulating septin dynamics during anaphase. Neither conditional alleles nor mutants of BIR1",
    "direct",
    "17652458"
   ]
  ]
 },
 "Aurora B,INCENP": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "data that is consistent with there being multiple passenger protein complexes. Our data show that Bir1p links together a large passenger complex containing Ndc10p, Sli15p (<e2>INCENP</e2>), and Ipl1p (<e1>Aurora B</e1>) and that the interaction between Bir1p and Sli15p is specifically involved in regulating septin dynamics during anaphase. Neither conditional alleles nor mutants of BIR1",
    "direct",
    "17652458"
   ]
  ]
 },
 "Aurora B,Ndc10p": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "we present data that is consistent with there being multiple passenger protein complexes. Our data show that Bir1p links together a large passenger complex containing <e2>Ndc10p</e2>, Sli15p (INCENP), and Ipl1p (<e1>Aurora B</e1>) and that the interaction between Bir1p and Sli15p is specifically involved in regulating septin dynamics during anaphase. Neither conditional alleles nor mutants of BIR1",
    "direct",
    "17652458"
   ]
  ]
 },
 "Bir1p,INCENP": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "the regulation of septin dynamics during anaphase. Here, we present data that is consistent with there being multiple passenger protein complexes. Our data show that <e1>Bir1p</e1> links together a large passenger complex containing Ndc10p, Sli15p (<e2>INCENP</e2>), and Ipl1p (Aurora B) and that the interaction between Bir1p and Sli15p is specifically involved in regulating septin dynamics during anaphase. Neither conditional alleles",
    "direct",
    "17652458"
   ]
  ]
 },
 "Bir1p,Ndc10p": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "the regulation of septin dynamics during anaphase. Here, we present data that is consistent with there being multiple passenger protein complexes. Our data show that <e1>Bir1p</e1> links together a large passenger complex containing <e2>Ndc10p</e2>, Sli15p (INCENP), and Ipl1p (Aurora B) and that the interaction between Bir1p and Sli15p is specifically involved in regulating septin dynamics during anaphase. Neither",
    "direct",
    "17652458"
   ]
  ]
 },
 "INCENP,Ndc10p": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "we present data that is consistent with there being multiple passenger protein complexes. Our data show that Bir1p links together a large passenger complex containing <e2>Ndc10p</e2>, Sli15p (<e1>INCENP</e1>), and Ipl1p (Aurora B) and that the interaction between Bir1p and Sli15p is specifically involved in regulating septin dynamics during anaphase. Neither conditional alleles",
    "direct",
    "17652458"
   ]
  ]
 },
 "Sli15p,Bir1p": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "complexes. Our data show that Bir1p links together a large passenger complex containing Ndc10p, Sli15p (INCENP), and Ipl1p (Aurora B) and that the interaction between <e2>Bir1p</e2> and <e1>Sli15p</e1> is specifically involved in regulating septin dynamics during anaphase. Neither conditional alleles nor mutants of BIR1 that disrupt the interaction between Bir1p and Sli15p",
    "direct",
    "17652458"
   ],
   [
    "between Bir1p and Sli15p is specifically involved in regulating septin dynamics during anaphase. Neither conditional alleles nor mutants of BIR1 that disrupt the interaction between <e2>Bir1p</e2> and <e1>Sli15p</e1> resulted in mono-attached kinetochores, suggesting that the Bir1p-Sli15p complex functions in anaphase and independently from Sli15p-Ipl1p complexes. We present a model for how discrete",
    "direct",
    "17652458"
   ]
  ]
 },
 "tumor necrosis factor receptor,SIVA": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "the mechanism by which p53 induces apoptosis is cell type-dependent. Using DNA microarray analysis, we have found a striking induction of the proapoptotic gene, SIVA. <e2>SIVA</e2> is a proapoptotic protein containing a death domain and interacts with members of the <e1>tumor necrosis factor receptor</e1> family as well as anti-apoptotic Bcl-2 family proteins. SIVA is induced following direct p53 gene delivery, treatment with a DNA-damaging agent camptothecin, and stroke",
    "direct",
    "15105421"
   ]
  ]
 },
 "SIVA,Bcl-2": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "the mechanism by which p53 induces apoptosis is cell type-dependent. Using DNA microarray analysis, we have found a striking induction of the proapoptotic gene, SIVA. <e1>SIVA</e1> is a proapoptotic protein containing a death domain and interacts with members of the tumor necrosis factor receptor family as well as anti-apoptotic <e2>Bcl-2</e2> family proteins. SIVA is induced following direct p53 gene delivery, treatment with a DNA-damaging agent camptothecin, and stroke injury in vivo. SIVA up-regulation is",
    "direct",
    "15105421"
   ]
  ]
 },
 "ras,NF-kappaB": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "Regulation of <e2>NF-kappaB</e2> RelA phosphorylation and transcriptional activity by p21(<e1>ras</e1>) and protein kinase Czeta in primary endothelial cells. The activity of the transcription factor NF-kappaB is thought to be regulated mainly through cytoplasmic retention",
    "direct",
    "10224130"
   ]
  ]
 },
 "protein kinase Czeta,NF-kappaB": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "Regulation of <e2>NF-kappaB</e2> RelA phosphorylation and transcriptional activity by p21(ras) and <e1>protein kinase Czeta</e1> in primary endothelial cells. The activity of the transcription factor NF-kappaB is thought to be regulated mainly through cytoplasmic retention by IkappaB molecules.",
    "direct",
    "10224130"
   ]
  ]
 },
 "protein kinase Czeta,RelA": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-expression-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "Regulation of NF-kappaB <e2>RelA</e2> phosphorylation and transcriptional activity by p21(ras) and <e1>protein kinase Czeta</e1> in primary endothelial cells. The activity of the transcription factor NF-kappaB is thought to be regulated mainly through cytoplasmic retention by IkappaB molecules.",
    "direct",
    "10224130"
   ],
   [
    "Regulation of NF-kappaB <e2>RelA</e2> phosphorylation and transcriptional activity by p21(ras) and <e1>protein kinase Czeta</e1> in primary endothelial cells. The activity of the transcription factor NF-kappaB is thought to be regulated mainly through cytoplasmic retention by IkappaB molecules.",
    "direct",
    "10224130"
   ]
  ]
 },
 "ras,RelA": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-expression-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "Regulation of NF-kappaB <e2>RelA</e2> phosphorylation and transcriptional activity by p21(<e1>ras</e1>) and protein kinase Czeta in primary endothelial cells. The activity of the transcription factor NF-kappaB is thought to be regulated mainly through cytoplasmic retention",
    "direct",
    "10224130"
   ],
   [
    "Regulation of NF-kappaB <e2>RelA</e2> phosphorylation and transcriptional activity by p21(<e1>ras</e1>) and protein kinase Czeta in primary endothelial cells. The activity of the transcription factor NF-kappaB is thought to be regulated mainly through cytoplasmic retention",
    "direct",
    "10224130"
   ]
  ]
 },
 "Mec1,Ddc1": {
  "relations": [
   "controls-phosphorylation-of",
   "in-complex-with",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "effector kinase. The checkpoint clamp greatly activates the kinase activity of Mec1, but only if the clamp is appropriately loaded upon partial duplex DNA. Activated <e1>Mec1</e1> phosphorylates the <e2>Ddc1</e2> and Mec3 subunits of the clamp, the Rad24 subunit of the loader, and the Rpa1 and Rpa2 subunits of RPA. Phosphorylation of Rad53,",
    "direct",
    "17189191"
   ],
   [
    "Rad53, and of human PHAS-1, a nonspecific target, also requires a properly loaded clamp. Phosphorylation and binding studies with individual clamp subunits indicate that the <e2>Ddc1</e2> subunit mediates the functional interactions with <e1>Mec1</e1>.",
    "direct",
    "17189191"
   ]
  ]
 },
 "Mec1,Mec3": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "effector kinase. The checkpoint clamp greatly activates the kinase activity of Mec1, but only if the clamp is appropriately loaded upon partial duplex DNA. Activated <e1>Mec1</e1> phosphorylates the Ddc1 and <e2>Mec3</e2> subunits of the clamp, the Rad24 subunit of the loader, and the Rpa1 and Rpa2 subunits of RPA. Phosphorylation of Rad53, and of",
    "direct",
    "17189191"
   ]
  ]
 },
 "Mec1,Rad24": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "effector kinase. The checkpoint clamp greatly activates the kinase activity of Mec1, but only if the clamp is appropriately loaded upon partial duplex DNA. Activated <e1>Mec1</e1> phosphorylates the Ddc1 and Mec3 subunits of the clamp, the <e2>Rad24</e2> subunit of the loader, and the Rpa1 and Rpa2 subunits of RPA. Phosphorylation of Rad53, and of human PHAS-1, a nonspecific target, also requires",
    "direct",
    "17189191"
   ]
  ]
 },
 "Mec1,Rpa1": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "effector kinase. The checkpoint clamp greatly activates the kinase activity of Mec1, but only if the clamp is appropriately loaded upon partial duplex DNA. Activated <e1>Mec1</e1> phosphorylates the Ddc1 and Mec3 subunits of the clamp, the Rad24 subunit of the loader, and the <e2>Rpa1</e2> and Rpa2 subunits of RPA. Phosphorylation of Rad53, and of human PHAS-1, a nonspecific target, also requires a properly loaded clamp. Phosphorylation and",
    "direct",
    "17189191"
   ]
  ]
 },
 "Mec1,Rpa2": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "effector kinase. The checkpoint clamp greatly activates the kinase activity of Mec1, but only if the clamp is appropriately loaded upon partial duplex DNA. Activated <e1>Mec1</e1> phosphorylates the Ddc1 and Mec3 subunits of the clamp, the Rad24 subunit of the loader, and the Rpa1 and <e2>Rpa2</e2> subunits of RPA. Phosphorylation of Rad53, and of human PHAS-1, a nonspecific target, also requires a properly loaded clamp. Phosphorylation and binding studies",
    "direct",
    "17189191"
   ]
  ]
 },
 "IL-1,IL-1R AcP": {
  "relations": [
   "controls-expression-of"
  ],
  "mentions": [
   [
    "putative extracellular domain and also bears limited homology throughout the protein to both Type I and Type II IL-1 receptors. Northern analysis reveals that murine <e2>IL-1R AcP</e2> mRNA is expressed in many tissues and appears to be regulated by <e1>IL-1</e1>. In mammalian cells expressing natural or recombinant Type I IL-1R and IL-1R AcP, the accessory protein forms a complex with the Type I",
    "direct",
    "7775431"
   ]
  ]
 },
 "IL-1 alpha,Type I IL-1R": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "be regulated by IL-1. In mammalian cells expressing natural or recombinant Type I IL-1R and IL-1R AcP, the accessory protein forms a complex with the <e2>Type I IL-1R</e2> and either <e1>IL-1 alpha</e1> or IL-1 beta but not IL-1ra. The recombinant accessory protein also increases the binding affinity of the recombinant Type I IL-1R for IL-1 beta",
    "direct",
    "7775431"
   ]
  ]
 },
 "Type I IL-1R,IL-1 beta": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "be regulated by IL-1. In mammalian cells expressing natural or recombinant Type I IL-1R and IL-1R AcP, the accessory protein forms a complex with the <e1>Type I IL-1R</e1> and either IL-1 alpha or <e2>IL-1 beta</e2> but not IL-1ra. The recombinant accessory protein also increases the binding affinity of the recombinant Type I IL-1R for IL-1 beta when the two",
    "direct",
    "7775431"
   ]
  ]
 },
 "Type I IL-1R,IL-1ra": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "be regulated by IL-1. In mammalian cells expressing natural or recombinant Type I IL-1R and IL-1R AcP, the accessory protein forms a complex with the <e1>Type I IL-1R</e1> and either IL-1 alpha or IL-1 beta but not <e2>IL-1ra</e2>. The recombinant accessory protein also increases the binding affinity of the recombinant Type I IL-1R for IL-1 beta when the two receptor proteins are",
    "direct",
    "7775431"
   ]
  ]
 },
 "IL-1 beta,Type I IL-1R": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Type I IL-1R and either IL-1 alpha or IL-1 beta but not IL-1ra. The recombinant accessory protein also increases the binding affinity of the recombinant <e2>Type I IL-1R</e2> for <e1>IL-1 beta</e1> when the two receptor proteins are coexpressed. Therefore, the functional IL-1 receptor appears to be a complex composed of at least two subunits.",
    "direct",
    "7775431"
   ]
  ]
 },
 "asparagine,oligosaccharides": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "The role of glucosidase II and endomannosidase in glucose trimming of <e1>asparagine</e1>-linked <e2>oligosaccharides</e2>. This review covers various aspects of glucose trimming reactions occurring on asparagine-linked oligosaccharides. Structural and functional features of two enzymes, glucosidase II and endo-alpha-mannosidase, prominently",
    "direct",
    "12770767"
   ]
  ]
 },
 "oligosaccharides,asparagine": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "The role of glucosidase II and endomannosidase in glucose trimming of asparagine-linked oligosaccharides. This review covers various aspects of glucose trimming reactions occurring on <e2>asparagine</e2>-linked <e1>oligosaccharides</e1>. Structural and functional features of two enzymes, glucosidase II and endo-alpha-mannosidase, prominently involved in this process are summarized and their striking differences in terms of",
    "direct",
    "12770767"
   ]
  ]
 },
 "thioredoxin,ASK1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "p38 MAP kinase pathways and is required for tumor necrosis factor (TNF)-alpha-induced apoptosis; however, the mechanism regulating ASK1 activity is unknown. Through genetic screening for <e2>ASK1</e2>-binding proteins, <e1>thioredoxin</e1> (Trx), a reduction/oxidation (redox)-regulatory protein thought to have anti-apoptotic effects, was identified as an interacting partner of ASK1. Trx associated with the N-terminal portion of",
    "direct",
    "9564042"
   ],
   [
    "kinase pathways and is required for tumor necrosis factor (TNF)-alpha-induced apoptosis; however, the mechanism regulating ASK1 activity is unknown. Through genetic screening for ASK1-binding proteins, <e1>thioredoxin</e1> (Trx), a reduction/oxidation (redox)-regulatory protein thought to have anti-apoptotic effects, was identified as an interacting partner of <e2>ASK1</e2>. Trx associated with the N-terminal portion of ASK1 in vitro and in vivo. Expression of Trx inhibited ASK1 kinase activity and the subsequent",
    "direct",
    "9564042"
   ]
  ]
 },
 "ASK1,Trx": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Through genetic screening for ASK1-binding proteins, thioredoxin (Trx), a reduction/oxidation (redox)-regulatory protein thought to have anti-apoptotic effects, was identified as an interacting partner of ASK1. <e2>Trx</e2> associated with the N-terminal portion of <e1>ASK1</e1> in vitro and in vivo. Expression of Trx inhibited ASK1 kinase activity and the subsequent ASK1-dependent apoptosis. Treatment of cells with N-acetyl-L-cysteine also",
    "direct",
    "9564042"
   ],
   [
    "ASK1-dependent apoptosis. Treatment of cells with N-acetyl-L-cysteine also inhibited serum withdrawal-, TNF-alpha- and hydrogen peroxide-induced activation of ASK1 as well as apoptosis. The interaction between <e2>Trx</e2> and <e1>ASK1</e1> was found to be highly dependent on the redox status of Trx. Moreover, inhibition of Trx resulted in activation of endogenous ASK1 activity,",
    "direct",
    "9564042"
   ]
  ]
 },
 "Ace2p,chitinase": {
  "relations": [
   "controls-expression-of"
  ],
  "mentions": [
   [
    "Regulated nuclear localisation of the yeast transcription factor Ace2p controls expression of chitinase (CTS1) in Saccharomyces cerevisiae. The yeast transcription factor <e1>Ace2p</e1> regulates expression of the <e2>chitinase</e2> gene CTS1 in a cell cycle-dependent manner. Nuclear localisation of Ace2p is restricted to late M and early G phases of the mitotic cell cycle.",
    "direct",
    "10517323"
   ]
  ]
 },
 "Ace2p,CTS1": {
  "relations": [
   "controls-expression-of"
  ],
  "mentions": [
   [
    "Regulated nuclear localisation of the yeast transcription factor Ace2p controls expression of chitinase (CTS1) in Saccharomyces cerevisiae. The yeast transcription factor <e1>Ace2p</e1> regulates expression of the chitinase gene <e2>CTS1</e2> in a cell cycle-dependent manner. Nuclear localisation of Ace2p is restricted to late M and early G phases of the mitotic cell cycle. We",
    "direct",
    "10517323"
   ]
  ]
 },
 "MAP4K3,S6K1": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "is stimulated by administration of amino acids, but not growth factors, and this is insensitive to rapamycin, most likely placing MAP4K3 upstream of mTOR. Indeed, <e1>MAP4K3</e1> is required for phosphorylation of known mTOR targets such as <e2>S6K1</e2> (S6 kinase 1), and overexpression of MAP4K3 promotes the rapamycin-sensitive phosphorylation of these same targets. Finally, knockdown of MAP4K3 levels causes a decrease",
    "direct",
    "17346240"
   ]
  ]
 },
 "Hsp70,protein kinase C": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "The turn motif is a phosphorylation switch that regulates the binding of <e1>Hsp70</e1> to <e2>protein kinase C</e2>. Heat shock proteins play central roles in ensuring the correct folding and maturation of cellular proteins. Here we show that the heat shock",
    "direct",
    "12080070"
   ],
   [
    "proteins. Here we show that the heat shock protein Hsp70 has a novel role in prolonging the lifetime of activated protein kinase C. We identified <e1>Hsp70</e1> in a screen for binding partners for the carboxyl terminus of <e2>protein kinase C</e2>. Co-immunoprecipitation experiments revealed that Hsp70 specifically binds the unphosphorylated turn motif (Thr(641) in protein kinase C beta II), one of three priming sites",
    "direct",
    "12080070"
   ],
   [
    "(Thr(641) in protein kinase C beta II), one of three priming sites phosphorylated during the maturation of protein kinase C family members. The interaction of <e1>Hsp70</e1> with <e2>protein kinase C</e2> can be abolished in vivo by co-expression of fusion proteins encoding the carboxyl terminus of protein kinase C or the carboxyl terminus of",
    "direct",
    "12080070"
   ],
   [
    "superfamily (Akt/protein kinase B and protein kinase A) also bind Hsp70 via their unphosphorylated turn motifs. Our data are consistent with a model in which <e1>Hsp70</e1> binds the dephosphorylated carboxyl terminus of mature <e2>protein kinase C</e2>, thus stabilizing the protein and allowing re-phosphorylation of the enzyme. Disruption of this interaction prevents re-phosphorylation and targets the enzyme for down-regulation.",
    "direct",
    "12080070"
   ],
   [
    "superfamily (Akt/protein kinase B and protein kinase A) also bind Hsp70 via their unphosphorylated turn motifs. Our data are consistent with a model in which <e1>Hsp70</e1> binds the dephosphorylated carboxyl terminus of mature <e2>protein kinase C</e2>, thus stabilizing the protein and allowing re-phosphorylation of the enzyme. Disruption of this interaction prevents re-phosphorylation and targets the enzyme for down-regulation.",
    "direct",
    "12080070"
   ]
  ]
 },
 "protein kinase C beta II,Hsp70": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "activated protein kinase C. We identified Hsp70 in a screen for binding partners for the carboxyl terminus of protein kinase C. Co-immunoprecipitation experiments revealed that <e2>Hsp70</e2> specifically binds the unphosphorylated turn motif (Thr(641) in <e1>protein kinase C beta II</e1>), one of three priming sites phosphorylated during the maturation of protein kinase C family members. The interaction of Hsp70 with protein kinase",
    "direct",
    "12080070"
   ]
  ]
 },
 "protein kinase C,Hsp70": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "regulate the maturation of protein kinase C: the rate of processing by phosphorylation is the same in the presence or absence of disrupting constructs. Rather, <e2>Hsp70</e2> prolongs the lifetime of mature <e1>protein kinase C</e1>; disruption of the interaction promotes the accumulation of matured and then dephosphorylated protein kinase C in the detergent-insoluble fraction of cells. Furthermore, studies",
    "direct",
    "12080070"
   ]
  ]
 },
 "Hsp70,protein kinase B": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Hsp70 slows the protein kinase C beta II-mediated recovery of cells from PMA-induced growth arrest. Last, we show that other members of the AGC superfamily (Akt/<e2>protein kinase B</e2> and protein kinase A) also bind <e1>Hsp70</e1> via their unphosphorylated turn motifs. Our data are consistent with a model in which Hsp70 binds the dephosphorylated carboxyl terminus of mature protein kinase",
    "direct",
    "12080070"
   ]
  ]
 },
 "Hsp70,protein kinase A": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "kinase C beta II-mediated recovery of cells from PMA-induced growth arrest. Last, we show that other members of the AGC superfamily (Akt/protein kinase B and <e2>protein kinase A</e2>) also bind <e1>Hsp70</e1> via their unphosphorylated turn motifs. Our data are consistent with a model in which Hsp70 binds the dephosphorylated carboxyl terminus of mature protein kinase",
    "direct",
    "12080070"
   ]
  ]
 },
 "Myt1,Cdc2": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "a pivotal step of mitotic initiation. This step is mediated principally by the dephosphorylation of residues threonine 14 (Thr14) and tyrosine 15 (Tyr15) on the <e2>Cdc2</e2> catalytic subunit. In several organisms homologs of the Wee1 kinase have been shown to be the major activity responsible for phosphorylating the Tyr15 inhibitory site. A membrane-bound kinase capable of phosphorylating residue Thr14, the <e1>Myt1</e1> kinase, has been identified in the frog Xenopus laevis and more recently in human. In this study, we have examined the substrate specificity",
    "direct",
    "9268380"
   ],
   [
    "Overproduction of human Myt1 kinase induces a G2 cell cycle delay by interfering with the intracellular trafficking of Cdc2-cyclin B1 complexes. The <e1>Myt1</e1> protein kinase functions to negatively regulate Cdc2-cyclin B complexes by phosphorylating <e2>Cdc2</e2> on threonine 14 and tyrosine 15. Throughout interphase, human Myt1 localizes to the endoplasmic reticulum and Golgi complex, whereas Cdc2-cyclin B1 complexes shuttle between",
    "direct",
    "10373560"
   ],
   [
    "Overproduction of human Myt1 kinase induces a G2 cell cycle delay by interfering with the intracellular trafficking of Cdc2-cyclin B1 complexes. The <e1>Myt1</e1> protein kinase functions to negatively regulate Cdc2-cyclin B complexes by phosphorylating <e2>Cdc2</e2> on threonine 14 and tyrosine 15. Throughout interphase, human Myt1 localizes to the endoplasmic reticulum and Golgi complex, whereas Cdc2-cyclin B1 complexes shuttle between",
    "direct",
    "10373560"
   ]
  ]
 },
 "Myt1,cyclin complexes": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "recently in human. In this study, we have examined the substrate specificity and cell cycle regulation of the human Myt1 kinase. We find that human <e1>Myt1</e1> phosphorylates and inactivates Cdc2-containing <e2>cyclin complexes</e2> but not complexes containing Cdk2 or Cdk4. Analysis of endogenous Myt1 demonstrates that it remains membrane-bound throughout the cell cycle, but its kinase activity",
    "direct",
    "9268380"
   ]
  ]
 },
 "Myt1,Cdk2": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "recently in human. In this study, we have examined the substrate specificity and cell cycle regulation of the human Myt1 kinase. We find that human <e1>Myt1</e1> phosphorylates and inactivates Cdc2-containing cyclin complexes but not complexes containing <e2>Cdk2</e2> or Cdk4. Analysis of endogenous Myt1 demonstrates that it remains membrane-bound throughout the cell cycle, but its kinase activity decreased during M phase arrest,",
    "direct",
    "9268380"
   ]
  ]
 },
 "Myt1,Cdk4": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "recently in human. In this study, we have examined the substrate specificity and cell cycle regulation of the human Myt1 kinase. We find that human <e1>Myt1</e1> phosphorylates and inactivates Cdc2-containing cyclin complexes but not complexes containing Cdk2 or <e2>Cdk4</e2>. Analysis of endogenous Myt1 demonstrates that it remains membrane-bound throughout the cell cycle, but its kinase activity decreased during M phase arrest, when",
    "direct",
    "9268380"
   ]
  ]
 },
 "cyclin complexes,Cdc2": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "this study, we have examined the substrate specificity and cell cycle regulation of the human Myt1 kinase. We find that human Myt1 phosphorylates and inactivates <e2>Cdc2</e2>-containing <e1>cyclin complexes</e1> but not complexes containing Cdk2 or Cdk4. Analysis of endogenous Myt1 demonstrates that it remains membrane-bound throughout the cell cycle, but its kinase activity",
    "direct",
    "9268380"
   ]
  ]
 },
 "cyclin complexes,Cdk2": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "study, we have examined the substrate specificity and cell cycle regulation of the human Myt1 kinase. We find that human Myt1 phosphorylates and inactivates Cdc2-containing <e1>cyclin complexes</e1> but not complexes containing <e2>Cdk2</e2> or Cdk4. Analysis of endogenous Myt1 demonstrates that it remains membrane-bound throughout the cell cycle, but its kinase activity decreased during M phase arrest,",
    "direct",
    "9268380"
   ]
  ]
 },
 "Cdk4,cyclin complexes": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "study, we have examined the substrate specificity and cell cycle regulation of the human Myt1 kinase. We find that human Myt1 phosphorylates and inactivates Cdc2-containing <e2>cyclin complexes</e2> but not complexes containing Cdk2 or <e1>Cdk4</e1>. Analysis of endogenous Myt1 demonstrates that it remains membrane-bound throughout the cell cycle, but its kinase activity decreased during M phase arrest, when",
    "direct",
    "9268380"
   ]
  ]
 },
 "Cdc2. cyclin B1,Myt1": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "endogenous Myt1 demonstrates that it remains membrane-bound throughout the cell cycle, but its kinase activity decreased during M phase arrest, when Myt1 became hyperphosphorylated. Further, <e1>Cdc2. cyclin B1</e1> was capable of phosphorylating <e2>Myt1</e2> in vitro, but this phosphorylation did not affect Myt1 kinase activity. These findings suggest that human Myt1 is negatively regulated by an M phase-activated",
    "direct",
    "9268380"
   ]
  ]
 },
 "14-3-3,TSC2": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "mechanism and physiologic significance of this effect of hypoxia remain unknown. Here, we demonstrate that hypoxia and REDD1 suppress mammalian TORC1 (mTORC1) activity by releasing <e2>TSC2</e2> from its growth factor-induced association with inhibitory <e1>14-3-3</e1> proteins. Endogenous REDD1 is required for both dissociation of endogenous TSC2/14-3-3 and inhibition of mTORC1 in response to hypoxia. REDD1 mutants that fail to",
    "direct",
    "18198340"
   ]
  ]
 },
 "REDD1,14-3-3": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "growth factor-induced association with inhibitory 14-3-3 proteins. Endogenous REDD1 is required for both dissociation of endogenous TSC2/14-3-3 and inhibition of mTORC1 in response to hypoxia. <e1>REDD1</e1> mutants that fail to bind <e2>14-3-3</e2> are defective in eliciting TSC2/14-3-3 dissociation and mTORC1 inhibition, while TSC2 mutants that do not bind 14-3-3 are inactive in hypoxia signaling to mTORC1.",
    "direct",
    "18198340"
   ]
  ]
 },
 "TSC2,14-3-3": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "and inhibition of mTORC1 in response to hypoxia. REDD1 mutants that fail to bind 14-3-3 are defective in eliciting TSC2/14-3-3 dissociation and mTORC1 inhibition, while <e1>TSC2</e1> mutants that do not bind <e2>14-3-3</e2> are inactive in hypoxia signaling to mTORC1. In vitro, loss of REDD1 signaling promotes proliferation and anchorage-independent growth under hypoxia through mTORC1 dysregulation. In",
    "direct",
    "18198340"
   ]
  ]
 },
 "activator protein 1,NF-{kappa}B": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "The <e1>activator protein 1</e1> binding motifs within the human cytomegalovirus major immediate-early enhancer are functionally redundant and act in a cooperative manner with the <e2>NF-{kappa}B</e2> sites during acute infection. Human cytomegalovirus (HCMV) infection causes a rapid induction of c-Fos and c-Jun, the major subunits of activator protein 1 (AP-1), which",
    "direct",
    "21106746"
   ]
  ]
 },
 "AP-1,c-Fosc-Jun": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "site. In this study we explored the role of these AP-1 elements in the context of the infection. We first show that the distal candidate <e1>AP-1</e1> motif binds <e2>c-Fos/c-Jun</e2> heterodimers (AP-1 complex) and confers c-Fos/c-Jun-mediated activity to a core promoter. Site-directed mutagenesis studies indicate that both AP-1 response elements are critical for 12-O-tetradecanoylphorbol-13-acetate (TPA)-enhanced",
    "direct",
    "21106746"
   ]
  ]
 },
 "cyclin Ecdk2,p21": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "phase) hypertrophy at 72 h while attenuating high glucose-induced p21(WAF1) gene transcription and protein expression at 36-48 h. LY294002 also attenuated high glucose-induced binding of <e2>p21</e2>(WAF1) to the <e1>cyclin E/cdk2</e1> complex, whereas attenuating high glucose-induced TGF-beta bioactivity, Smad2/3 phosphorylation, and Smad2/3 DNA-binding activity at 36-48 h. We concluded that PI3K is required for high",
    "direct",
    "17332736"
   ],
   [
    "Smad2/3 phosphorylation, and Smad2/3 DNA-binding activity at 36-48 h. We concluded that PI3K is required for high glucose-induced cell cycle-dependent hypertrophy, p21(WAF1) transcription and expression, <e2>p21</e2>(WAF1) binding to the <e1>cyclin E/cdk2</e1> complex, TGF-beta bioactivity, and Smad2/3 activity in LLC-PK1 cells.",
    "direct",
    "17332736"
   ]
  ]
 },
 "Nud1p,Spc72p": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "exit. Here, we describe that the core SPB component Nud1p is a key protein that functions in both processes. The astral microtubule organizing function of <e1>Nud1p</e1> is mediated by its interaction with the gamma-tubulin complex binding protein <e2>Spc72p</e2>. This function of Nud1p is distinct from its role in cell-cycle control: Nud1p binds the spindle checkpoint control proteins Bfa1p and Bub2p to the",
    "direct",
    "11101520"
   ]
  ]
 },
 "gamma-tubulin,Spc72p": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "component Nud1p is a key protein that functions in both processes. The astral microtubule organizing function of Nud1p is mediated by its interaction with the <e1>gamma-tubulin</e1> complex binding protein <e2>Spc72p</e2>. This function of Nud1p is distinct from its role in cell-cycle control: Nud1p binds the spindle checkpoint control proteins Bfa1p and Bub2p to the",
    "direct",
    "11101520"
   ]
  ]
 },
 "Bfa1p,Nud1p": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Nud1p is mediated by its interaction with the gamma-tubulin complex binding protein Spc72p. This function of Nud1p is distinct from its role in cell-cycle control: <e2>Nud1p</e2> binds the spindle checkpoint control proteins <e1>Bfa1p</e1> and Bub2p to the SPB, and is part of the mitotic exit network (MEN) in which it functions upstream of CDC15 but downstream of",
    "direct",
    "11101520"
   ]
  ]
 },
 "Bub2p,Nud1p": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Nud1p is mediated by its interaction with the gamma-tubulin complex binding protein Spc72p. This function of Nud1p is distinct from its role in cell-cycle control: <e2>Nud1p</e2> binds the spindle checkpoint control proteins Bfa1p and <e1>Bub2p</e1> to the SPB, and is part of the mitotic exit network (MEN) in which it functions upstream of CDC15 but downstream of LTE1. In",
    "direct",
    "11101520"
   ]
  ]
 },
 "Tem1p,Cdc15p": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "the MEN component Tem1p, a GTPase, is mislocalized, whereas the kinase Cdc15p is still associated with the SPB. Thus, in nud1-2 cells the failure of <e1>Tem1p</e1> to interact with <e2>Cdc15p</e2> at the SPB probably prevents mitotic exit.",
    "direct",
    "11101520"
   ]
  ]
 },
 "Pdcd4,eukaryotic translation initiation factor 4A": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "The transformation suppressor <e1>Pdcd4</e1> is a novel <e2>eukaryotic translation initiation factor 4A</e2> binding protein that inhibits translation. Pdcd4 is a novel transformation suppressor that inhibits tumor promoter-induced neoplastic transformation and the activation of AP-1-dependent transcription",
    "direct",
    "12482958"
   ]
  ]
 },
 "Pdcd4,eIF4AII": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "a novel transformation suppressor that inhibits tumor promoter-induced neoplastic transformation and the activation of AP-1-dependent transcription required for transformation. A yeast two-hybrid analysis revealed that <e1>Pdcd4</e1> associates with the eukaryotic translation initiation factors eIF4AI and <e2>eIF4AII</e2>. Immunofluorescent confocal microscopy showed that Pdcd4 colocalizes with eIF4A in the cytoplasm. eIF4A is an ATP-dependent RNA helicase needed to unwind 5' mRNA secondary",
    "direct",
    "12482958"
   ]
  ]
 },
 "Pdcd4,eIF4AI": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "a novel transformation suppressor that inhibits tumor promoter-induced neoplastic transformation and the activation of AP-1-dependent transcription required for transformation. A yeast two-hybrid analysis revealed that <e1>Pdcd4</e1> associates with the eukaryotic translation initiation factors <e2>eIF4AI</e2> and eIF4AII. Immunofluorescent confocal microscopy showed that Pdcd4 colocalizes with eIF4A in the cytoplasm. eIF4A is an ATP-dependent RNA helicase needed to unwind 5'",
    "direct",
    "12482958"
   ]
  ]
 },
 "Pdcd4(D418A),eIF4A": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "helicase activity of eIF4A and eIF4F. In vivo translation assays showed that Pdcd4 inhibited cap-dependent but not internal ribosome entry site (IRES)-dependent translation. In contrast, <e1>Pdcd4(D418A)</e1>, a mutant inactivated for binding to <e2>eIF4A</e2>, failed to inhibit cap-dependent or IRES-dependent translation or AP-1 transactivation. Recombinant Pdcd4 prevented eIF4A from binding to the C-terminal region of eIF4G (amino",
    "direct",
    "12482958"
   ]
  ]
 },
 "eIF4A,eIF4G": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "(IRES)-dependent translation. In contrast, Pdcd4(D418A), a mutant inactivated for binding to eIF4A, failed to inhibit cap-dependent or IRES-dependent translation or AP-1 transactivation. Recombinant Pdcd4 prevented <e1>eIF4A</e1> from binding to the C-terminal region of <e2>eIF4G</e2> (amino acids 1040 to 1560) but not to the middle region of eIF4G(amino acids 635 to 1039). In addition, both Pdcd4 and Pdcd4(D418A)",
    "direct",
    "12482958"
   ],
   [
    "Pdcd4(D418A) bound to the middle region of eIF4G. The mechanism by which Pdcd4 inhibits translation thus appears to involve inhibition of eIF4A helicase, interference with <e1>eIF4A</e1> association-dissociation from <e2>eIF4G</e2>, and inhibition of eIF4A binding to the C-terminal domain of eIF4G. Pdcd4 binding to eIF4A is linked to its transformation-suppressing activity, as Pdcd4-eIF4A binding",
    "direct",
    "12482958"
   ],
   [
    "Pdcd4(D418A) bound to the middle region of eIF4G. The mechanism by which Pdcd4 inhibits translation thus appears to involve inhibition of eIF4A helicase, interference with <e1>eIF4A</e1> association-dissociation from <e2>eIF4G</e2>, and inhibition of eIF4A binding to the C-terminal domain of eIF4G. Pdcd4 binding to eIF4A is linked to its transformation-suppressing activity, as Pdcd4-eIF4A binding",
    "direct",
    "12482958"
   ]
  ]
 },
 "eIF4G,eIF4A": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "(IRES)-dependent translation. In contrast, Pdcd4(D418A), a mutant inactivated for binding to eIF4A, failed to inhibit cap-dependent or IRES-dependent translation or AP-1 transactivation. Recombinant Pdcd4 prevented <e2>eIF4A</e2> from binding to the C-terminal region of eIF4G (amino acids 1040 to 1560) but not to the middle region of <e1>eIF4G</e1>(amino acids 635 to 1039). In addition, both Pdcd4 and Pdcd4(D418A) bound to the middle region of eIF4G. The mechanism by which Pdcd4 inhibits",
    "direct",
    "12482958"
   ],
   [
    "eIF4G. The mechanism by which Pdcd4 inhibits translation thus appears to involve inhibition of eIF4A helicase, interference with eIF4A association-dissociation from eIF4G, and inhibition of <e2>eIF4A</e2> binding to the C-terminal domain of <e1>eIF4G</e1>. Pdcd4 binding to eIF4A is linked to its transformation-suppressing activity, as Pdcd4-eIF4A binding and consequent inhibition of translation are required for Pdcd4 transrepression",
    "direct",
    "12482958"
   ]
  ]
 },
 "Pdcd4,eIF4G": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "the C-terminal region of eIF4G (amino acids 1040 to 1560) but not to the middle region of eIF4G(amino acids 635 to 1039). In addition, both <e1>Pdcd4</e1> and Pdcd4(D418A) bound to the middle region of <e2>eIF4G</e2>. The mechanism by which Pdcd4 inhibits translation thus appears to involve inhibition of eIF4A helicase, interference with eIF4A association-dissociation from eIF4G, and inhibition",
    "direct",
    "12482958"
   ]
  ]
 },
 "Pdcd4(D418A),eIF4G": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "region of eIF4G (amino acids 1040 to 1560) but not to the middle region of eIF4G(amino acids 635 to 1039). In addition, both Pdcd4 and <e1>Pdcd4(D418A)</e1> bound to the middle region of <e2>eIF4G</e2>. The mechanism by which Pdcd4 inhibits translation thus appears to involve inhibition of eIF4A helicase, interference with eIF4A association-dissociation from eIF4G, and inhibition",
    "direct",
    "12482958"
   ]
  ]
 },
 "eIF4A,Pdcd4": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "thus appears to involve inhibition of eIF4A helicase, interference with eIF4A association-dissociation from eIF4G, and inhibition of eIF4A binding to the C-terminal domain of eIF4G. <e2>Pdcd4</e2> binding to <e1>eIF4A</e1> is linked to its transformation-suppressing activity, as Pdcd4-eIF4A binding and consequent inhibition of translation are required for Pdcd4 transrepression of AP-1.",
    "direct",
    "12482958"
   ],
   [
    "association-dissociation from eIF4G, and inhibition of eIF4A binding to the C-terminal domain of eIF4G. Pdcd4 binding to eIF4A is linked to its transformation-suppressing activity, as <e2>Pdcd4</e2>-<e1>eIF4A</e1> binding and consequent inhibition of translation are required for Pdcd4 transrepression of AP-1.",
    "direct",
    "12482958"
   ]
  ]
 },
 "p53,E6": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "that is involved in the regulation of the G1/S phase transition by activating cyclin E/Cdk2 and cyclin A/Cdk2 complexes through removal of inhibitory phosphorylations. The <e2>E6</e2> and E7 oncoproteins of the high-risk human papillomaviruses (HPV) interact with and functionally abrogate the <e1>p53</e1> and pRB proteins, respectively. In the present study we have investigated the regulation of the Cdc25A promoter during G1 and S-phases of the",
    "direct",
    "11313986"
   ]
  ]
 },
 "pRB,E6": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "that is involved in the regulation of the G1/S phase transition by activating cyclin E/Cdk2 and cyclin A/Cdk2 complexes through removal of inhibitory phosphorylations. The <e2>E6</e2> and E7 oncoproteins of the high-risk human papillomaviruses (HPV) interact with and functionally abrogate the p53 and <e1>pRB</e1> proteins, respectively. In the present study we have investigated the regulation of the Cdc25A promoter during G1 and S-phases of the cell cycle",
    "direct",
    "11313986"
   ]
  ]
 },
 "p53,E7": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "involved in the regulation of the G1/S phase transition by activating cyclin E/Cdk2 and cyclin A/Cdk2 complexes through removal of inhibitory phosphorylations. The E6 and <e2>E7</e2> oncoproteins of the high-risk human papillomaviruses (HPV) interact with and functionally abrogate the <e1>p53</e1> and pRB proteins, respectively. In the present study we have investigated the regulation of the Cdc25A promoter during G1 and S-phases of the",
    "direct",
    "11313986"
   ]
  ]
 },
 "E7,pRB": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "involved in the regulation of the G1/S phase transition by activating cyclin E/Cdk2 and cyclin A/Cdk2 complexes through removal of inhibitory phosphorylations. The E6 and <e1>E7</e1> oncoproteins of the high-risk human papillomaviruses (HPV) interact with and functionally abrogate the p53 and <e2>pRB</e2> proteins, respectively. In the present study we have investigated the regulation of the Cdc25A promoter during G1 and S-phases of the cell cycle",
    "direct",
    "11313986"
   ]
  ]
 },
 "Pkh2,Pkc1": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "function. A temperature-sensitive mutant, pkh1(D398G) pkh2, was phenotypically similar to mutants defective in the Pkc1-mitogen-activated protein kinase (MAPK) pathway. Genetic epistasis analyses, the phosphorylation of <e2>Pkc1</e2> by <e1>Pkh2</e1> in vitro, and reduced Pkc1 activity in the pkh1(D398G) pkh2 mutant indicate that Pkh functions upstream of Pkc1. The Pkh2 phosphorylation site in",
    "direct",
    "10567559"
   ]
  ]
 },
 "PA,mTOR": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "our study, mitogenic stimulation of mammalian cells led to a phospholipase D-dependent accumulation of cellular PA, which was required for activation of mTOR downstream effectors. <e1>PA</e1> directly interacted with the domain in <e2>mTOR</e2> that is targeted by rapamycin, and this interaction was positively correlated with mTOR's ability to activate downstream effectors. The involvement of PA in",
    "direct",
    "11729323"
   ],
   [
    "our study, mitogenic stimulation of mammalian cells led to a phospholipase D-dependent accumulation of cellular PA, which was required for activation of mTOR downstream effectors. <e1>PA</e1> directly interacted with the domain in <e2>mTOR</e2> that is targeted by rapamycin, and this interaction was positively correlated with mTOR's ability to activate downstream effectors. The involvement of PA in",
    "direct",
    "11729323"
   ]
  ]
 },
 "Bub3,Mad2": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "<e1>Bub3</e1> interaction with <e2>Mad2</e2>, Mad3 and Cdc20 is mediated by WD40 repeats and does not require intact kinetochores. The kinetochore checkpoint pathway, involving the Mad1, Mad2, Mad3,",
    "direct",
    "11726501"
   ],
   [
    "Cdc20. Formation of the Bub3-Cdc20 complex requires all kinetochore checkpoint proteins but, surprisingly, not intact kinetochores. Conversely, point mutations altering the conserved WD40 motifs of <e1>Bub3</e1>, which might be involved in the formation of a beta-propeller fold devoted to protein-protein interactions, disrupt its association with <e2>Mad2</e2>, Mad3 and Cdc20, as well as proper checkpoint response. We suggest that Bub3 could serve as a platform for interactions between kinetochore checkpoint proteins,",
    "direct",
    "11726501"
   ]
  ]
 },
 "Bub3,Mad3": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "<e1>Bub3</e1> interaction with Mad2, <e2>Mad3</e2> and Cdc20 is mediated by WD40 repeats and does not require intact kinetochores. The kinetochore checkpoint pathway, involving the Mad1, Mad2, Mad3, Bub1, Bub3",
    "direct",
    "11726501"
   ]
  ]
 },
 "Bub3,Cdc20": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "<e1>Bub3</e1> interaction with Mad2, Mad3 and <e2>Cdc20</e2> is mediated by WD40 repeats and does not require intact kinetochores. The kinetochore checkpoint pathway, involving the Mad1, Mad2, Mad3, Bub1, Bub3 and",
    "direct",
    "11726501"
   ]
  ]
 },
 "Cdc20,Mad2": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "mitotic exit by inhibiting the anaphase promoting complex activator Cdc20 in response to monopolar attachment of sister kinetochores to spindle fibres. We show here that <e1>Cdc20</e1>, which had previously been shown to interact physically with <e2>Mad2</e2> and Mad3, associates also with Bub3 and association is up-regulated upon checkpoint activation. Moreover, co-fractionation experiments suggest that Mad2, Mad3 and Bub3 may be",
    "direct",
    "11726501"
   ]
  ]
 },
 "Mad3,Cdc20": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "mitotic exit by inhibiting the anaphase promoting complex activator Cdc20 in response to monopolar attachment of sister kinetochores to spindle fibres. We show here that <e2>Cdc20</e2>, which had previously been shown to interact physically with Mad2 and <e1>Mad3</e1>, associates also with Bub3 and association is up-regulated upon checkpoint activation. Moreover, co-fractionation experiments suggest that Mad2, Mad3 and Bub3 may be concomitantly",
    "direct",
    "11726501"
   ]
  ]
 },
 "Cdc20,Bub3": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "mitotic exit by inhibiting the anaphase promoting complex activator Cdc20 in response to monopolar attachment of sister kinetochores to spindle fibres. We show here that <e1>Cdc20</e1>, which had previously been shown to interact physically with Mad2 and Mad3, associates also with <e2>Bub3</e2> and association is up-regulated upon checkpoint activation. Moreover, co-fractionation experiments suggest that Mad2, Mad3 and Bub3 may be concomitantly present in protein complexes with",
    "direct",
    "11726501"
   ],
   [
    "mitotic exit by inhibiting the anaphase promoting complex activator Cdc20 in response to monopolar attachment of sister kinetochores to spindle fibres. We show here that <e1>Cdc20</e1>, which had previously been shown to interact physically with Mad2 and Mad3, associates also with <e2>Bub3</e2> and association is up-regulated upon checkpoint activation. Moreover, co-fractionation experiments suggest that Mad2, Mad3 and Bub3 may be concomitantly present in protein complexes with",
    "direct",
    "11726501"
   ],
   [
    "Cdc20. Formation of the Bub3-Cdc20 complex requires all kinetochore checkpoint proteins but, surprisingly, not intact kinetochores. Conversely, point mutations altering the conserved WD40 motifs of <e2>Bub3</e2>, which might be involved in the formation of a beta-propeller fold devoted to protein-protein interactions, disrupt its association with Mad2, Mad3 and <e1>Cdc20</e1>, as well as proper checkpoint response. We suggest that Bub3 could serve as a platform for interactions between kinetochore checkpoint proteins, and its association",
    "direct",
    "11726501"
   ],
   [
    "of a beta-propeller fold devoted to protein-protein interactions, disrupt its association with Mad2, Mad3 and Cdc20, as well as proper checkpoint response. We suggest that <e2>Bub3</e2> could serve as a platform for interactions between kinetochore checkpoint proteins, and its association with Mad2, Mad3 and <e1>Cdc20</e1> might be instrumental for checkpoint activation.",
    "direct",
    "11726501"
   ]
  ]
 },
 "Mad3,Bub3": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Cdc20. Formation of the Bub3-Cdc20 complex requires all kinetochore checkpoint proteins but, surprisingly, not intact kinetochores. Conversely, point mutations altering the conserved WD40 motifs of <e2>Bub3</e2>, which might be involved in the formation of a beta-propeller fold devoted to protein-protein interactions, disrupt its association with Mad2, <e1>Mad3</e1> and Cdc20, as well as proper checkpoint response. We suggest that Bub3 could serve as a platform for interactions between kinetochore checkpoint proteins, and",
    "direct",
    "11726501"
   ],
   [
    "of a beta-propeller fold devoted to protein-protein interactions, disrupt its association with Mad2, Mad3 and Cdc20, as well as proper checkpoint response. We suggest that <e2>Bub3</e2> could serve as a platform for interactions between kinetochore checkpoint proteins, and its association with Mad2, <e1>Mad3</e1> and Cdc20 might be instrumental for checkpoint activation.",
    "direct",
    "11726501"
   ]
  ]
 },
 "Mad2,Bub3": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "of a beta-propeller fold devoted to protein-protein interactions, disrupt its association with Mad2, Mad3 and Cdc20, as well as proper checkpoint response. We suggest that <e2>Bub3</e2> could serve as a platform for interactions between kinetochore checkpoint proteins, and its association with <e1>Mad2</e1>, Mad3 and Cdc20 might be instrumental for checkpoint activation.",
    "direct",
    "11726501"
   ]
  ]
 },
 "14-3-3 tau,phosphoserine": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "events that are dependent on DNA damage-responsive protein kinases, such as ATM. How ATM phosphorylation leads to E2F1 stabilization is unknown. We now show that <e1>14-3-3 tau</e1>, a <e2>phosphoserine</e2>-binding protein, mediates E2F1 stabilization. 14-3-3 tau interacts with ATM-phosphorylated E2F1 during DNA damage and inhibits E2F1 ubiquitination. Depletion of 14-3-3 tau or E2F1, but not",
    "direct",
    "15494392"
   ]
  ]
 },
 "14-3-3 tau,E2F1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "kinases, such as ATM. How ATM phosphorylation leads to E2F1 stabilization is unknown. We now show that 14-3-3 tau, a phosphoserine-binding protein, mediates E2F1 stabilization. <e1>14-3-3 tau</e1> interacts with ATM-phosphorylated <e2>E2F1</e2> during DNA damage and inhibits E2F1 ubiquitination. Depletion of 14-3-3 tau or E2F1, but not E2F2 or E2F3, blocks adriamycin-induced apoptosis. 14-3-3 tau is",
    "direct",
    "15494392"
   ]
  ]
 },
 "ATM,E2F1": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "How ATM phosphorylation leads to E2F1 stabilization is unknown. We now show that 14-3-3 tau, a phosphoserine-binding protein, mediates E2F1 stabilization. 14-3-3 tau interacts with <e1>ATM</e1>-phosphorylated <e2>E2F1</e2> during DNA damage and inhibits E2F1 ubiquitination. Depletion of 14-3-3 tau or E2F1, but not E2F2 or E2F3, blocks adriamycin-induced apoptosis. 14-3-3 tau is",
    "direct",
    "15494392"
   ]
  ]
 },
 "protein kinase A catalytic subunit,nuclear factor-kappaB": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "DNA binding of repressor <e2>nuclear factor-kappaB</e2> p50/p50 depends on phosphorylation of Ser337 by the <e1>protein kinase A catalytic subunit</e1>. The NF-kappaB p50/p50 homodimer is mainly associated with transcriptional repression. Previously, we demonstrated that phosphorylation of NF-kappaB p50 Ser(337) is critical for DNA binding.",
    "direct",
    "15642694"
   ]
  ]
 },
 "protein kinase A catalytic subunit,p50p50": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "DNA binding of repressor nuclear factor-kappaB <e2>p50/p50</e2> depends on phosphorylation of Ser337 by the <e1>protein kinase A catalytic subunit</e1>. The NF-kappaB p50/p50 homodimer is mainly associated with transcriptional repression. Previously, we demonstrated that phosphorylation of NF-kappaB p50 Ser(337) is critical for DNA binding.",
    "direct",
    "15642694"
   ]
  ]
 },
 "NF-kappaB,p50p50": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "DNA binding of repressor nuclear factor-kappaB p50/p50 depends on phosphorylation of Ser337 by the protein kinase A catalytic subunit. The <e1>NF-kappaB</e1> <e2>p50/p50</e2> homodimer is mainly associated with transcriptional repression. Previously, we demonstrated that phosphorylation of NF-kappaB p50 Ser(337) is critical for DNA binding. Here, we report",
    "direct",
    "15642694"
   ]
  ]
 },
 "PKAc,p50": {
  "relations": [
   "controls-phosphorylation-of",
   "in-complex-with",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "homodimer is mainly associated with transcriptional repression. Previously, we demonstrated that phosphorylation of NF-kappaB p50 Ser(337) is critical for DNA binding. Here, we report that <e2>p50</e2> Ser(337) is constitutively phosphorylated by the protein kinase A catalytic subunit (<e1>PKAc</e1>) in three different cell types, which may account for the constant binding of p50/p50 to DNA in unstimulated cells. This was demonstrated first by",
    "direct",
    "15642694"
   ],
   [
    "to DNA in unstimulated cells. This was demonstrated first by showing that treatment of cells with PKAc-specific inhibitors blocked p50/p50 DNA binding. Second, phosphorylation of <e2>p50</e2> by <e1>PKAc</e1> was prevented by substitution of Ser(337) to alanine. Third, both p50 and PKAc proteins as well as kinase activity that phosphorylates p50 were",
    "direct",
    "15642694"
   ],
   [
    "to alanine. Third, both p50 and PKAc proteins as well as kinase activity that phosphorylates p50 were found to co-fractionate following gel filtration chromatography. Finally, <e1>PKAc</e1> and <e2>p50</e2> were shown to be able to reciprocally co-immunoprecipitate one another, and their physical association was blocked by a PKA catalytic site inhibitory peptide.",
    "direct",
    "15642694"
   ],
   [
    "be able to reciprocally co-immunoprecipitate one another, and their physical association was blocked by a PKA catalytic site inhibitory peptide. This indicates that phosphorylation of <e2>p50</e2> Ser(337) involves direct contact with the <e1>PKAc</e1> catalytic center. In contrast to the dramatic elevation of nuclear p50/p65 heterodimers induced by tumor necrosis factor alpha, DNA binding of p50/p50 homodimers",
    "direct",
    "15642694"
   ],
   [
    "DNA binding of p50/p50 homodimers was not greatly altered. Taken together, these findings reveal for the first time that there is a direct interaction between <e1>PKAc</e1> and <e2>p50</e2> that accounts for constitutive phosphorylation of p50 Ser(337) and the existence of DNA bound p50/p50 in the nuclei of most resting cells. This",
    "direct",
    "15642694"
   ],
   [
    "DNA binding of p50/p50 homodimers was not greatly altered. Taken together, these findings reveal for the first time that there is a direct interaction between <e1>PKAc</e1> and p50 that accounts for constitutive phosphorylation of <e2>p50</e2> Ser(337) and the existence of DNA bound p50/p50 in the nuclei of most resting cells. This mechanism of DNA binding by p50/p50 following",
    "direct",
    "15642694"
   ]
  ]
 },
 "PKAc,p50p50": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "constitutive phosphorylation of p50 Ser(337) and the existence of DNA bound p50/p50 in the nuclei of most resting cells. This mechanism of DNA binding by <e2>p50/p50</e2> following phosphorylation of Ser(337) by <e1>PKAc</e1> may represent an important means for maintaining stable negative regulation of NF-kappaB gene expression in the absence of extracellular stimulation.",
    "direct",
    "15642694"
   ]
  ]
 },
 "ASF1,histone H3": {
  "relations": [
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "Acetylation of lysine 56 of <e2>histone H3</e2> catalyzed by RTT109 and regulated by <e1>ASF1</e1> is required for replisome integrity. In budding yeast, acetylation of histone H3 lysine 56 (H3-K56) is catalyzed by the Rtt109-Vps75 histone acetyltransferase (HAT)",
    "direct",
    "17690098"
   ]
  ]
 },
 "Asf1,H3": {
  "relations": [
   "in-complex-with",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "being the catalytic subunit, and histone chaperone Asf1 is required for this modification. Cells lacking Rtt109 are susceptible to perturbations in DNA replication. However, how <e1>Asf1</e1> regulates acetylation of <e2>H3</e2>-K56 and how loss of H3-K56 acetylation affects DNA replication are unclear. We show that at low concentrations the Rtt109-Vps75 HAT complex acetylates H3-K56",
    "direct",
    "17690098"
   ],
   [
    "how loss of H3-K56 acetylation affects DNA replication are unclear. We show that at low concentrations the Rtt109-Vps75 HAT complex acetylates H3-K56 in vitro when <e2>H3</e2>/H4 is complexed with <e1>Asf1</e1>, but not H3/H4 tetramers, recapitulating the in vivo requirement of Asf1 for H3-K56 acetylation using recombinant proteins. Moreover, the Rtt109-Vps75 complex interacts with Asf1-H3/H4",
    "direct",
    "17690098"
   ],
   [
    "concentrations the Rtt109-Vps75 HAT complex acetylates H3-K56 in vitro when H3/H4 is complexed with Asf1, but not H3/H4 tetramers, recapitulating the in vivo requirement of <e1>Asf1</e1> for <e2>H3</e2>-K56 acetylation using recombinant proteins. Moreover, the Rtt109-Vps75 complex interacts with Asf1-H3/H4 but not Asf1. In vivo, the Rtt109-Asf1 interaction is also dependent on",
    "direct",
    "17690098"
   ],
   [
    "Asf1 to bind H3/H4. Furthermore, the Rtt109 homolog in Schizosaccharomyces pombe (SpRtt109) also displayed an Asf1-dependent H3-K56 HAT activity in vitro. These results indicate that <e1>Asf1</e1> regulates <e2>H3</e2>-K56 acetylation by presenting histones H3 and H4 to Rtt109-Vps575 for acetylation, and this mechanism is likely to be conserved. Finally, we have shown that",
    "direct",
    "17690098"
   ]
  ]
 },
 "HAT,H3": {
  "relations": [
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "how Asf1 regulates acetylation of H3-K56 and how loss of H3-K56 acetylation affects DNA replication are unclear. We show that at low concentrations the Rtt109-Vps75 <e1>HAT</e1> complex acetylates <e2>H3</e2>-K56 in vitro when H3/H4 is complexed with Asf1, but not H3/H4 tetramers, recapitulating the in vivo requirement of Asf1 for H3-K56 acetylation using recombinant",
    "direct",
    "17690098"
   ]
  ]
 },
 "Rtt109-Vps75,H3": {
  "relations": [
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "However, how Asf1 regulates acetylation of H3-K56 and how loss of H3-K56 acetylation affects DNA replication are unclear. We show that at low concentrations the <e1>Rtt109-Vps75</e1> HAT complex acetylates <e2>H3</e2>-K56 in vitro when H3/H4 is complexed with Asf1, but not H3/H4 tetramers, recapitulating the in vivo requirement of Asf1 for H3-K56 acetylation using recombinant",
    "direct",
    "17690098"
   ]
  ]
 },
 "H4,Asf1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "how loss of H3-K56 acetylation affects DNA replication are unclear. We show that at low concentrations the Rtt109-Vps75 HAT complex acetylates H3-K56 in vitro when H3/<e1>H4</e1> is complexed with <e2>Asf1</e2>, but not H3/H4 tetramers, recapitulating the in vivo requirement of Asf1 for H3-K56 acetylation using recombinant proteins. Moreover, the Rtt109-Vps75 complex interacts with Asf1-H3/H4",
    "direct",
    "17690098"
   ]
  ]
 },
 "H3H4,H3": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "how loss of H3-K56 acetylation affects DNA replication are unclear. We show that at low concentrations the Rtt109-Vps75 HAT complex acetylates H3-K56 in vitro when <e2>H3</e2>/H4 is complexed with Asf1, but not <e1>H3/H4</e1> tetramers, recapitulating the in vivo requirement of Asf1 for H3-K56 acetylation using recombinant proteins. Moreover, the Rtt109-Vps75 complex interacts with Asf1-H3/H4 but not Asf1.",
    "direct",
    "17690098"
   ]
  ]
 },
 "H4,H3H4": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "how loss of H3-K56 acetylation affects DNA replication are unclear. We show that at low concentrations the Rtt109-Vps75 HAT complex acetylates H3-K56 in vitro when H3/<e1>H4</e1> is complexed with Asf1, but not <e2>H3/H4</e2> tetramers, recapitulating the in vivo requirement of Asf1 for H3-K56 acetylation using recombinant proteins. Moreover, the Rtt109-Vps75 complex interacts with Asf1-H3/H4 but not Asf1.",
    "direct",
    "17690098"
   ]
  ]
 },
 "Rtt109-Vps75,Asf1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "when H3/H4 is complexed with Asf1, but not H3/H4 tetramers, recapitulating the in vivo requirement of Asf1 for H3-K56 acetylation using recombinant proteins. Moreover, the <e1>Rtt109-Vps75</e1> complex interacts with Asf1-H3/H4 but not <e2>Asf1</e2>. In vivo, the Rtt109-Asf1 interaction is also dependent on the ability of Asf1 to bind H3/H4. Furthermore, the Rtt109 homolog in Schizosaccharomyces pombe",
    "direct",
    "17690098"
   ]
  ]
 },
 "Asf1-H3,Rtt109-Vps75": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "when H3/H4 is complexed with Asf1, but not H3/H4 tetramers, recapitulating the in vivo requirement of Asf1 for H3-K56 acetylation using recombinant proteins. Moreover, the <e2>Rtt109-Vps75</e2> complex interacts with <e1>Asf1-H3</e1>/H4 but not Asf1. In vivo, the Rtt109-Asf1 interaction is also dependent on the ability of Asf1 to bind H3/H4. Furthermore, the Rtt109 homolog in",
    "direct",
    "17690098"
   ]
  ]
 },
 "Rtt109-Vps75,H4": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "when H3/H4 is complexed with Asf1, but not H3/H4 tetramers, recapitulating the in vivo requirement of Asf1 for H3-K56 acetylation using recombinant proteins. Moreover, the <e1>Rtt109-Vps75</e1> complex interacts with Asf1-H3/<e2>H4</e2> but not Asf1. In vivo, the Rtt109-Asf1 interaction is also dependent on the ability of Asf1 to bind H3/H4. Furthermore, the Rtt109 homolog in Schizosaccharomyces",
    "direct",
    "17690098"
   ]
  ]
 },
 "Asf1,H3H4": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "using recombinant proteins. Moreover, the Rtt109-Vps75 complex interacts with Asf1-H3/H4 but not Asf1. In vivo, the Rtt109-Asf1 interaction is also dependent on the ability of <e1>Asf1</e1> to bind <e2>H3/H4</e2>. Furthermore, the Rtt109 homolog in Schizosaccharomyces pombe (SpRtt109) also displayed an Asf1-dependent H3-K56 HAT activity in vitro. These results indicate that Asf1 regulates H3-K56",
    "direct",
    "17690098"
   ]
  ]
 },
 "Snf4,Snf1": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "Regulation of <e2>Snf1</e2> kinase. Activation requires phosphorylation of threonine 210 by an upstream kinase as well as a distinct step mediated by the <e1>Snf4</e1> subunit. The yeast Snf1 kinase and its metazoan orthologues, the AMP-activated protein kinases, are activated in response to nutrient limitation. Activation requires the",
    "direct",
    "11486005"
   ]
  ]
 },
 "Snf1,Snf1": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "threonine 210 correlates with Snf1 activity, since it is detected in cells subjected to glucose limitation but not in cells grown in abundant glucose. A <e2>Snf1</e2><e1>Snf1</e1> mutant completely lacking kinase activity was phosphorylated normally on threonine 210 in glucose-starved cells, eliminating the possibility that the threonine 210 modification is due to",
    "direct",
    "11486005"
   ]
  ]
 },
 "SWI6,SWI4": {
  "relations": [
   "controls-expression-of"
  ],
  "mentions": [
   [
    "at least one other periodically regulated element must be present. Since SWI6 is known to bind to MCBs and regulate their activity, the role of <e1>SWI6</e1> in <e2>SWI4</e2> expression was analyzed. Although the MCBs cannot account for the full cell cycle regulation of SWI4, mutations in SWI6 eliminate the normal periodicity",
    "direct",
    "8497280"
   ]
  ]
 },
 "Cdc2-cyclin B1,Myt1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "forms of Myt1 lacking the interaction domain exhibited normal trafficking of cyclin B1 and unperturbed cell cycle progression. These results suggest that the docking of <e1>Cdc2-cyclin B1</e1> complexes to the COOH terminus of <e2>Myt1</e2> facilitates the phosphorylation of Cdc2 by Myt1 and that overproduction of Myt1 perturbs cell cycle progression by sequestering Cdc2-cyclin B1 complexes in the",
    "direct",
    "10373560"
   ]
  ]
 },
 "spermidinespermine N(1) -acetyl-transferase,spermine": {
  "relations": [
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "Genomic identification and biochemical characterization of a second spermidine/spermine N1-acetyltransferase. In the polyamine back-conversion pathway, <e2>spermine</e2> and spermidine are first acetylated by <e1>spermidine/spermine N(1) -acetyl-transferase</e1> (SSAT-1) and then oxidized by polyamine oxidase to produce spermidine and putrescine respectively. Herein we apply homology-search methods to identify novel sequences belonging to a",
    "direct",
    "12803540"
   ]
  ]
 },
 "spermidinespermine N(1) -acetyl-transferase,spermidine": {
  "relations": [
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "Genomic identification and biochemical characterization of a second spermidine/spermine N1-acetyltransferase. In the polyamine back-conversion pathway, spermine and <e2>spermidine</e2> are first acetylated by <e1>spermidine/spermine N(1) -acetyl-transferase</e1> (SSAT-1) and then oxidized by polyamine oxidase to produce spermidine and putrescine respectively. Herein we apply homology-search methods to identify novel sequences belonging to a",
    "direct",
    "12803540"
   ]
  ]
 },
 "mTORC1,PRAS40": {
  "relations": [
   "controls-phosphorylation-of",
   "in-complex-with",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "required for signaling downstream of this complex. Signaling through the mammalian target of rapamycin complex 1 (mTORC1) is positively regulated by amino acids and insulin. <e2>PRAS40</e2> associates with <e1>mTORC1</e1> (which contains raptor) but not mTORC2. PRAS40 interacts with raptor, and this requires an intact TOR-signaling (TOS) motif in PRAS40. Like TOS motif-containing proteins",
    "direct",
    "17604271"
   ],
   [
    "mTORC2. PRAS40 interacts with raptor, and this requires an intact TOR-signaling (TOS) motif in PRAS40. Like TOS motif-containing proteins such as eIF4E-binding protein 1 (4E-BP1), <e2>PRAS40</e2> is a substrate for phosphorylation by <e1>mTORC1</e1>. Consistent with this, starvation of cells of amino acids or treatment with rapamycin alters the phosphorylation of PRAS40. PRAS40 binds 14-3-3 proteins, and this",
    "direct",
    "17604271"
   ]
  ]
 },
 "mTORC2,PRAS40": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "required for signaling downstream of this complex. Signaling through the mammalian target of rapamycin complex 1 (mTORC1) is positively regulated by amino acids and insulin. <e2>PRAS40</e2> associates with mTORC1 (which contains raptor) but not <e1>mTORC2</e1>. PRAS40 interacts with raptor, and this requires an intact TOR-signaling (TOS) motif in PRAS40. Like TOS motif-containing proteins such as eIF4E-binding protein 1 (4E-BP1),",
    "direct",
    "17604271"
   ]
  ]
 },
 "raptor,PRAS40": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "mammalian target of rapamycin complex 1 (mTORC1) is positively regulated by amino acids and insulin. PRAS40 associates with mTORC1 (which contains raptor) but not mTORC2. <e2>PRAS40</e2> interacts with <e1>raptor</e1>, and this requires an intact TOR-signaling (TOS) motif in PRAS40. Like TOS motif-containing proteins such as eIF4E-binding protein 1 (4E-BP1), PRAS40 is a substrate",
    "direct",
    "17604271"
   ]
  ]
 },
 "mTORC1,eIF4E-binding protein 1": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "contains raptor) but not mTORC2. PRAS40 interacts with raptor, and this requires an intact TOR-signaling (TOS) motif in PRAS40. Like TOS motif-containing proteins such as <e2>eIF4E-binding protein 1</e2> (4E-BP1), PRAS40 is a substrate for phosphorylation by <e1>mTORC1</e1>. Consistent with this, starvation of cells of amino acids or treatment with rapamycin alters the phosphorylation of PRAS40. PRAS40 binds 14-3-3 proteins, and this",
    "direct",
    "17604271"
   ]
  ]
 },
 "rapamycin,PRAS40": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "as eIF4E-binding protein 1 (4E-BP1), PRAS40 is a substrate for phosphorylation by mTORC1. Consistent with this, starvation of cells of amino acids or treatment with <e1>rapamycin</e1> alters the phosphorylation of <e2>PRAS40</e2>. PRAS40 binds 14-3-3 proteins, and this requires both amino acids and insulin. Binding of PRAS40 to 14-3-3 proteins is inhibited by TSC1/2 (negative regulators",
    "direct",
    "17604271"
   ]
  ]
 },
 "14-3-3,PRAS40": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "amino acids or treatment with rapamycin alters the phosphorylation of PRAS40. PRAS40 binds 14-3-3 proteins, and this requires both amino acids and insulin. Binding of <e2>PRAS40</e2> to <e1>14-3-3</e1> proteins is inhibited by TSC1/2 (negative regulators of mTORC1) and stimulated by Rheb in a rapamycin-sensitive manner. This confirms that PRAS40 is a target",
    "direct",
    "17604271"
   ]
  ]
 },
 "Tir,TNFalpha receptor-associated factor": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "receptor (Tir) effector has a potent and specific ability to inhibit NF-kappaB activation. Indeed, biochemical, imaging and immunoprecipitation studies reveal a novel inhibitory mechanism whereby <e1>Tir</e1> interaction with cytoplasm-located <e2>TNFalpha receptor-associated factor</e2> (TRAF) adaptor proteins induces their proteasomal-independent degradation. Infection studies support this Tir-TRAF relationship but reveal that Tir, like NleC and NleH, has a non-essential",
    "direct",
    "22144899"
   ]
  ]
 },
 "GSK3,TSC2": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "Inoki et al. (2006) report that the kinases GSK3 and AMPK cooperate in the activation of TSC2 to inhibit mTOR activity. Surprisingly, the phosphorylation of <e2>TSC2</e2> by <e1>GSK3</e1> is markedly suppressed by Wnt signaling. This suggests that components of the mTOR pathway may be therapeutic targets for diseases linked to hyperactive",
    "direct",
    "16959561"
   ]
  ]
 },
 "TP53,HLA": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "genotyped 114 cases and 414 newborn controls from Wales (UK) for polymorphisms in TP53 (R72P), its negative regulator MDM2 (single-nucleotide polymorphism SNP309, rs2279744), and selected <e2>HLA</e2> complex genes whose products interact with <e1>TP53</e1>. TP53 R72P showed a risk association with gene dosage effect (P=0.002) resulting in a strong association of homozygous genotype (OR=2.9, 95% CI=1.5-5.6) and no",
    "direct",
    "19837266"
   ]
  ]
 },
 "quercetin,PML": {
  "relations": [
   "controls-expression-of"
  ],
  "mentions": [
   [
    "[Study of the effects of <e1>quercetin</e1> on <e2>PML</e2> gene and protein expression and localization in leukemia cells]. OBJECTIVE: To investigate PML gene and protein expression and localization in leukemia cell lines.",
    "direct",
    "12015078"
   ]
  ]
 },
 "Pyrin,Pyrin": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "alpha-helix (residues 1-19) is necessary and sufficient for both inflammasome and NF-kappaB inhibitory functions. Further, key acidic residues Glu(6), Asp(8), and Glu(16), believed critical for <e1>Pyrin</e1>/<e2>Pyrin</e2> domain interaction, are important for inflammasome inhibition. Moreover, these mutations did not reduce the effect of POP2 upon NF-kappaB, indicating that the inflammasome and NF-kappaB",
    "direct",
    "21976665"
   ]
  ]
 },
 "IKKbeta,TSC1": {
  "relations": [
   "controls-phosphorylation-of",
   "in-complex-with",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "tumor suppressor complex serves as a repressor of the mTOR pathway, and disruption of TSC1/TSC2 complex function may contribute to tumorigenesis. Here we show that <e1>IKKbeta</e1>, a major downstream kinase in the TNFalpha signaling pathway, physically interacts with and phosphorylates <e2>TSC1</e2> at Ser487 and Ser511, resulting in suppression of TSC1. The IKKbeta-mediated TSC1 suppression activates the mTOR pathway, enhances angiogenesis, and results in tumor development.",
    "direct",
    "17693255"
   ],
   [
    "tumor suppressor complex serves as a repressor of the mTOR pathway, and disruption of TSC1/TSC2 complex function may contribute to tumorigenesis. Here we show that <e1>IKKbeta</e1>, a major downstream kinase in the TNFalpha signaling pathway, physically interacts with and phosphorylates <e2>TSC1</e2> at Ser487 and Ser511, resulting in suppression of TSC1. The IKKbeta-mediated TSC1 suppression activates the mTOR pathway, enhances angiogenesis, and results in tumor development.",
    "direct",
    "17693255"
   ],
   [
    "tumor suppressor complex serves as a repressor of the mTOR pathway, and disruption of TSC1/TSC2 complex function may contribute to tumorigenesis. Here we show that <e1>IKKbeta</e1>, a major downstream kinase in the TNFalpha signaling pathway, physically interacts with and phosphorylates <e2>TSC1</e2> at Ser487 and Ser511, resulting in suppression of TSC1. The IKKbeta-mediated TSC1 suppression activates the mTOR pathway, enhances angiogenesis, and results in tumor development.",
    "direct",
    "17693255"
   ]
  ]
 },
 "retinol,cellular retinol-binding protein": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "an intermediate. Several retinol dehydrogenase (RDH) enzymes, members of the short-chain dehydrogenase/reductase (SDR) gene superfamily, catalyze the first and rate-limiting step that generates retinaldehyde from <e1>retinol</e1> bound to <e2>cellular retinol-binding protein</e2> (holo-CRBP). However, little is known about these enzymes and their genes in the epidermal cells. Our work describes the first member of the RDH",
    "direct",
    "10329026"
   ]
  ]
 },
 "CRBP,all-trans-retinol": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "and that it is under positive, feed-forward regulation by retinoic acid. It encodes a protein that, using NAD+ as a preferred cofactor, utilizes free and <e1>CRBP</e1>-bound <e2>all-trans-retinol</e2> and steroids as substrates.",
    "direct",
    "10329026"
   ]
  ]
 },
 "calcineurin,NFAT": {
  "relations": [
   "controls-phosphorylation-of",
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "Blockade of NFAT activation by the second calcineurin binding site. Activation of <e2>NFAT</e2> transcription factors requires their dephosphorylation by the phosphatase <e1>calcineurin</e1> (CN). NFATs contain two CN binding motifs: PxIxIT and CnBP-B/CNBR2 (which we call LxVP). Here we carry out a detailed comparative analysis of the CN",
    "direct",
    "16407284"
   ]
  ]
 },
 "NFATs,CN": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "calcineurin (CN). NFATs contain two CN binding motifs: PxIxIT and CnBP-B/CNBR2 (which we call LxVP). Here we carry out a detailed comparative analysis of the <e2>CN</e2> binding activity displayed by the PxIxIT and LxVP sites from different <e1>NFATs</e1>. Dose-response CN binding experiments with GST fusion proteins of NFATc1 and NFATc2 showed that NFATc1 binds CN in vitro more efficiently than does NFATc2.",
    "direct",
    "16407284"
   ]
  ]
 },
 "CN,NFATc1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "activity displayed by the PxIxIT and LxVP sites from different NFATs. Dose-response CN binding experiments with GST fusion proteins of NFATc1 and NFATc2 showed that <e2>NFATc1</e2> binds <e1>CN</e1> in vitro more efficiently than does NFATc2. This difference in binding appears to be caused by the different CN binding potencies of the",
    "direct",
    "16407284"
   ],
   [
    "activity displayed by the PxIxIT and LxVP sites from different NFATs. Dose-response CN binding experiments with GST fusion proteins of NFATc1 and NFATc2 showed that <e2>NFATc1</e2> binds <e1>CN</e1> in vitro more efficiently than does NFATc2. This difference in binding appears to be caused by the different CN binding potencies of the",
    "direct",
    "16407284"
   ]
  ]
 },
 "NFATc2,CN": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "by the PxIxIT and LxVP sites from different NFATs. Dose-response CN binding experiments with GST fusion proteins of NFATc1 and NFATc2 showed that NFATc1 binds <e2>CN</e2> in vitro more efficiently than does <e1>NFATc2</e1>. This difference in binding appears to be caused by the different CN binding potencies of the corresponding LxVP sites; thus while the LxVPc2 peptide",
    "direct",
    "16407284"
   ],
   [
    "by the PxIxIT and LxVP sites from different NFATs. Dose-response CN binding experiments with GST fusion proteins of NFATc1 and NFATc2 showed that NFATc1 binds <e2>CN</e2> in vitro more efficiently than does <e1>NFATc2</e1>. This difference in binding appears to be caused by the different CN binding potencies of the corresponding LxVP sites; thus while the LxVPc2 peptide",
    "direct",
    "16407284"
   ]
  ]
 },
 "CN,LxVPc2": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "than does NFATc2. This difference in binding appears to be caused by the different CN binding potencies of the corresponding LxVP sites; thus while the <e2>LxVPc2</e2> peptide fused to GST did not bind <e1>CN</e1>, GST-LxVPc1 bound it more efficiently than did GST-PxIxITc1 or GST-PxIxITc2. Furthermore, an NFATc2 chimera protein containing the LxVP motif from NFATc1 interacted with",
    "direct",
    "16407284"
   ]
  ]
 },
 "CN,GST-LxVPc1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "to be caused by the different CN binding potencies of the corresponding LxVP sites; thus while the LxVPc2 peptide fused to GST did not bind <e1>CN</e1>, <e2>GST-LxVPc1</e2> bound it more efficiently than did GST-PxIxITc1 or GST-PxIxITc2. Furthermore, an NFATc2 chimera protein containing the LxVP motif from NFATc1 interacted with CN much more",
    "direct",
    "16407284"
   ]
  ]
 },
 "CN,GST-PxIxITc1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "to be caused by the different CN binding potencies of the corresponding LxVP sites; thus while the LxVPc2 peptide fused to GST did not bind <e1>CN</e1>, GST-LxVPc1 bound it more efficiently than did <e2>GST-PxIxITc1</e2> or GST-PxIxITc2. Furthermore, an NFATc2 chimera protein containing the LxVP motif from NFATc1 interacted with CN much more potently than did wild-type NFATc2. Free peptides",
    "direct",
    "16407284"
   ]
  ]
 },
 "CN,GST-PxIxITc2": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "to be caused by the different CN binding potencies of the corresponding LxVP sites; thus while the LxVPc2 peptide fused to GST did not bind <e1>CN</e1>, GST-LxVPc1 bound it more efficiently than did GST-PxIxITc1 or <e2>GST-PxIxITc2</e2>. Furthermore, an NFATc2 chimera protein containing the LxVP motif from NFATc1 interacted with CN much more potently than did wild-type NFATc2. Free peptides spanning the",
    "direct",
    "16407284"
   ]
  ]
 },
 "CN,NFATc2": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "sites; thus while the LxVPc2 peptide fused to GST did not bind CN, GST-LxVPc1 bound it more efficiently than did GST-PxIxITc1 or GST-PxIxITc2. Furthermore, an <e2>NFATc2</e2> chimera protein containing the LxVP motif from NFATc1 interacted with <e1>CN</e1> much more potently than did wild-type NFATc2. Free peptides spanning the LxVP motifs from NFATc1, c3 or c4 displaced CN from GST-NFATc1 and",
    "direct",
    "16407284"
   ],
   [
    "bind CN, GST-LxVPc1 bound it more efficiently than did GST-PxIxITc1 or GST-PxIxITc2. Furthermore, an NFATc2 chimera protein containing the LxVP motif from NFATc1 interacted with <e1>CN</e1> much more potently than did wild-type <e2>NFATc2</e2>. Free peptides spanning the LxVP motifs from NFATc1, c3 or c4 displaced CN from GST-NFATc1 and GST-NFATc2 more efficiently than any PxIxIT peptide. PxIxITc2",
    "direct",
    "16407284"
   ]
  ]
 },
 "GST-NFATc1,CN": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "motif from NFATc1 interacted with CN much more potently than did wild-type NFATc2. Free peptides spanning the LxVP motifs from NFATc1, c3 or c4 displaced <e2>CN</e2> from <e1>GST-NFATc1</e1> and GST-NFATc2 more efficiently than any PxIxIT peptide. PxIxITc2 and LxVPc1 peptides were each able to cross-compete GST-LxVPc1-CN and GST-PxIxITc2-CN binding. In contrast with PxIxITc2,",
    "direct",
    "16407284"
   ]
  ]
 },
 "GST-NFATc2,CN": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "motif from NFATc1 interacted with CN much more potently than did wild-type NFATc2. Free peptides spanning the LxVP motifs from NFATc1, c3 or c4 displaced <e2>CN</e2> from GST-NFATc1 and <e1>GST-NFATc2</e1> more efficiently than any PxIxIT peptide. PxIxITc2 and LxVPc1 peptides were each able to cross-compete GST-LxVPc1-CN and GST-PxIxITc2-CN binding. In contrast with PxIxITc2, the LxVP",
    "direct",
    "16407284"
   ]
  ]
 },
 "CN,NFAT": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "PxIxIT peptide. PxIxITc2 and LxVPc1 peptides were each able to cross-compete GST-LxVPc1-CN and GST-PxIxITc2-CN binding. In contrast with PxIxITc2, the LxVP peptide not only blocked <e1>CN</e1>-<e2>NFAT</e2> binding but also inhibited CN phosphatase activity in vitro. Furthermore, exogenous LxVPc1 blocked NFATc2 phosphorylation and nuclear translocation in vivo. These results suggest a model",
    "direct",
    "16407284"
   ]
  ]
 },
 "alpha-tubulin,beta-tubulin": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "investigated tubulin and actin biogenesis in Chinese hamster ovary (CHO) cells. When extracts of pulse-labeled cells were analyzed by anion-exchange and size-exclusion chromatography, newly synthesized <e1>alpha-tubulin</e1>, <e2>beta-tubulin</e2>, and actin were observed to enter a large molecular mass complex (approximately 900 kDa). These proteins were released from this complex capable, in the case",
    "direct",
    "8105476"
   ],
   [
    "investigated tubulin and actin biogenesis in Chinese hamster ovary (CHO) cells. When extracts of pulse-labeled cells were analyzed by anion-exchange and size-exclusion chromatography, newly synthesized <e1>alpha-tubulin</e1>, <e2>beta-tubulin</e2>, and actin were observed to enter a large molecular mass complex (approximately 900 kDa). These proteins were released from this complex capable, in the case",
    "direct",
    "8105476"
   ]
  ]
 },
 "alpha-tubulin,actin": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "investigated tubulin and actin biogenesis in Chinese hamster ovary (CHO) cells. When extracts of pulse-labeled cells were analyzed by anion-exchange and size-exclusion chromatography, newly synthesized <e1>alpha-tubulin</e1>, beta-tubulin, and <e2>actin</e2> were observed to enter a large molecular mass complex (approximately 900 kDa). These proteins were released from this complex capable, in the case of",
    "direct",
    "8105476"
   ],
   [
    "investigated tubulin and actin biogenesis in Chinese hamster ovary (CHO) cells. When extracts of pulse-labeled cells were analyzed by anion-exchange and size-exclusion chromatography, newly synthesized <e1>alpha-tubulin</e1>, beta-tubulin, and <e2>actin</e2> were observed to enter a large molecular mass complex (approximately 900 kDa). These proteins were released from this complex capable, in the case of",
    "direct",
    "8105476"
   ]
  ]
 },
 "beta-tubulin,actin": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "tubulin and actin biogenesis in Chinese hamster ovary (CHO) cells. When extracts of pulse-labeled cells were analyzed by anion-exchange and size-exclusion chromatography, newly synthesized alpha-tubulin, <e1>beta-tubulin</e1>, and <e2>actin</e2> were observed to enter a large molecular mass complex (approximately 900 kDa). These proteins were released from this complex capable, in the case of",
    "direct",
    "8105476"
   ],
   [
    "tubulin and actin biogenesis in Chinese hamster ovary (CHO) cells. When extracts of pulse-labeled cells were analyzed by anion-exchange and size-exclusion chromatography, newly synthesized alpha-tubulin, <e1>beta-tubulin</e1>, and <e2>actin</e2> were observed to enter a large molecular mass complex (approximately 900 kDa). These proteins were released from this complex capable, in the case of",
    "direct",
    "8105476"
   ]
  ]
 },
 "tubulin,actin": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "mass complexes coeluted with TCP1 and could be immunoprecipitated by using an anti-TCP1 antibody. These findings demonstrate that there is a cytosolic pathway for folding <e1>tubulin</e1> and <e2>actin</e2> in vivo that involves the TCP1 complex.",
    "direct",
    "8105476"
   ]
  ]
 },
 "E2F6,EZH2": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "A novel repressive <e1>E2F6</e1> complex containing the polycomb group protein, EPC1, that interacts with <e2>EZH2</e2> in a proliferation-specific manner. The transcriptional repressor E2F6 has been identified as a component of two distinct polycomb group protein (PcG)-containing complexes, suggesting",
    "direct",
    "15536069"
   ]
  ]
 },
 "E2F6,EPC1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "repression of classic E2F target genes in G0, a role for E2F6 within the cell cycle has yet to be defined. We searched for novel <e1>E2F6</e1>-binding proteins using a yeast two-hybrid screen and identified the PcG protein, <e2>EPC1</e2>. We showed that, both in vitro and in vivo, E2F6, DP1, and EPC1 form a stable core complex with repressive activity. Furthermore, we identified",
    "direct",
    "15536069"
   ],
   [
    "searched for novel E2F6-binding proteins using a yeast two-hybrid screen and identified the PcG protein, EPC1. We showed that, both in vitro and in vivo, <e1>E2F6</e1>, DP1, and <e2>EPC1</e2> form a stable core complex with repressive activity. Furthermore, we identified the proliferation-specific PcG, EZH2, as an EPC1-interacting protein. Using affinity purification, we",
    "direct",
    "15536069"
   ]
  ]
 },
 "E2F6,DP1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "searched for novel E2F6-binding proteins using a yeast two-hybrid screen and identified the PcG protein, EPC1. We showed that, both in vitro and in vivo, <e1>E2F6</e1>, <e2>DP1</e2>, and EPC1 form a stable core complex with repressive activity. Furthermore, we identified the proliferation-specific PcG, EZH2, as an EPC1-interacting protein. Using affinity purification,",
    "direct",
    "15536069"
   ]
  ]
 },
 "EPC1,DP1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "for novel E2F6-binding proteins using a yeast two-hybrid screen and identified the PcG protein, EPC1. We showed that, both in vitro and in vivo, E2F6, <e2>DP1</e2>, and <e1>EPC1</e1> form a stable core complex with repressive activity. Furthermore, we identified the proliferation-specific PcG, EZH2, as an EPC1-interacting protein. Using affinity purification, we",
    "direct",
    "15536069"
   ]
  ]
 },
 "EZH2,E2F6-EPC1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "for cellular proliferation and consistent with this, EZH2 elutes with the E2F6-EPC1 complex only in proliferating cells. Thus we have identified a novel E2F6-PcG complex (<e2>E2F6-EPC1</e2>) that interacts with <e1>EZH2</e1> and may regulate genes required for cell cycle progression.",
    "direct",
    "15536069"
   ]
  ]
 },
 "E2F,E2F1": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "negative (CHR) control. Chromatin immunoprecipitation assays identify multiple interactions of E2F proteins that include those previously shown to activate and repress transcription. We find that <e2>E2F1</e2>, E2F2, and E2F3 bind to the positive-acting <e1>E2F</e1> site in the cdc2 promoter, whereas E2F4 binds to the negative-acting site. We also find that binding of an activator E2F is dependent on",
    "direct",
    "15510213"
   ]
  ]
 },
 "E2F1,cdc2": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "negative (CHR) control. Chromatin immunoprecipitation assays identify multiple interactions of E2F proteins that include those previously shown to activate and repress transcription. We find that <e1>E2F1</e1>, E2F2, and E2F3 bind to the positive-acting E2F site in the <e2>cdc2</e2> promoter, whereas E2F4 binds to the negative-acting site. We also find that binding of an activator E2F is dependent on an adjacent CCAAT",
    "direct",
    "15510213"
   ]
  ]
 },
 "E2F,E2F2": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "(CHR) control. Chromatin immunoprecipitation assays identify multiple interactions of E2F proteins that include those previously shown to activate and repress transcription. We find that E2F1, <e2>E2F2</e2>, and E2F3 bind to the positive-acting <e1>E2F</e1> site in the cdc2 promoter, whereas E2F4 binds to the negative-acting site. We also find that binding of an activator E2F is dependent on",
    "direct",
    "15510213"
   ]
  ]
 },
 "E2F3,cdc2": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Chromatin immunoprecipitation assays identify multiple interactions of E2F proteins that include those previously shown to activate and repress transcription. We find that E2F1, E2F2, and <e1>E2F3</e1> bind to the positive-acting E2F site in the <e2>cdc2</e2> promoter, whereas E2F4 binds to the negative-acting site. We also find that binding of an activator E2F is dependent on an adjacent CCAAT",
    "direct",
    "15510213"
   ]
  ]
 },
 "E2F,E2F3": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "Chromatin immunoprecipitation assays identify multiple interactions of E2F proteins that include those previously shown to activate and repress transcription. We find that E2F1, E2F2, and <e2>E2F3</e2> bind to the positive-acting <e1>E2F</e1> site in the cdc2 promoter, whereas E2F4 binds to the negative-acting site. We also find that binding of an activator E2F is dependent on",
    "direct",
    "15510213"
   ]
  ]
 },
 "E2F2,cdc2": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "(CHR) control. Chromatin immunoprecipitation assays identify multiple interactions of E2F proteins that include those previously shown to activate and repress transcription. We find that E2F1, <e1>E2F2</e1>, and E2F3 bind to the positive-acting E2F site in the <e2>cdc2</e2> promoter, whereas E2F4 binds to the negative-acting site. We also find that binding of an activator E2F is dependent on an adjacent CCAAT",
    "direct",
    "15510213"
   ]
  ]
 },
 "E2F,E2F4": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "interactions of E2F proteins that include those previously shown to activate and repress transcription. We find that E2F1, E2F2, and E2F3 bind to the positive-acting <e1>E2F</e1> site in the cdc2 promoter, whereas <e2>E2F4</e2> binds to the negative-acting site. We also find that binding of an activator E2F is dependent on an adjacent CCAAT site that is bound",
    "direct",
    "15510213"
   ]
  ]
 },
 "E2F4,cdc2": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "that include those previously shown to activate and repress transcription. We find that E2F1, E2F2, and E2F3 bind to the positive-acting E2F site in the <e2>cdc2</e2> promoter, whereas <e1>E2F4</e1> binds to the negative-acting site. We also find that binding of an activator E2F is dependent on an adjacent CCAAT site that is bound",
    "direct",
    "15510213"
   ]
  ]
 },
 "B-Myb,cdc2": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "the G2-regulated promoters coincides with the activation of the genes, and RNAi-mediated reduction of B-Myb inhibits expression of cyclin B1 and cdc2. The ability of <e1>B-Myb</e1> to interact with the <e2>cdc2</e2> promoter is dependent on an intact E2F binding site. These results thus point to a role for E2Fs, together with B-Myb, which is",
    "direct",
    "15510213"
   ]
  ]
 },
 "NEMO,c-Myc": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "<e1>NEMO</e1> stabilizes <e2>c-Myc</e2> through direct interaction in the nucleus. The transcription factor c-Myc is a cellular oncoprotein generally upregulated in most of human cancers. NF-kappaB essential modulator",
    "direct",
    "20970423"
   ]
  ]
 },
 "c-Myc,NEMO": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "c-Myc through direct interaction in the nucleus. The transcription factor c-Myc is a cellular oncoprotein generally upregulated in most of human cancers. NF-kappaB essential modulator (<e2>NEMO</e2>) caused phosphorylation and stabilization of <e1>c-Myc</e1> protein in the nucleus through direct interaction. The interaction caused reduced ubiquitination of c-Myc by inhibiting ubiquitinating activity of Fbw7 without blocking the",
    "direct",
    "20970423"
   ],
   [
    "enhanced the expression of several selected c-Myc targets. Compared to the classical role as an essential subunit for the activity of IKK complex, stabilization of <e1>c-Myc</e1> by direct interaction is a unique function of <e2>NEMO</e2>, representing a new mechanism to regulate c-Myc activity.",
    "direct",
    "20970423"
   ]
  ]
 },
 "c-Myc,Fbw7": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "protein in the nucleus through direct interaction. The interaction caused reduced ubiquitination of c-Myc by inhibiting ubiquitinating activity of Fbw7 without blocking the interaction between <e1>c-Myc</e1> and <e2>Fbw7</e2>. As a consequence, NEMO enhanced the expression of several selected c-Myc targets. Compared to the classical role as an essential subunit for the",
    "direct",
    "20970423"
   ]
  ]
 },
 "p300,-3": {
  "relations": [
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "and -3 belong to a structural and functional subfamily distinct from those of the other E2F family members. Here we report that E2F-1, -2, and <e2>-3</e2>, but not E2F-4, -5, and -6, associate with and are acetylated by <e1>p300</e1> and cAMP-response element-binding protein acetyltransferases. Acetylation occurs at three conserved lysine residues located at the N-terminal boundary of their DNA binding domains. Acetylation",
    "direct",
    "10753885"
   ]
  ]
 },
 "p300,E2F-4": {
  "relations": [
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "to a structural and functional subfamily distinct from those of the other E2F family members. Here we report that E2F-1, -2, and -3, but not <e2>E2F-4</e2>, -5, and -6, associate with and are acetylated by <e1>p300</e1> and cAMP-response element-binding protein acetyltransferases. Acetylation occurs at three conserved lysine residues located at the N-terminal boundary of their DNA binding domains. Acetylation",
    "direct",
    "10753885"
   ]
  ]
 },
 "cAMP-response element-binding protein,E2F-4": {
  "relations": [
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "to a structural and functional subfamily distinct from those of the other E2F family members. Here we report that E2F-1, -2, and -3, but not <e2>E2F-4</e2>, -5, and -6, associate with and are acetylated by p300 and <e1>cAMP-response element-binding protein</e1> acetyltransferases. Acetylation occurs at three conserved lysine residues located at the N-terminal boundary of their DNA binding domains. Acetylation of E2F-1 in vitro and",
    "direct",
    "10753885"
   ]
  ]
 },
 "p300,-5": {
  "relations": [
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "a structural and functional subfamily distinct from those of the other E2F family members. Here we report that E2F-1, -2, and -3, but not E2F-4, <e2>-5</e2>, and -6, associate with and are acetylated by <e1>p300</e1> and cAMP-response element-binding protein acetyltransferases. Acetylation occurs at three conserved lysine residues located at the N-terminal boundary of their DNA binding domains. Acetylation",
    "direct",
    "10753885"
   ]
  ]
 },
 "cAMP-response element-binding protein,-5": {
  "relations": [
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "a structural and functional subfamily distinct from those of the other E2F family members. Here we report that E2F-1, -2, and -3, but not E2F-4, <e2>-5</e2>, and -6, associate with and are acetylated by p300 and <e1>cAMP-response element-binding protein</e1> acetyltransferases. Acetylation occurs at three conserved lysine residues located at the N-terminal boundary of their DNA binding domains. Acetylation of E2F-1 in vitro and",
    "direct",
    "10753885"
   ]
  ]
 },
 "p300,-6": {
  "relations": [
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "and functional subfamily distinct from those of the other E2F family members. Here we report that E2F-1, -2, and -3, but not E2F-4, -5, and <e2>-6</e2>, associate with and are acetylated by <e1>p300</e1> and cAMP-response element-binding protein acetyltransferases. Acetylation occurs at three conserved lysine residues located at the N-terminal boundary of their DNA binding domains. Acetylation",
    "direct",
    "10753885"
   ]
  ]
 },
 "cAMP-response element-binding protein,-6": {
  "relations": [
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "and functional subfamily distinct from those of the other E2F family members. Here we report that E2F-1, -2, and -3, but not E2F-4, -5, and <e2>-6</e2>, associate with and are acetylated by p300 and <e1>cAMP-response element-binding protein</e1> acetyltransferases. Acetylation occurs at three conserved lysine residues located at the N-terminal boundary of their DNA binding domains. Acetylation of E2F-1 in vitro and",
    "direct",
    "10753885"
   ]
  ]
 },
 "cAMP-response element-binding protein,-3": {
  "relations": [
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "and -3 belong to a structural and functional subfamily distinct from those of the other E2F family members. Here we report that E2F-1, -2, and <e2>-3</e2>, but not E2F-4, -5, and -6, associate with and are acetylated by p300 and <e1>cAMP-response element-binding protein</e1> acetyltransferases. Acetylation occurs at three conserved lysine residues located at the N-terminal boundary of their DNA binding domains. Acetylation of E2F-1 in vitro and",
    "direct",
    "10753885"
   ]
  ]
 },
 "p300,-2": {
  "relations": [
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "E2F-1, -2, and -3 belong to a structural and functional subfamily distinct from those of the other E2F family members. Here we report that E2F-1, <e2>-2</e2>, and -3, but not E2F-4, -5, and -6, associate with and are acetylated by <e1>p300</e1> and cAMP-response element-binding protein acetyltransferases. Acetylation occurs at three conserved lysine residues located at the N-terminal boundary of their DNA binding domains. Acetylation",
    "direct",
    "10753885"
   ]
  ]
 },
 "cAMP-response element-binding protein,-2": {
  "relations": [
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "E2F-1, -2, and -3 belong to a structural and functional subfamily distinct from those of the other E2F family members. Here we report that E2F-1, <e2>-2</e2>, and -3, but not E2F-4, -5, and -6, associate with and are acetylated by p300 and <e1>cAMP-response element-binding protein</e1> acetyltransferases. Acetylation occurs at three conserved lysine residues located at the N-terminal boundary of their DNA binding domains. Acetylation of E2F-1 in vitro and",
    "direct",
    "10753885"
   ]
  ]
 },
 "p300,E2F-1": {
  "relations": [
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "proliferation. E2F-1, -2, and -3 belong to a structural and functional subfamily distinct from those of the other E2F family members. Here we report that <e2>E2F-1</e2>, -2, and -3, but not E2F-4, -5, and -6, associate with and are acetylated by <e1>p300</e1> and cAMP-response element-binding protein acetyltransferases. Acetylation occurs at three conserved lysine residues located at the N-terminal boundary of their DNA binding domains. Acetylation",
    "direct",
    "10753885"
   ]
  ]
 },
 "cAMP-response element-binding protein,E2F-1": {
  "relations": [
   "controls-state-change-of"
  ],
  "mentions": [
   [
    "proliferation. E2F-1, -2, and -3 belong to a structural and functional subfamily distinct from those of the other E2F family members. Here we report that <e2>E2F-1</e2>, -2, and -3, but not E2F-4, -5, and -6, associate with and are acetylated by p300 and <e1>cAMP-response element-binding protein</e1> acetyltransferases. Acetylation occurs at three conserved lysine residues located at the N-terminal boundary of their DNA binding domains. Acetylation of E2F-1 in vitro and",
    "direct",
    "10753885"
   ]
  ]
 },
 "E2F-1,E2F": {
  "relations": [
   "in-complex-with"
  ],
  "mentions": [
   [
    "p300 and cAMP-response element-binding protein acetyltransferases. Acetylation occurs at three conserved lysine residues located at the N-terminal boundary of their DNA binding domains. Acetylation of <e1>E2F-1</e1> in vitro and in vivo markedly increases its binding affinity for a consensus <e2>E2F</e2> DNA-binding site, which is paralleled by enhanced transactivation of an E2F-responsive promoter. Acetylation of E2F-1 can be reversed by histone deacetylase-1, indicating that reversible",
    "direct",
    "10753885"
   ]
  ]
 }
}